{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T04:59:51.392430",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "520e5b0b-a32c-4972-ab26-e33154577727",
    "instanceType": "Study",
    "versions": [
      {
        "id": "d4868a6f-727b-40b4-96c6-6256cbb2f177",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "62ff64a7-6973-4468-a6b4-43225cfa8fa6",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "a6877025-eb37-4c2c-94f3-151bab838b0d",
              "standardCode": {
                "id": "a56fb168-bf83-441a-972e-9f3a1a3930af",
                "code": "Double Blind",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Double Blind",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Randomized"
            },
            "arms": [
              {
                "id": "220dcde1-c3f3-40f6-962f-36a8ae79e1de",
                "name": "SAR442168 Arm",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants receive 60 mg oral SAR442168 daily plus a placebo matching the teriflunomide tablet.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "b9995241-eab7-4558-b264-ab87e7518298",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "4c6485ad-d37d-4a0e-b651-4150eb99d0d6",
                "name": "Teriflunomide Arm",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants receive 14 mg oral teriflunomide daily plus a placebo matching the SAR442168 tablet.",
                "type": {
                  "id": "C174267",
                  "code": "C174267",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.12e",
                  "decode": "Active Comparator Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "3e42ee00-cbc4-4e8e-bbb6-fa489301b6cc",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [],
            "studyCells": [
              {
                "id": "d99c75bf-4a25-4422-8f79-5f46787518e2",
                "armId": "220dcde1-c3f3-40f6-962f-36a8ae79e1de",
                "epochId": "5d662d97-437a-4465-b8dd-eec29cf64505",
                "elementIds": [
                  "6a4a8abf-d56f-4250-b6e6-ae2861b37822"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "f907d9a4-548f-4572-8780-ee369b6ebd04",
                "armId": "220dcde1-c3f3-40f6-962f-36a8ae79e1de",
                "epochId": "053860d7-6f3d-4f28-af9d-58088638a041",
                "elementIds": [
                  "679e4b55-54f2-4164-92df-2964c18938a3"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "fa8e6743-d6d7-4c5e-8a28-84782804c559",
                "armId": "220dcde1-c3f3-40f6-962f-36a8ae79e1de",
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "elementIds": [
                  "f53fbbe0-ddaf-4f14-8a7b-66df337e4a6b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "cb304878-984d-4b8c-bc7c-38aa3a2cffcc",
                "armId": "4c6485ad-d37d-4a0e-b651-4150eb99d0d6",
                "epochId": "5d662d97-437a-4465-b8dd-eec29cf64505",
                "elementIds": [
                  "efe59c32-d947-439a-906e-085f8b1ccd48"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "7c06d41c-bd51-479f-b2e0-af32320725c3",
                "armId": "4c6485ad-d37d-4a0e-b651-4150eb99d0d6",
                "epochId": "053860d7-6f3d-4f28-af9d-58088638a041",
                "elementIds": [
                  "6352fe2c-54cb-4699-b033-8bbf6109cdbd"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "6b3da134-77c5-4c79-8f56-cb95bf027bb7",
                "armId": "4c6485ad-d37d-4a0e-b651-4150eb99d0d6",
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "elementIds": [
                  "01c97d64-8b6b-4622-a8c1-7c6da2e54ce1"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "6a4a8abf-d56f-4250-b6e6-ae2861b37822",
                "name": "SAR442168 Arm - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for SAR442168 Arm during Screening"
              },
              {
                "id": "679e4b55-54f2-4164-92df-2964c18938a3",
                "name": "SAR442168 Arm - Treatment Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for SAR442168 Arm during Treatment Period"
              },
              {
                "id": "f53fbbe0-ddaf-4f14-8a7b-66df337e4a6b",
                "name": "SAR442168 Arm - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for SAR442168 Arm during Follow-up"
              },
              {
                "id": "efe59c32-d947-439a-906e-085f8b1ccd48",
                "name": "Teriflunomide Arm - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Teriflunomide Arm during Screening"
              },
              {
                "id": "6352fe2c-54cb-4699-b033-8bbf6109cdbd",
                "name": "Teriflunomide Arm - Treatment Period",
                "instanceType": "StudyElement",
                "description": "Treatment period for Teriflunomide Arm during Treatment Period"
              },
              {
                "id": "01c97d64-8b6b-4622-a8c1-7c6da2e54ce1",
                "name": "Teriflunomide Arm - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Teriflunomide Arm during Follow-up"
              }
            ],
            "maskingRoles": [
              {
                "id": "c3bac3a6-aca8-4da8-a23e-b85cc067f225",
                "text": "Subject is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "0f7a0048-46de-49e3-b6b3-662beb66328d",
                "text": "Investigator is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "1f93de6f-04e6-4e88-9c2b-c0571ffec00e",
                "text": "Caregiver is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "ba72aa64-6022-4bc2-b786-f59b06e71f55",
                "text": "Outcome Assessor is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "f8ac5fff-9c4a-4975-a08c-6f0c30033a48",
                "text": "Data Analyst is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "56efc650-171c-4873-a766-8755915dae82",
                "identifier": "I 01",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "99e152af-e3bc-48b3-a0d4-7fe1d362d0a8",
                "instanceType": "EligibilityCriterion",
                "name": "Age requirement",
                "nextId": "0d0e4656-f246-413a-b3a0-f14e94eda34d"
              },
              {
                "id": "0d0e4656-f246-413a-b3a0-f14e94eda34d",
                "identifier": "I 02",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "a0798009-75da-4cd5-bfd3-9a6c5ad60f41",
                "instanceType": "EligibilityCriterion",
                "name": "RMS Diagnosis",
                "previousId": "56efc650-171c-4873-a766-8755915dae82",
                "nextId": "a195d267-13a8-4818-ad62-b48157ce6121"
              },
              {
                "id": "a195d267-13a8-4818-ad62-b48157ce6121",
                "identifier": "I 03",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "343f697e-6c41-42b0-80b0-1dd09f7e3cea",
                "instanceType": "EligibilityCriterion",
                "name": "EDSS Score",
                "previousId": "0d0e4656-f246-413a-b3a0-f14e94eda34d",
                "nextId": "ba25a953-d142-44aa-b086-a7e876471abb"
              },
              {
                "id": "ba25a953-d142-44aa-b086-a7e876471abb",
                "identifier": "I 04",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5b87859f-6159-4dc8-822e-18731d66955a",
                "instanceType": "EligibilityCriterion",
                "name": "Relapse or MRI Activity",
                "previousId": "a195d267-13a8-4818-ad62-b48157ce6121",
                "nextId": "c1496353-e687-4c4d-b3ea-2ec250036cb6"
              },
              {
                "id": "c1496353-e687-4c4d-b3ea-2ec250036cb6",
                "identifier": "I 06",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "af992d15-a8f7-4c31-b395-a435be4642d1",
                "instanceType": "EligibilityCriterion",
                "name": "Sex and Contraception",
                "previousId": "ba25a953-d142-44aa-b086-a7e876471abb",
                "nextId": "bdbb2d38-adce-4ff4-a42b-f3e63a028550"
              },
              {
                "id": "bdbb2d38-adce-4ff4-a42b-f3e63a028550",
                "identifier": "I 07",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "28a6af55-cc9b-49da-95c1-61cbdeba413c",
                "instanceType": "EligibilityCriterion",
                "name": "Informed Consent",
                "previousId": "c1496353-e687-4c4d-b3ea-2ec250036cb6"
              },
              {
                "id": "0bdb464a-230f-49ed-a25f-ba595aeca47c",
                "identifier": "E 01",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "1a028804-0aa2-4bec-a0e3-87b61f2a4414",
                "instanceType": "EligibilityCriterion",
                "name": "PPMS or nonrelapsing SPMS Diagnosis",
                "nextId": "dd9cdaea-9bf7-4e50-9386-964bd5a87353"
              },
              {
                "id": "dd9cdaea-9bf7-4e50-9386-964bd5a87353",
                "identifier": "E 02",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "486ad176-f6a3-4c0c-8672-0354a5c5b874",
                "instanceType": "EligibilityCriterion",
                "name": "Infection Risk",
                "previousId": "0bdb464a-230f-49ed-a25f-ba595aeca47c",
                "nextId": "5c4d9432-07a6-4493-a746-50930544825d"
              },
              {
                "id": "5c4d9432-07a6-4493-a746-50930544825d",
                "identifier": "E 03",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "05c52a97-8035-43c1-9ecb-95574d5cfc48",
                "instanceType": "EligibilityCriterion",
                "name": "Psychiatric or Substance Abuse",
                "previousId": "dd9cdaea-9bf7-4e50-9386-964bd5a87353",
                "nextId": "eefeab03-e0fb-4904-b36f-2961292b3fe8"
              },
              {
                "id": "eefeab03-e0fb-4904-b36f-2961292b3fe8",
                "identifier": "E 04",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b3d604e0-0b73-42e1-835d-fc7673b6671b",
                "instanceType": "EligibilityCriterion",
                "name": "Clinically Significant Screening Findings",
                "previousId": "5c4d9432-07a6-4493-a746-50930544825d",
                "nextId": "44c3c65e-6394-4fb5-bc07-59b7f0273f2e"
              },
              {
                "id": "44c3c65e-6394-4fb5-bc07-59b7f0273f2e",
                "identifier": "E 05",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "70e9a3d1-e4a7-4f96-bfe8-e350f8c8015b",
                "instanceType": "EligibilityCriterion",
                "name": "Bleeding Predisposition",
                "previousId": "eefeab03-e0fb-4904-b36f-2961292b3fe8",
                "nextId": "e5cae1fb-d3b8-43a5-9ea0-37acd8ecec36"
              },
              {
                "id": "e5cae1fb-d3b8-43a5-9ea0-37acd8ecec36",
                "identifier": "E 06",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b8a9e5e2-e5ff-48be-a667-deaab56724ef",
                "instanceType": "EligibilityCriterion",
                "name": "General Participation Contraindications",
                "previousId": "44c3c65e-6394-4fb5-bc07-59b7f0273f2e"
              }
            ],
            "population": {
              "id": "86d2bd9a-07b1-4389-9e68-2a50efdf0d78",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "56efc650-171c-4873-a766-8755915dae82",
                "0d0e4656-f246-413a-b3a0-f14e94eda34d",
                "a195d267-13a8-4818-ad62-b48157ce6121",
                "ba25a953-d142-44aa-b086-a7e876471abb",
                "c1496353-e687-4c4d-b3ea-2ec250036cb6",
                "bdbb2d38-adce-4ff4-a42b-f3e63a028550",
                "0bdb464a-230f-49ed-a25f-ba595aeca47c",
                "dd9cdaea-9bf7-4e50-9386-964bd5a87353",
                "5c4d9432-07a6-4493-a746-50930544825d",
                "eefeab03-e0fb-4904-b36f-2961292b3fe8",
                "44c3c65e-6394-4fb5-bc07-59b7f0273f2e",
                "e5cae1fb-d3b8-43a5-9ea0-37acd8ecec36"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "fe7abdc6-f051-41e3-93f4-33a8e59ee7c0",
                "name": "Primary Efficacy Objective",
                "text": "To evaluate the efficacy of SAR442168 in an intent to treat (ITT) setting",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "794e3730-9561-4bec-9f00-a47f3f947396"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "edfcae77-79b4-4227-afc2-a513e14473a2",
                "name": "Secondary Efficacy Objective - Disability",
                "text": "To assess the benefit of SAR442168 for participants with RMS regarding disability progression",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "a064521c-1fa6-41ac-a971-ae47a80e74d7"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "c6bc17a9-9306-4c2a-bc35-19133feec13b",
                "name": "Secondary Efficacy Objective - MRI",
                "text": "To assess MRI findings of disease activity",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "2d64705f-d0cc-4121-a5b8-fd47e768f694",
                  "18dae3ac-79d3-4725-8736-c9fc518aea34"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "da2fa410-391a-46dd-a7b0-731ddc7df412",
                "name": "Safety Objective",
                "text": "To evaluate the safety and tolerability of SAR442168 in the RMS population",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "9ea0b685-835a-44b1-8400-c55352f3b20b"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "19631ec0-bc37-412e-b8b5-a63159bce348",
                "name": "Exploratory Objective",
                "text": "To provide additional evidence for SAR442168 activity on neuroinflammation and neurodegeneration and the impact of SAR442168 on participantsâ€™ daily living functionality and quality of life",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "e53e6885-42b9-4232-acc0-29632b97638f",
                  "a364c994-5fd5-4107-85d3-efe61899b2a1"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "794e3730-9561-4bec-9f00-a47f3f947396",
                "name": "Primary Efficacy Endpoint",
                "text": "Annualized adjudicated relapse rate (ARR)",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "a064521c-1fa6-41ac-a971-ae47a80e74d7",
                "name": "Key Secondary Efficacy Endpoint",
                "text": "Time to onset of 6-month confirmed disability worsening (CDW)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "2d64705f-d0cc-4121-a5b8-fd47e768f694",
                "name": "Secondary MRI Endpoint - Gd-enhancing lesions",
                "text": "Gd-enhancing T1-hyperintense lesions on MRI",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "18dae3ac-79d3-4725-8736-c9fc518aea34",
                "name": "Secondary MRI Endpoint - T2 lesions",
                "text": "New/enlarging T2-hyperintense lesions",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "9ea0b685-835a-44b1-8400-c55352f3b20b",
                "name": "Safety Endpoints",
                "text": "Treatment-emergent adverse events (TEAEs), clinical laboratory evaluations, safety scales, electrocardiograms (ECGs), and vital signs",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "e53e6885-42b9-4232-acc0-29632b97638f",
                "name": "Exploratory Neuroinflammation Endpoints",
                "text": "Modulation of chronic active lesions (slowly evolving lesions [SEL], T2 phase rims) observed by MRI",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              },
              {
                "id": "a364c994-5fd5-4107-85d3-efe61899b2a1",
                "name": "Exploratory Quality of Life Endpoints",
                "text": "Daily living functionality and quality of life parameters",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "QualityOfLife"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "fbe81d9c-8f95-458a-82e9-86178dcdcdcb",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "41e609b2-171a-417f-915b-be55a74ab573",
                "instances": [
                  {
                    "id": "41e609b2-171a-417f-915b-be55a74ab573",
                    "activityIds": [
                      "0c2933ca-1e7d-4754-b38c-3b8ceffc17dd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_2",
                    "encounterId": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                    "epochId": "053860d7-6f3d-4f28-af9d-58088638a041"
                  },
                  {
                    "id": "becca0d8-746f-4658-a694-ed1016cf2837",
                    "activityIds": [
                      "1dc9ad67-bfac-49bd-aaf9-0fda0c5f7c03"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_2",
                    "encounterId": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                    "epochId": "053860d7-6f3d-4f28-af9d-58088638a041"
                  },
                  {
                    "id": "054c9255-3a50-4cfb-833c-6007d86f6186",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_2",
                    "encounterId": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                    "epochId": "053860d7-6f3d-4f28-af9d-58088638a041"
                  },
                  {
                    "id": "314b2c1c-4a9f-458d-814c-840e6cbb1294",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_6",
                    "encounterId": "2ce2512b-22db-4de0-af2c-91cc01640d3e",
                    "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801"
                  },
                  {
                    "id": "68fd00e8-de41-4ed8-911e-45840092fbc1",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_8",
                    "encounterId": "7c827e9d-542a-4143-bea7-ebdc24a23277",
                    "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801"
                  },
                  {
                    "id": "2cfefe2d-3f8f-41c2-b8c2-5286045b7979",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_10",
                    "encounterId": "f5be94d0-4bde-4c54-b071-492980b87efa",
                    "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801"
                  },
                  {
                    "id": "289aaf79-b8af-4ddc-886d-bbc1316b34fc",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_14",
                    "encounterId": "2ceba77c-d3ca-446f-b03b-c14a75e3baf7",
                    "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801"
                  },
                  {
                    "id": "9b38aa13-8372-40c1-9672-f03b429e6f2b",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_16",
                    "encounterId": "5dab25d8-491b-4a69-8bad-b87b06ef0693",
                    "epochId": "9d0fadf6-4b30-41e6-9c43-67294882423f"
                  },
                  {
                    "id": "a90405fb-62c1-4b67-a61b-23657a5fa131",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_17",
                    "encounterId": "bff4a144-f181-4cd1-8675-84597c2a19d1",
                    "epochId": "d16ca637-2d31-44af-a9e2-9e43bb656dd6"
                  },
                  {
                    "id": "e5c0e675-a3ce-400e-9fbd-9086c4b13278",
                    "activityIds": [
                      "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_18",
                    "encounterId": "9267c461-e897-4c5e-b79c-5399a533e3c1",
                    "epochId": "938a28d6-8773-4f3a-b3a2-7dc5c9913207"
                  },
                  {
                    "id": "1abf39f1-f8d7-4296-90db-f69f916b2444",
                    "activityIds": [
                      "df3107a0-a496-4a9f-8a78-550782733e37"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_2",
                    "encounterId": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                    "epochId": "053860d7-6f3d-4f28-af9d-58088638a041"
                  },
                  {
                    "id": "743f5417-895f-48d1-9c85-b97c75a0cc68",
                    "activityIds": [
                      "df3107a0-a496-4a9f-8a78-550782733e37"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_8",
                    "encounterId": "7c827e9d-542a-4143-bea7-ebdc24a23277",
                    "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801"
                  },
                  {
                    "id": "9969e356-5bbb-487a-9aa5-99a5599ae602",
                    "activityIds": [
                      "df3107a0-a496-4a9f-8a78-550782733e37"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_10",
                    "encounterId": "f5be94d0-4bde-4c54-b071-492980b87efa",
                    "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801"
                  },
                  {
                    "id": "4110d245-34bb-4a5b-9fe1-dd9e9f2accab",
                    "activityIds": [
                      "df3107a0-a496-4a9f-8a78-550782733e37"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_14",
                    "encounterId": "2ceba77c-d3ca-446f-b03b-c14a75e3baf7",
                    "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801"
                  },
                  {
                    "id": "21869097-1ee5-48e9-be26-2e8f929fe42a",
                    "activityIds": [
                      "df3107a0-a496-4a9f-8a78-550782733e37"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_16",
                    "encounterId": "5dab25d8-491b-4a69-8bad-b87b06ef0693",
                    "epochId": "9d0fadf6-4b30-41e6-9c43-67294882423f"
                  },
                  {
                    "id": "c50dca4b-3d64-4ef5-aff8-0014746f652d",
                    "activityIds": [
                      "df3107a0-a496-4a9f-8a78-550782733e37"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_17",
                    "encounterId": "bff4a144-f181-4cd1-8675-84597c2a19d1",
                    "epochId": "d16ca637-2d31-44af-a9e2-9e43bb656dd6"
                  },
                  {
                    "id": "943ead44-dcae-4f20-88d1-ab1d7be86546",
                    "activityIds": [
                      "df3107a0-a496-4a9f-8a78-550782733e37"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_18",
                    "encounterId": "9267c461-e897-4c5e-b79c-5399a533e3c1",
                    "epochId": "938a28d6-8773-4f3a-b3a2-7dc5c9913207"
                  },
                  {
                    "id": "c9560072-f19e-48d2-a7d0-1ae13b9410ce",
                    "name": "InformedConsent",
                    "description": "Event anchor: InformedConsent",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "a4682977-117e-44eb-bed8-202c78da8cee",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "f1fc50ab-fae7-401c-942b-43e200698665",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 10
                      }
                    ],
                    "epochId": "bd2710dc-0010-4279-bd78-0d3160f2649f",
                    "scheduledDay": 1
                  },
                  {
                    "id": "13c3b66d-e074-4b3d-9331-29e01b6a0ba5",
                    "name": "Screening",
                    "description": "Visit anchor: Screening",
                    "encounterId": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                    "epochId": "bd2710dc-0010-4279-bd78-0d3160f2649f",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "a4682977-117e-44eb-bed8-202c78da8cee",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "f1fc50ab-fae7-401c-942b-43e200698665",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 20
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "3a554015-174b-4761-b6f6-f13c52ec96a4",
                    "name": "Randomization",
                    "description": "Event anchor: Randomization",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "a4682977-117e-44eb-bed8-202c78da8cee",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "f1fc50ab-fae7-401c-942b-43e200698665",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 40
                      }
                    ],
                    "epochId": "bd2710dc-0010-4279-bd78-0d3160f2649f",
                    "scheduledDay": 1
                  },
                  {
                    "id": "df38c7bf-1a72-4d42-b528-ea9dcfddda5a",
                    "name": "FirstDose",
                    "description": "Event anchor: FirstDose",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "a4682977-117e-44eb-bed8-202c78da8cee",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "f1fc50ab-fae7-401c-942b-43e200698665",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 60
                      }
                    ],
                    "epochId": "bd2710dc-0010-4279-bd78-0d3160f2649f",
                    "scheduledDay": 1
                  },
                  {
                    "id": "f6c0f747-9c63-49cc-b3a8-8cd7e4e7018a",
                    "name": "Anchor: Safety Follow-up Visit",
                    "activityIds": [],
                    "encounterId": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "81800523-265a-431a-ac77-24c26c9c61c0",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "4273dbc1-0d91-46b8-ac96-524ecff9d4a3",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "053860d7-6f3d-4f28-af9d-58088638a041"
                  },
                  {
                    "id": "7f0c718d-4ac7-4ee0-86ef-13ea346aba5c",
                    "name": "Anchor: Emergency Visit Window Expansion",
                    "activityIds": [],
                    "encounterId": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "ed685e93-88f8-4eab-b0d8-ab6077946ac9",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "550ea01a-9b29-4e01-85d0-ec70d6102515",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "053860d7-6f3d-4f28-af9d-58088638a041"
                  }
                ],
                "timings": [
                  {
                    "id": "a6686f87-50bb-43ff-af2d-3c559adacb15",
                    "name": "Screening Period",
                    "type": {
                      "id": "e6181fe6-c68f-476c-974f-06d90d7e4348",
                      "code": "C71152",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Between",
                      "instanceType": "Code"
                    },
                    "value": "P28D",
                    "valueLabel": "Day 28",
                    "relativeToFrom": {
                      "id": "e0484237-add9-4ac3-8a49-571bb3256df6",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "13c3b66d-e074-4b3d-9331-29e01b6a0ba5",
                    "instanceType": "Timing",
                    "windowLower": "-P28D",
                    "windowUpper": "-P1D"
                  },
                  {
                    "id": "3ace19b5-b249-40d1-b2a3-cb0ef5c3d643",
                    "name": "Screening to Randomization Interval",
                    "type": {
                      "id": "33b8a146-6ef5-4019-8b5d-391ff3beac10",
                      "code": "C71152",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Between",
                      "instanceType": "Code"
                    },
                    "value": "P11D",
                    "valueLabel": "Day 11",
                    "relativeToFrom": {
                      "id": "85edf3b8-53f2-48a8-bf4c-37bee5de9b35",
                      "code": "C71158",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Screening",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "3a554015-174b-4761-b6f6-f13c52ec96a4",
                    "instanceType": "Timing",
                    "windowLower": "P11D",
                    "windowUpper": "P28D"
                  },
                  {
                    "id": "2687c7f5-75da-4d03-8e9f-8b87daefe297",
                    "name": "MRI Rescheduling Extension",
                    "type": {
                      "id": "76f95cc7-495e-42d0-9b9f-79492ce6fee9",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P7D",
                    "valueLabel": "Day 7",
                    "relativeToFrom": {
                      "id": "8f4e65c8-52bb-4d36-ae4f-5b7e8a2295ae",
                      "code": "C71158",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Screening",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "4e9cfb03-2239-4561-b61d-46e04cc69a80",
                    "instanceType": "Timing",
                    "windowLower": "P0D",
                    "windowUpper": "P7D"
                  },
                  {
                    "id": "07dc18ce-4212-40a3-a32b-7a25d42b21ed",
                    "name": "Post-D1 MRI Window",
                    "type": {
                      "id": "d21a5eba-0882-4f27-a4bd-3c389a1c7c8c",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P0D",
                    "valueLabel": "Day 0",
                    "relativeToFrom": {
                      "id": "310333da-e2fb-4a38-8fee-d5442181dcca",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "f873d964-6452-4db0-8185-ebd7f88ded8f",
                    "instanceType": "Timing",
                    "windowLower": "-P21D",
                    "windowUpper": "P21D"
                  },
                  {
                    "id": "306bc3ad-a608-4f23-8d5a-7c2336c9d83d",
                    "name": "Safety Follow-up Visit",
                    "type": {
                      "id": "69ac9d79-6cfe-496e-9133-bc267faf72ef",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P4W",
                    "valueLabel": "4 weeks",
                    "relativeToFrom": {
                      "id": "041bf21f-aaea-41f0-ac07-8bb1b7fc36c8",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "f6c0f747-9c63-49cc-b3a8-8cd7e4e7018a",
                    "instanceType": "Timing",
                    "windowLower": "P28W",
                    "windowUpper": "P28W"
                  },
                  {
                    "id": "228b20c5-f477-4d8d-968a-41500069df40",
                    "name": "Emergency Visit Window Expansion",
                    "type": {
                      "id": "0afd6381-554b-4332-8794-579cbad17e94",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P0D",
                    "valueLabel": "Day 0",
                    "relativeToFrom": {
                      "id": "8042ceac-dd9b-4dcd-9474-23361e13f25d",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "7f0c718d-4ac7-4ee0-86ef-13ea346aba5c",
                    "instanceType": "Timing",
                    "windowLower": "-P14D",
                    "windowUpper": "P14D"
                  },
                  {
                    "id": "1bd29cb6-1f25-4f99-a3e7-b21ea0f09572",
                    "name": "Lab Retest Confirmation",
                    "type": {
                      "id": "1b569405-e83b-44ab-87e5-eb9a80171f84",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "PT24H",
                    "valueLabel": "24 hours",
                    "relativeToFrom": {
                      "id": "c30de3e1-40a4-4dcd-a485-0b6421af72d8",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "c93e640c-3a4e-4d5d-b0ff-6919e8507cdb",
                    "instanceType": "Timing",
                    "windowLower": "PT24H",
                    "windowUpper": "PT24H"
                  }
                ],
                "exits": [
                  {
                    "id": "b3363b6e-0e7a-430f-9065-ca0a8d56a3d8",
                    "name": "Lost to Follow Up",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Repeated failure to return for visits and 3 failed phone contact attempts plus a certified letter."
                  },
                  {
                    "id": "dedd76ed-a987-4599-94d5-bea44fe188a4",
                    "name": "Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Completion of all periods including the EOS visit, regardless of IMP status."
                  },
                  {
                    "id": "ebc38585-ab83-4460-b2f9-6692e48253b9",
                    "name": "Transition to Long-term Safety Study",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Participants completing the trial on IMP may roll over into the LTS study."
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "16e9a951-fc02-49e2-9cd4-055f0eada6a0",
                "name": "Screening (D-28 to D-1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "78aad3b4-3333-4218-9a77-4e4cd6ad8700",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Visit",
                  "instanceType": "Code"
                },
                "epochId": "5d662d97-437a-4465-b8dd-eec29cf64505",
                "extensionAttributes": [
                  {
                    "id": "7e7f6108-563f-461a-90c4-19a8945c91f6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "54c9ca05-8196-481a-b9fe-dc16bdd76ac4",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "014e6cd9-27a5-46ff-ba55-d5492a33b153",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -28
                  }
                ]
              },
              {
                "id": "baa7cdc3-fb8b-4053-9dd9-fedeb185c908",
                "name": "Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "5cf46028-7e4e-4de4-b64e-3fe51f043952",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "053860d7-6f3d-4f28-af9d-58088638a041",
                "extensionAttributes": [
                  {
                    "id": "0a670662-1d94-4711-bdde-310f75c60950",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "46e3383e-d38c-418a-b494-0788b417a837",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "160e7b75-0424-41fd-aa09-5cbbbed9b909",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "9267c461-e897-4c5e-b79c-5399a533e3c1",
                "name": "EOS Common study end date visit",
                "instanceType": "Encounter",
                "type": {
                  "id": "e907c308-58ed-4658-a8a8-051aa75ef4a7",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "End of Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "938a28d6-8773-4f3a-b3a2-7dc5c9913207",
                "extensionAttributes": [
                  {
                    "id": "39a08362-a6e1-4733-ab3f-7c2c435084db",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "66fbae36-77e3-41d3-bf9c-affb0fe4a638",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "bc4e7da6-04f0-4e27-a08b-977b010f6ef8",
                "name": "Follow-up visit (4 weeks)",
                "instanceType": "Encounter",
                "type": {
                  "id": "ae543c01-c1d3-4695-9e06-a60d7e8fdf1f",
                  "code": "C98777",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Visit",
                  "instanceType": "Code"
                },
                "epochId": "bd2710dc-0010-4279-bd78-0d3160f2649f",
                "extensionAttributes": [
                  {
                    "id": "61960cb4-e98f-4187-b6e3-622922d54c2f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "cf60e7e9-b848-464a-ac4d-16a6c9f7f73f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "ce335f3e-7eca-4fa7-94f3-f44168fb8b5f",
                "name": "M0.5 (W2) M0.75 (W3)",
                "instanceType": "Encounter",
                "type": {
                  "id": "33f02926-b908-4873-a0a9-8196c68ac0ab",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "b92e2639-1589-4636-af07-a8b2b6f0c8eb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6afca5f6-32f7-4bf1-ac10-bbfc19957f0f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "f0ba8667-0201-4fa4-87de-efb0dc30603d",
                "name": "M1 (W4)",
                "instanceType": "Encounter",
                "type": {
                  "id": "ff26d556-472c-4041-aca6-0b0120cc8047",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "edd30bae-c813-496d-bdad-1e192f115a60",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "51c713ed-c059-4edd-810b-1c40155b0a62",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "6ac95c81-9a10-4094-bfe7-b77b3a208134",
                "name": "M1.25 (W5) M1.5 (W6) M1.75 (W7)",
                "instanceType": "Encounter",
                "type": {
                  "id": "3ce43461-9015-4021-ac60-37d4ca570612",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "55f3804b-04e5-43f7-9669-006435ed877c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "189e5bfc-d1d5-433c-9b24-f589de5bfa92",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "9ba74323-e870-4990-9298-5a7b74b51a83",
                "name": "M10, M11",
                "instanceType": "Encounter",
                "type": {
                  "id": "bacb7607-dc25-4bba-9fe7-35650be9e155",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "389f2e7c-4f13-4147-888c-490bfdb0e815",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "51ae5247-5dfb-4840-b68d-09feebf251bb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "2ceba77c-d3ca-446f-b03b-c14a75e3baf7",
                "name": "M12",
                "instanceType": "Encounter",
                "type": {
                  "id": "d8d73224-b6f9-4e42-8a9c-241820553c04",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "4aca9b00-7aae-4343-b6de-ec1ca0e61dc5",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c0cd5dcd-8f9a-4447-917e-5b261ee4ba36",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "2ce2512b-22db-4de0-af2c-91cc01640d3e",
                "name": "M2 (W8)",
                "instanceType": "Encounter",
                "type": {
                  "id": "6b3f959c-11ec-4a2a-bd98-5dfcf9473d68",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "f4e7f215-5de2-4c10-9ad4-682ebaa7e395",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1d293a32-8a8c-471c-8da3-ecfa4e9211ec",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "903d269d-c8c7-46d7-8ae6-eaf36586ebb1",
                "name": "M2.25 (W9) M2.5 (W10) M2.75 (W11)",
                "instanceType": "Encounter",
                "type": {
                  "id": "ece62788-f72c-443b-869a-b4e3631e1675",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "12d04b6a-e84b-4a90-b556-7e7cc9a0c484",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b9cb90ec-7038-4486-a28f-6febbdd6ab4d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "7c827e9d-542a-4143-bea7-ebdc24a23277",
                "name": "M3",
                "instanceType": "Encounter",
                "type": {
                  "id": "9563e320-039a-4567-b752-9da09b44a0b1",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "39bfbdfc-bd6c-4cb7-92cc-535ee55d594a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "63ba1cf1-e906-4b53-adee-4084d8eef64b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "7aacb400-6d9b-42a5-9d2e-ab21b11f23eb",
                "name": "M4, M5",
                "instanceType": "Encounter",
                "type": {
                  "id": "fa029a38-c3a8-44d0-807b-704228b10c29",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "0d76bcc7-aa87-4255-a508-5f2744630918",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "14d8b399-2333-4ef9-a9c3-d772733106d1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "f5be94d0-4bde-4c54-b071-492980b87efa",
                "name": "M6",
                "instanceType": "Encounter",
                "type": {
                  "id": "c307afa4-eb98-46bf-a7d0-b48845bd8fa9",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "7c54de1b-d4d9-4580-bc61-f4e7032d89eb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7f9fd907-d5bc-4f45-a60e-02e25e17be57",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "be58b318-a043-4c12-a3fb-a08ec87dae8c",
                "name": "M7, M8",
                "instanceType": "Encounter",
                "type": {
                  "id": "fa77d061-d494-438d-8842-ec75313f18c6",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "b44f40cb-7fd2-48ea-9d63-4f57bb8bc1c1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "a5b30e20-1ac5-4e80-bf48-adaf0338e43b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "3baad402-07d3-4ab9-b236-083266606596",
                "name": "M9",
                "instanceType": "Encounter",
                "type": {
                  "id": "44ca2bf5-214d-4211-b63c-18d338949428",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "extensionAttributes": [
                  {
                    "id": "be11281a-caa6-4b9c-a518-c9e7e0727378",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e53c4572-8317-444a-bced-6fbd35702cb8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "fa22d86f-b66f-4acb-96bf-1e0dd896a804",
                "name": "Quarterly visits (M15 to M36...)",
                "instanceType": "Encounter",
                "type": {
                  "id": "a1ba463c-d775-4c15-b7dc-3aa1652f7766",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "9d0fadf6-4b30-41e6-9c43-67294882423f",
                "extensionAttributes": [
                  {
                    "id": "cda2f4dc-0bca-4b8f-9ff4-aa72f149fd2b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "48cf5d40-8448-4e0e-8f24-a8d8c317cbd5",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "5dab25d8-491b-4a69-8bad-b87b06ef0693",
                "name": "Semi-annual visits (M18 to M36...)",
                "instanceType": "Encounter",
                "type": {
                  "id": "8b2d9f20-14d1-4d39-aca2-e4294d718184",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "9d0fadf6-4b30-41e6-9c43-67294882423f",
                "extensionAttributes": [
                  {
                    "id": "d7063e20-5c2b-4cd6-ae95-b847d1cf30bb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1aa44130-5f7f-4c18-bbda-08e044045a9a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "bff4a144-f181-4cd1-8675-84597c2a19d1",
                "name": "pEOT",
                "instanceType": "Encounter",
                "type": {
                  "id": "9dc9e0fc-f6b1-48d5-b44b-dbb1b2de66d5",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "d16ca637-2d31-44af-a9e2-9e43bb656dd6",
                "extensionAttributes": [
                  {
                    "id": "0ce05afd-dfd7-47fe-aaac-9171842eebcf",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6ca683d2-95b9-4986-ac20-6e87d5bf6578",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "16a58fd2-3254-47be-9a76-8e1dec577ce0",
                "name": "9-hole peg test",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "16a58fd2-3254-47be-9a76-8e1dec577ce0",
                    "name": "9-hole peg test",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "937b016b-93b8-4910-b5f4-9564a413b565",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "9-HPT",
                    "description": "Quantitative measure of upper extremity (arm and hand) function"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c9aeeef4-0a6e-4600-acbe-7ef326ad8412",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "d8741779-bf56-4082-a7a2-509c05d3bb32",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "298df7e8-0927-431e-984d-904a04d0a8e0",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "1dc9ad67-bfac-49bd-aaf9-0fda0c5f7c03",
                "name": "Blood sample for archiving",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6cef7a9f-7b8d-4eae-9061-3c7f9699c36b",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "2b00625e-6086-43af-bb5f-f6051ec0808c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "95f41152-b364-422c-ad12-6c3718a53ba3",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "0c2933ca-1e7d-4754-b38c-3b8ceffc17dd",
                "name": "DNA sample",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "828f1d1a-d127-4fad-ba59-7121b770e0a6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "67eac73a-b369-4e58-8426-f6c935e18675",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "95cb6ed9-fb55-4d07-bb06-e5d90ed96b4e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b3df6fd2-f07e-49b2-acb0-fd239016e8c4",
                "name": "Electrocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "b3df6fd2-f07e-49b2-acb0-fd239016e8c4",
                    "name": "Electrocardiogram",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "e98ab414-b7f1-4601-b46f-5a53ea1ff716",
                      "code": "93000",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "12-lead ECG",
                    "description": "Monitoring of cardiac electrical activity"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c7a3a4de-3a62-48be-a88a-ad8f13fa277d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "9db0e148-9cd9-4ec9-8991-00aa450391ff",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "a5cb1a86-a68e-40ec-83d6-706cec6aba21",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "20f8caef-a335-4f6c-a261-bb2e616668a8",
                "name": "Expanded Disability Status Scale",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "20f8caef-a335-4f6c-a261-bb2e616668a8",
                    "name": "Expanded Disability Status Scale",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "72d11fa4-6a9f-45a4-b76e-e7f24f7d63cc",
                      "code": "EDSS",
                      "codeSystem": "Standardized Scale",
                      "codeSystemVersion": "",
                      "decode": "Expanded Disability Status Scale",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "EDSS Assessment",
                    "description": "Standardized assessment of disability in multiple sclerosis"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e78163a1-d4f3-472f-b6b9-8c8ec25d8a87",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "40ed03b9-6b2d-4968-add2-5e5f41da2a29",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "e66dee56-bde5-42e0-a4ff-7e5a57f3d812",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "02c82108-504d-45f6-adc8-6b9e63242ca7",
                "name": "Magnetic Resonance Imaging",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "02c82108-504d-45f6-adc8-6b9e63242ca7",
                    "name": "Magnetic Resonance Imaging",
                    "procedureType": "Imaging Technique",
                    "code": {
                      "id": "b1ec12f0-9050-4bd2-bfad-9c15f10ad695",
                      "code": "70551",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "MRI Brain without contrast",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "MRI Scan",
                    "description": "Brain imaging with and without gadolinium contrast to detect lesions"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b51a75c4-10d3-44a7-b1c4-23259ee12e92",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "c8281a07-4ae0-464b-bb80-0f91b64f40e9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "3ca3fce8-2ceb-4fcc-b2a7-641414c623e3",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "766ec4d2-69dc-46ca-8585-200232deb6f7",
                "name": "Physical Examination",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "766ec4d2-69dc-46ca-8585-200232deb6f7",
                    "name": "Physical Examination",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "4e68a6ac-7716-4798-bc4a-9047a463bb56",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Physical Exam",
                    "description": "Complete or brief physical and neurological examination"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "8eb75cc8-04ac-4577-bd66-d67a3a001311",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "76d2d5a7-4f88-4a56-8487-d2e81b9b0faf",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "7077770e-5278-4938-88fd-577df54a34f9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a",
                "name": "Plasma samples (NfL), serum samples (Chi3L1)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "fca19790-523b-4d76-be0d-a4ca966b6d0d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3a173bde-f81d-4d18-a5d1-34e6e2768d1a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "68a4bc55-6158-4809-8601-23ee8d4a0372",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "df3107a0-a496-4a9f-8a78-550782733e37",
                "name": "Serum samples (Ig levels)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6ce7fb2c-29e7-4418-88de-a8ddc1eb0e3a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3979a278-7c26-4e13-b013-2dd883521798",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "a3ce0f7a-29b2-4fee-99fa-42d0fc302849",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "0f2276b7-5d0b-49cf-bc1d-2c54e68bf190",
                "name": "Symbol Digit Modalities Test",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "0f2276b7-5d0b-49cf-bc1d-2c54e68bf190",
                    "name": "Symbol Digit Modalities Test",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "761a8e25-fec6-41ac-a417-d1d2ad663d05",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "SDMT",
                    "description": "Cognitive test assessing processing speed"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d916f279-efdf-49a0-8c0c-bc212da944cd",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "feb914b1-c357-4675-8950-f10ee5b060e2",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "f42c2d2a-8db5-454d-b168-1580c89f790a",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "489ede47-760a-4f27-aaab-627be052bb62",
                "name": "Timed 25-foot walk test",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "489ede47-760a-4f27-aaab-627be052bb62",
                    "name": "Timed 25-foot walk test",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "68e2c225-2dac-41ac-8535-379f87b98165",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "T25-FW",
                    "description": "Quantitative measure of mobility and leg function"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1a168af8-fbcd-49f7-a227-c2c54511927d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "c20dbdf7-6847-4363-9517-86959bf3fc4c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "d2d20c8a-3469-42d4-bf73-b49a613f4cb5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e6150a2b-55e8-46fd-b0a6-42ae3bb4707a",
                "name": "Urine Collection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "e6150a2b-55e8-46fd-b0a6-42ae3bb4707a",
                    "name": "Urine Collection",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "274a43e3-ec34-4a35-9835-b04efc3fc02c",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Urinalysis/Pregnancy Test",
                    "description": "Collection of urine for pregnancy testing"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "bd523433-f18f-429b-a1e5-fc764b31a60b",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "96d0cda4-15e3-4432-b67a-f6e3791d92d6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "41debb93-aa2a-415e-a616-76dab033ec93",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "959bceae-4890-4d83-b83c-4e4415546eca",
                "name": "Venipuncture",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "959bceae-4890-4d83-b83c-4e4415546eca",
                    "name": "Venipuncture",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "dc848fcc-d808-426e-b8c4-1fd9bf97069b",
                      "code": "36415",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Collection of venous blood by venipuncture",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Blood Draw",
                    "description": "Collection of blood for hematology, biochemistry, and biomarkers"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4ccba336-3a08-439d-bcda-088cd7a60d7c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "86f003b6-6139-45e8-87c0-bff807c2fba7",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "33565eef-de89-4d8e-8473-745cc663af5d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d05202da-e2a5-4d76-b674-fd9f0786602e",
                "name": "Vital Signs Monitoring",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "d05202da-e2a5-4d76-b674-fd9f0786602e",
                    "name": "Vital Signs Monitoring",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "afc63ee6-156e-4532-a727-ec667daf002d",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Vital Signs",
                    "description": "Measurement of blood pressure, heart rate, and temperature"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e9a24286-8137-4c2d-81ef-9e93744cf3ba",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "ff0619c8-6d07-4d2d-a412-132a2816fedc",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "92c22383-c505-4468-9a5f-c3234ebf3206",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "5d662d97-437a-4465-b8dd-eec29cf64505",
                "name": "Screening",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "693f3e3c-a6d9-4cce-9969-95d48916bf4c",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "759a2885-e322-4013-b576-7c6b52ba165f",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "41b6cdb6-76fe-42d6-8291-f628758e2e9f",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "0012a1cc-b837-4c97-b22a-772cd71540e9",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "e3c8c9b6-375e-415e-b77a-3a6df562e801",
                "name": "Year 1 (M12)",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "9f1c005a-1629-4d30-85fb-f1e4bb404ba6",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "da20280e-05a7-491b-ba77-930e1a5141b4",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "10a808e1-fd1f-4cbe-b0e1-64d59472bca7",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "fe15819d-c10c-49ee-8c65-4364e6eaa5e4",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "2"
                  }
                ]
              },
              {
                "id": "9d0fadf6-4b30-41e6-9c43-67294882423f",
                "name": "From M15 to EOS",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "d8e7a413-6c6a-4380-b0c2-36f687b82183",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "fd0e258d-05ad-49c0-90eb-c927c5742c78",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "8ea033a5-0eba-42d4-8ba1-365bcbc6f028",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "e5a1019b-0bd0-4728-a34f-718641f02ef8",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "3"
                  }
                ]
              },
              {
                "id": "938a28d6-8773-4f3a-b3a2-7dc5c9913207",
                "name": "For all participants",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "e8dac729-2705-428b-a73a-7c85e2af17ae",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "4556e84d-14bd-4633-8d45-1e172d18fa16",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "2dd02ea1-5805-4f53-8704-3459103aefc9",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "ffd3f1fd-38c5-4364-95c4-bd1d5ae216ab",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "4"
                  }
                ]
              },
              {
                "id": "bd2710dc-0010-4279-bd78-0d3160f2649f",
                "name": "Only for participants who completed treatment to EOS but do not enter LTS",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "af247b3c-f49d-4b43-8afc-ccfa2978c48f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "e51d4e3a-ff1d-4911-9d88-fcd55c249549",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "e5c93062-2715-4575-ba17-19fc0e0fb9fa",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "54993c3a-f082-43da-aa9d-70c8602cbb8a",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "5"
                  }
                ]
              },
              {
                "id": "053860d7-6f3d-4f28-af9d-58088638a041",
                "name": "Randomization / Start of IMP",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "728a0f05-93c2-41e9-9401-df2c490c46ea",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "74600ab5-e735-427e-b8ff-6a2a5a0ca97b",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b304881f-9569-4c3f-9bc3-5dcc5a973223",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              },
              {
                "id": "d16ca637-2d31-44af-a9e2-9e43bb656dd6",
                "name": "Only for participants who prematurely discontinue IMP",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "f10a9a39-c4bf-4271-a964-4b72d2878235",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "271646c2-c899-4275-a82e-ca6dbdf694e0",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "af9b2a8a-0a6c-4da5-8c7c-732079ecff93",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "3bea05f6-04fb-4d11-aeca-79a3da10aabd",
                "name": "Pharmacogenetics",
                "description": null,
                "childIds": [
                  "0c2933ca-1e7d-4754-b38c-3b8ceffc17dd"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "DNA sample"
                ]
              },
              {
                "id": "d29e8c36-3a34-4b61-b22e-db135ecb4620",
                "name": "Pharmacodynamics/biomarkers",
                "description": null,
                "childIds": [
                  "1dc9ad67-bfac-49bd-aaf9-0fda0c5f7c03",
                  "cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a",
                  "df3107a0-a496-4a9f-8a78-550782733e37"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Blood sample for archiving",
                  "Plasma samples (NfL), serum samples (Chi3L1)",
                  "Serum samples (Ig levels)"
                ]
              }
            ],
            "notes": [
              {
                "id": "034da9e0-7e68-4eb2-b57c-89c8323c355f",
                "text": "a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs are available at site. The interval between screening and randomization visits can range from 11 days (minimum) to 28 days (maximum). However, if required, the randomization visit can be performed earlier than 11 days upon IMP receipt at the site, assuming the participant is eligible for randomization. In case the screening MRI must be rescheduled (eg, technical issues) or repeated, an additional 1 week (7 days) is allowed.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a38c4e96-f0b6-408d-b903-f3270f29cb24",
                "text": "b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evaluation of an adverse event). Assessments may be done as needed to evaluate the participant in accordance with the Investigator's best judgment and in line with the study protocol. At a minimum, a physical examination should be performed, and, body temperature and vital signs should be measured.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "cf7288e5-349b-4d9f-b017-1c85e2eb7634",
                "text": "c At the EOS, the participants who have completed the study and remain on IMP will be offered participation in a long-term safety study. Follow-up visit assessment only performed for those participants who are not willing to take part in the long-term safety study. For other situations where a follow-up visit is needed, please see Section 7.1 and the Study Manual.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "2b30dd2f-f5e4-4a2f-8b76-120617ce6ec1",
                "text": "d These visits may be done as home health visits (where applicable) or onsite visits (preferable that tests are performed at the central laboratory). In any situations where this is not possible (to be documented in source documents), the tests for these visits may be performed at a local laboratory.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "69517d16-e475-4dad-94a9-28aa0739b6cf",
                "text": "e If a participant prematurely permanently discontinues treatment with IMP, the participant will undergo a premature EOT visit as soon as possible. Participants will then be asked to continue with the study visits as scheduled, until global EOS visit is reached. During these visits, all study procedures/assessments will be performed except IMP administration and blood sampling for biomarkers (NfL, Chi3L1, and Ig levels). MRI scans for these participants will only be performed annually (using the next annual visit as the starting point).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "e79bf903-0d45-4218-98e5-add5a972a4bb",
                "text": "f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected to be reached. The timing and window of this visit will be communicated to sites.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "49a5b654-1f5b-4305-a4ff-038464e84ab3",
                "text": "g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need to be reported in the CRF; other prior medications will be reported for the period of 6 months prior to signing the ICF.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "15a803a4-89bc-495e-b58b-7d61344ced24",
                "text": "h Additional safety assessments can be performed if required by local regulations; such testing may be performed locally. Additional visits may be added if required by local regulations.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "0ef39db2-0d2a-445b-b8bf-d59575c9fa19",
                "text": "i Complete physical examination due at screening, baseline, yearly and EOS. Brief physical examination is sufficient for the rest of the visits (complete and brief physical examination will include neurological examination and collection of the following vital signs: arterial blood pressure, heart rate, and temperature).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "27154747-6a74-4ee0-a84b-155372ce27a7",
                "text": "j To be performed at screening for all participants. To be repeated based on clinical judgment, borderline results, or clinical suspicion of TB infection. Screening tests for TB are described in Appendix 2 (Section 10.2).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5241ab72-6e0d-4060-9275-791f03fbd1eb",
                "text": "k Hematology (platelet count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, reticulocytes, white blood cell count with differential: neutrophils, lymphocytes, monocytes, eosinophils, basophils). Biochemistry (blood urea nitrogen [BUN], creatinine, glucose, potassium, sodium, chloride, bicarbonate, calcium; liver function tests [AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein; creatine phosphokinase], lipase at Screening Visit, then quarterly). Monthly visits (M1, M2, M4, M5) will include hematology and full liver panel only. Additional safety assessments can be performed if required by local regulations. Such testing shall be performed at local laboratories. Note: a one-time retest at screening may be performed if an abnormal laboratory test value is considered temporary. Additional visits may be added if required by local regulations.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5271da6a-7f68-4ca5-a15b-a0dddf221c41",
                "text": "l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver function tests will be collected (AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein) and creatine phosphokinase; these can be performed at central laboratory (preferred, as on-site visits or home nursing as applicable for the site) or at local laboratory.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "e74b9ce7-4f46-4c82-9337-2235e9776b09",
                "text": "m Serum Î²-HCG pregnancy test at central laboratory at screening and urine pregnancy tests within 24 hours before the first dose of IMP and at scheduled times during study. Additional serum or urine pregnancy tests may be performed, as determined necessary by the Investigator or required by local regulation, to establish the absence of pregnancy at any time during the participant's participation in the study. Communication by phone of the result of a pregnancy test performed at home to the site is allowed. See also Appendix 4 (Section 10.4).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "25df5745-a291-478e-a6aa-9397fb8e3fa9",
                "text": "n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section 10.11.2]).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "42f1b641-034b-4648-b36a-6ac29bafca7c",
                "text": "o Only in female participants, if needed to establish menopausal status.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "b351b982-c2f9-47d5-8c4c-a1387112a5b3",
                "text": "p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not available at a given site due to reasons such as lack of translation, local certification, etc, then only the SDMT will be assessed for that participant.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a6fffd36-81a5-45a1-80a5-de072d7ccbdc",
                "text": "q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further details will be defined in a separate central MRI manual. For systemic corticosteroids and adrenocorticotropic hormone, 1 month washout is required prior to the MRI scans. A visit window of Â±21 days is acceptable for MRIs performed after D1. The screening MRI scan should be performed as close as possible before the start of IMP. As much as possible, the MRI scan should be performed during the screening period after it has been established that the participant meets all inclusion and no exclusion criteria.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "65f8719d-e16f-4b8f-87b3-d8af8819f4a3",
                "text": "r When available, clinical outcome assessments are to be completed by the participant prior to discussing their health status and prior to study treatment administration or other study-related procedures.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9539d7de-2f44-4476-84d4-2803b7df1e47",
                "text": "s Where available per local regulations.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "f7105673-4f57-4d1b-a088-ebbf185ca61d",
                "text": "t Pharmacodynamics/biomarkers samples collected are not timed samples.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "6ad3ae01-3ae6-4916-aa9f-56ca65403d33",
                "text": "u The DNA testing may be done, if locally applicable, at any time after signature of consent (in case it could not be done for some reason at Day 1).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "3084f766-c17d-47ca-a4f5-893fb2c9ed7a",
                "text": "v This sample will be collected and stored for use if any unexpected safety issue occurs to ensure that a pre-dose baseline value is available for previously not assessed parameters (eg, serology) and for biomarkers research, if agreed.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5e9ae298-4e4e-4376-860c-6c7437860b90",
                "text": "w Samples for hematology and biochemistry tests on Day 1 (randomization) must be collected prior to administration of the first IMP dose.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "808c5cc4-c96f-451f-b13b-a452b0841e2b",
                "text": "a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs are available at site. The interval between screening and randomization visits can range from 11 days (minimum) to 28 days (maximum). However, if required, the randomization visit can be performed earlier than 11 days upon IMP receipt at the site, assuming the participant is eligible for randomization. In case the screening MRI must be rescheduled (eg, technical issues) or repeated, an additional 1",
                "instanceType": "Note"
              },
              {
                "id": "869db152-e08b-40d8-a71c-58c753c191d7",
                "text": "b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evaluation of an adverse event). Assessments may be done as needed to evaluate the participant in accordance with the Investigator's best judgment and in line with the study protocol. At a minimum, a physical examination should be performed, and, body temperature and vital signs should be measured.",
                "instanceType": "Note"
              },
              {
                "id": "f1d8a8ed-64be-4d7a-98ce-f77d485bd6d3",
                "text": "c At the EOS, the participants who have completed the study and remain on IMP will be offered participation in a long-term safety study. Follow-up visit assessment only performed for those participants who are not willing to take part in the long-term safety study. For other situations where a follow-up visit is needed, please see Section 7.1 and the Study Manual.",
                "instanceType": "Note"
              },
              {
                "id": "4bc95259-2f09-4cf2-9d39-c6388d482788",
                "text": "d These visits may be done as home health visits (where applicable) or onsite visits (preferable that tests are performed at the central laboratory). In any situations where this is not possible (to be documented in source documents), the tests for these visits may be performed at a local laboratory.",
                "instanceType": "Note"
              },
              {
                "id": "b9bfb354-29ef-43e8-8930-171db38437c1",
                "text": "f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected to be reached. The timing and window of this visit will be communicated to sites.",
                "instanceType": "Note"
              },
              {
                "id": "ea3f961b-0752-4602-acc7-4a7795ec0bc0",
                "text": "g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need to be reported in the CRF; other prior medications will be reported for the period of 6 months prior to signing the ICF.",
                "instanceType": "Note"
              },
              {
                "id": "96360c45-415b-411e-980c-bbcb469792ce",
                "text": "h Additional safety assessments can be performed if required by local regulations; such testing may be performed locally. Additional visits may be added if required by local regulations.",
                "instanceType": "Note"
              },
              {
                "id": "21d32bfc-c198-4918-a412-902c2975e60d",
                "text": "j To be performed at screening for all participants. To be repeated based on clinical judgment, borderline results, or clinical suspicion of TB infection. Screening tests for TB are described in Appendix 2 (Section 10.2).",
                "instanceType": "Note"
              },
              {
                "id": "4f51722b-1b8f-4b82-ae59-6a5173cc650f",
                "text": "l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver function tests will be collected (AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein) and creatine phosphokinase; these can be performed at central laboratory (preferred, as on-site visits or home nursing as applicable for the site) or at local laboratory.",
                "instanceType": "Note"
              },
              {
                "id": "072d4f9c-49ef-47b5-acd3-2c46ac110911",
                "text": "n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section 10.11.2]).",
                "instanceType": "Note"
              },
              {
                "id": "0cef9708-bda3-402d-a2e3-d144354862ac",
                "text": "o Only in female participants, if needed to establish menopausal status.",
                "instanceType": "Note"
              },
              {
                "id": "f536cf36-2c61-4cf9-9cd8-af60306a0e2f",
                "text": "p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not available at a given site due to reasons such as lack of translation, local certification, etc, then only the SDMT will be assessed for that participant.",
                "instanceType": "Note"
              },
              {
                "id": "6104cbd4-a587-448b-9b18-4186f345dd2a",
                "text": "q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further details will be defined in a separate central MRI manual. For systemic corticosteroids and adrenocorticotropic hormone, 1 month washout is required prior to the MRI scans. A visit window of Â±21 days is acceptable for MRIs performed after D1. The screening MRI scan should be performed as close as possible before the start of IMP. As much as possible, the MRI scan should be performed during the scree",
                "instanceType": "Note"
              },
              {
                "id": "48f9773a-a846-4755-b8ae-423e923a3daf",
                "text": "r When available, clinical outcome assessments are to be completed by the participant prior to discussing their health status and prior to study treatment administration or other study-related procedures.",
                "instanceType": "Note"
              },
              {
                "id": "89a00f7e-6ab8-4e35-9060-2ff3b4449c59",
                "text": "u The DNA testing may be done, if locally applicable, at any time after signature of consent (in case it could not be done for some reason at Day 1).",
                "instanceType": "Note"
              }
            ],
            "model": {
              "id": "d082c8c8-1ca4-45c4-aa60-054f1d289834",
              "code": "C82639",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Parallel Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "48fe1b67-0e86-4fac-9a17-3870ad73a192",
                "name": "Relapsing forms of multiple sclerosis",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Participants with relapsing forms of multiple sclerosis (RMS)"
              }
            ],
            "procedures": [
              {
                "id": "20f8caef-a335-4f6c-a261-bb2e616668a8",
                "name": "Expanded Disability Status Scale",
                "procedureType": "Assessment",
                "code": {
                  "id": "72d11fa4-6a9f-45a4-b76e-e7f24f7d63cc",
                  "code": "EDSS",
                  "codeSystem": "Standardized Scale",
                  "codeSystemVersion": "",
                  "decode": "Expanded Disability Status Scale",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "EDSS Assessment",
                "description": "Standardized assessment of disability in multiple sclerosis"
              },
              {
                "id": "02c82108-504d-45f6-adc8-6b9e63242ca7",
                "name": "Magnetic Resonance Imaging",
                "procedureType": "Imaging Technique",
                "code": {
                  "id": "b1ec12f0-9050-4bd2-bfad-9c15f10ad695",
                  "code": "70551",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "MRI Brain without contrast",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "MRI Scan",
                "description": "Brain imaging with and without gadolinium contrast to detect lesions"
              },
              {
                "id": "b3df6fd2-f07e-49b2-acb0-fd239016e8c4",
                "name": "Electrocardiogram",
                "procedureType": "Monitoring",
                "code": {
                  "id": "e98ab414-b7f1-4601-b46f-5a53ea1ff716",
                  "code": "93000",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "12-lead ECG",
                "description": "Monitoring of cardiac electrical activity"
              },
              {
                "id": "959bceae-4890-4d83-b83c-4e4415546eca",
                "name": "Venipuncture",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "dc848fcc-d808-426e-b8c4-1fd9bf97069b",
                  "code": "36415",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Collection of venous blood by venipuncture",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Blood Draw",
                "description": "Collection of blood for hematology, biochemistry, and biomarkers"
              },
              {
                "id": "489ede47-760a-4f27-aaab-627be052bb62",
                "name": "Timed 25-foot walk test",
                "procedureType": "Assessment",
                "code": {
                  "id": "68e2c225-2dac-41ac-8535-379f87b98165",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "T25-FW",
                "description": "Quantitative measure of mobility and leg function"
              },
              {
                "id": "16a58fd2-3254-47be-9a76-8e1dec577ce0",
                "name": "9-hole peg test",
                "procedureType": "Assessment",
                "code": {
                  "id": "937b016b-93b8-4910-b5f4-9564a413b565",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "9-HPT",
                "description": "Quantitative measure of upper extremity (arm and hand) function"
              },
              {
                "id": "0f2276b7-5d0b-49cf-bc1d-2c54e68bf190",
                "name": "Symbol Digit Modalities Test",
                "procedureType": "Assessment",
                "code": {
                  "id": "761a8e25-fec6-41ac-a417-d1d2ad663d05",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "SDMT",
                "description": "Cognitive test assessing processing speed"
              },
              {
                "id": "766ec4d2-69dc-46ca-8585-200232deb6f7",
                "name": "Physical Examination",
                "procedureType": "Assessment",
                "code": {
                  "id": "4e68a6ac-7716-4798-bc4a-9047a463bb56",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Physical Exam",
                "description": "Complete or brief physical and neurological examination"
              },
              {
                "id": "d05202da-e2a5-4d76-b674-fd9f0786602e",
                "name": "Vital Signs Monitoring",
                "procedureType": "Monitoring",
                "code": {
                  "id": "afc63ee6-156e-4532-a727-ec667daf002d",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Vital Signs",
                "description": "Measurement of blood pressure, heart rate, and temperature"
              },
              {
                "id": "e6150a2b-55e8-46fd-b0a6-42ae3bb4707a",
                "name": "Urine Collection",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "274a43e3-ec34-4a35-9835-b04efc3fc02c",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Urinalysis/Pregnancy Test",
                "description": "Collection of urine for pregnancy testing"
              }
            ],
            "analysisPopulations": [
              {
                "id": "86d2bd9a-07b1-4389-9e68-2a50efdf0d78",
                "name": "",
                "text": "",
                "populationType": "Analysis",
                "instanceType": "AnalysisPopulation"
              }
            ],
            "extensionAttributes": [
              {
                "id": "8a741466-5960-4c86-995c-f76aca38dac1",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMaps",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"epochAliases\": {\"SCREENING\": \"epoch_1\", \"RANDOMIZATION / START OF IMP\": \"epoch_2\", \"RANDOMIZATION_/_START_OF_IMP\": \"epoch_2\", \"YEAR 1 (M12)\": \"epoch_3\", \"YEAR_1_(M12)\": \"epoch_3\", \"FROM M15 TO EOS\": \"epoch_4\", \"FROM_M15_TO_EOS\": \"epoch_4\", \"ONLY FOR PARTICIPANTS WHO PREMATURELY DISCONTINUE IMP\": \"epoch_5\", \"ONLY_FOR_PARTICIPANTS_WHO_PREMATURELY_DISCONTINUE_IMP\": \"epoch_5\", \"FOR ALL PARTICIPANTS\": \"epoch_6\", \"FOR_ALL_PARTICIPANTS\": \"epoch_6\", \"ONLY FOR PARTICIPANTS WHO COMPLETED TREATMENT TO EOS BUT DO NOT ENTER LTS\": \"epoch_7\", \"ONLY_FOR_PARTICIPANTS_WHO_COMPLETED_TREATMENT_TO_EOS_BUT_DO_NOT_ENTER_LTS\": \"epoch_7\", \"TREATMENT\": \"epoch_7\"}, \"visitAliases\": {\"SCREENING (D-28 TO D-1)\": \"enc_1\", \"SCREENING_(D-28_TO_D-1)\": \"enc_1\", \"DAY 1\": \"enc_2\", \"DAY_1\": \"enc_2\", \"M0.5 (W2) M0.75 (W3)\": \"enc_3\", \"M0.5_(W2)_M0.75_(W3)\": \"enc_3\", \"M1 (W4)\": \"enc_4\", \"M1_(W4)\": \"enc_4\", \"M1.25 (W5) M1.5 (W6) M1.75 (W7)\": \"enc_5\", \"M1.25_(W5)_M1.5_(W6)_M1.75_(W7)\": \"enc_5\", \"M2 (W8)\": \"enc_6\", \"M2_(W8)\": \"enc_6\", \"M2.25 (W9) M2.5 (W10) M2.75 (W11)\": \"enc_7\", \"M2.25_(W9)_M2.5_(W10)_M2.75_(W11)\": \"enc_7\", \"M3\": \"enc_8\", \"M4, M5\": \"enc_9\", \"M4,_M5\": \"enc_9\", \"M6\": \"enc_10\", \"M7, M8\": \"enc_11\", \"M7,_M8\": \"enc_11\", \"M9\": \"enc_12\", \"M10, M11\": \"enc_13\", \"M10,_M11\": \"enc_13\", \"M12\": \"enc_14\", \"QUARTERLY VISITS (M15 TO M36...)\": \"enc_15\", \"QUARTERLY_VISITS_(M15_TO_M36...)\": \"enc_15\", \"SEMI-ANNUAL VISITS (M18 TO M36...)\": \"enc_16\", \"SEMI-ANNUAL_VISITS_(M18_TO_M36...)\": \"enc_16\", \"PEOT\": \"enc_17\", \"EOS COMMON STUDY END DATE VISIT\": \"enc_18\", \"EOS_COMMON_STUDY_END_DATE_VISIT\": \"enc_18\", \"FOLLOW-UP VISIT (4 WEEKS)\": \"enc_19\", \"FOLLOW-UP_VISIT_(4_WEEKS)\": \"enc_19\", \"screening\": \"enc_1\", \"EOS\": \"enc_18\", \"EOT\": \"enc_17\", \"Randomization\": \"enc_2\", \"Follow-up\": \"enc_19\"}}"
              },
              {
                "id": "838d3ba1-4663-4496-b56e-fb8d33b2814c",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-classifiedIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"warning\", \"category\": \"dosing_fragmentation\", \"message\": \"Dosing regimen has prose fragment as treatment name: 'the SAR442168...'\", \"affectedPath\": \"$.dosingRegimens[]\", \"affectedIds\": [\"3e2b12e0-60d2-435b-930e-83c5ebb998ac\"], \"suggestion\": \"Consolidate with parent intervention regimen\"}]"
              },
              {
                "id": "ext_conceptual_5dfed743-6543-4e06-9dd7-23779211589b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"4e9cfb03-2239-4561-b61d-46e04cc69a80\", \"name\": \"MRI Rescheduling Extension\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"f873d964-6452-4db0-8185-ebd7f88ded8f\", \"name\": \"Post-D1 MRI Window\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"c93e640c-3a4e-4d5d-b0ff-6919e8507cdb\", \"name\": \"Lab Retest Confirmation\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "1ada7dfb-e717-4141-b9f1-0af0a83835fc",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"warning\", \"category\": \"timing_reference_remapped\", \"message\": \"Timing 'Screening Period' reference remapped: daf65b03-845f-43b0-980e-526534bc3624 \\u2192 anchor_inst_anchor_2\", \"affectedPath\": \"$.timings[?(@.id=='timing_1')]\"}, {\"severity\": \"warning\", \"category\": \"timing_reference_remapped\", \"message\": \"Timing 'Screening to Randomization Interval' reference remapped: 84c8d531-2c79-4d30-ab22-1c7f5f1eb2c0 \\u2192 anchor_inst_anchor_1\", \"affectedPath\": \"$.timings[?(@.id=='timing_2')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'MRI Rescheduling Extension' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Post-D1 MRI Window' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: f6c0f747-9c63-49cc-b3a8-8cd7e4e7018a (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 7f0c718d-4ac7-4ee0-86ef-13ea346aba5c (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Lab Retest Confirmation' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}]"
              },
              {
                "id": "b0eb8473-9a27-4bb9-8cae-4735297a08f3",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"e2c5bd20-140d-46c1-9b04-9eedfaa4c4ac\", \"definition\": \"First administration of investigational product\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 60, \"sourceText\": \"first dose\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"3b6a57cd-107d-48b6-bf3a-b926f34a3d20\", \"definition\": \"Date of subject randomization\", \"anchorType\": \"Randomization\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 40, \"sourceText\": \"Randomization visit\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"3be0d886-7787-4d46-827a-fabd8eeaea16\", \"definition\": \"Screening visit\", \"anchorType\": \"Screening\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 20, \"sourceText\": \"screening period\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"e4d54fbc-238a-4f1c-9941-db2bc2b8acc6\", \"definition\": \"Informed consent obtained\", \"anchorType\": \"InformedConsent\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 10, \"sourceText\": \"Informed \\nconsent\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"dfccf554-c2b4-414d-baef-df3fbd789df2\", \"definition\": \"Procedure\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 100, \"sourceText\": \"Procedure\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "61c95943-8126-48a4-bcf1-b6efe887424b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"9b563e26-94ca-4fec-83f9-ade5e8d38119\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"once daily\"}, {\"id\": \"f47ba148-3519-43b6-89b7-13d3338cb086\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"Once daily\"}, {\"id\": \"bb045e62-5631-4577-9619-4a99bb92645f\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"d66a8c7e-3406-430b-a42d-3b5e6ec3f70a\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"OD\"}, {\"id\": \"b02325d1-52e8-4dcd-b88e-226c8972749d\", \"type\": \"Interval\", \"sourceText\": \"tid\"}, {\"id\": \"41b10db5-a081-4d68-abb2-38d3c625167a\", \"type\": \"Continuous\", \"startOffset\": \"-P28D\", \"endOffset\": \"-P1D\", \"sourceText\": \"Day-28 to Day-1\"}, {\"id\": \"0a59707a-6f7d-49b0-bba6-668930b330b1\", \"type\": \"Continuous\", \"startOffset\": \"-P28D\", \"endOffset\": \"-P1D\", \"sourceText\": \"Day -28 to Day -1\"}, {\"id\": \"350cb697-f942-43cb-a64a-c63f5cc39336\", \"type\": \"Continuous\", \"sourceText\": \"screening period\"}, {\"id\": \"e22cf613-3b7c-44ad-950f-b56529699a38\", \"type\": \"Continuous\", \"sourceText\": \"Screening \\nPeriod\"}, {\"id\": \"1fd12671-fd33-47f3-99b5-1eb77ffd3cae\", \"type\": \"Continuous\", \"sourceText\": \"Screening period\"}, {\"id\": \"0f644d8f-0af8-4cf4-8f3f-0cd034520c9e\", \"type\": \"Continuous\", \"sourceText\": \"Screening Period\"}, {\"id\": \"8a73cb71-4b1a-4b1b-986b-8372ec1be7c2\", \"type\": \"Continuous\", \"sourceText\": \"Washout period\"}, {\"id\": \"448fdbe5-b52f-4907-b2ad-903eeeee8cfd\", \"type\": \"Continuous\", \"sourceText\": \"washout period\"}, {\"id\": \"0363fd6f-59b3-4317-9c5b-edf161d47b15\", \"type\": \"Continuous\", \"sourceText\": \"treatment period\"}, {\"id\": \"158a1c87-cbc4-4f61-bf44-2149c3d64133\", \"type\": \"Continuous\", \"sourceText\": \"Treatment Period\"}, {\"id\": \"95b379e6-7173-471e-ba30-783047a81bb5\", \"type\": \"Continuous\", \"sourceText\": \"observation \\nperiod\"}, {\"id\": \"8bee80aa-5dee-4fef-890e-11c298249f84\", \"type\": \"Continuous\", \"sourceText\": \"follow-up period\"}, {\"id\": \"144f8388-c485-417b-9143-118113a0cab5\", \"type\": \"Continuous\", \"sourceText\": \"7 days pre\"}, {\"id\": \"caefe85f-3573-4899-af40-103975f8aa61\", \"type\": \"Continuous\", \"sourceText\": \"24 hours before\"}, {\"id\": \"0880a0fd-8363-4c8e-b950-daa0342a4393\", \"type\": \"Continuous\", \"sourceText\": \"8 days before\"}, {\"id\": \"d3dc00bd-b99d-4469-b531-90a839d125c9\", \"type\": \"Daily\", \"startOffset\": \"P0D\", \"interval\": \"P1D\", \"minObservations\": 1, \"exitCondition\": \"End of study period\", \"sourceText\": \"To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio)\"}, {\"id\": \"ae7a3153-17c6-492f-b8c7-62b77d67cabf\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"minObservations\": 1, \"exitCondition\": \"End of study period\", \"sourceText\": \"ARR during the study period assessed by confirmed protocol-defined adjudicated relapses\"}]"
              },
              {
                "id": "8492cb7a-f548-43ad-ae0c-fb677e1dcecf",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"86036aa9-c2de-4c6f-8237-1c64414e9704\", \"requiredSequence\": [\"epoch_1\", \"epoch_3\", \"epoch_4\", \"epoch_6\", \"epoch_7\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_2\", \"enc_18\", \"enc_1\"], \"sourceText\": \"[{'condition': 'If subject experiences AE requiring discontinuation', 'path': ['DEFINITIVE_DISCONTINUATION', 'EARLY_TERMINATION_VISIT', 'SAFETY_FOLLOW_UP']}, {'condition': 'Temporary discontinuation', 'path': ['TEMPORARY_DISCONTINUATION', 'RECHALLENGE', 'RESUME_TREATMENT']}, {'condition': 'Suspected MS relapse', 'path': ['UNSCHEDULED_ASSESSMENT_VISIT']}]\"}]"
              },
              {
                "id": "ceacc7fd-21e2-44ad-93cb-6391732a9669",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"3ee2fd2b-9af9-4483-87b3-d007008df39d\", \"conditionType\": \"eligibility_conditional\", \"text\": \"a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs are available at site. The interval between screening and randomization visits can range from 11 days (minimum) to 28 days (maximum). However, if required, the randomization visit can be performed earlier than 11 days upon IMP receipt at the site, assuming the participant is eligible for randomization. In case the screening MRI must be rescheduled (eg, technical issues) or repeated, an additional 1 week (7 days) is allowed.\", \"footnoteId\": \"a42e01f3-b62a-4d2b-8bcd-6e6a28142334\", \"structuredCondition\": \"duration.between(Screening, Randomization).min(P11D).max(P28D)\", \"appliesToActivityIds\": [\"Randomization\"], \"sourceText\": \"a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs a\"}, {\"id\": \"cacc1fa6-47ee-4bab-bcd8-5daa9e6a07d4\", \"conditionType\": \"general\", \"text\": \"b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evaluation of an adverse event). Assessments may be done as needed to evaluate the participant in accordance with the Investigator's best judgment and in line with the study protocol. At a minimum, a physical examination should be performed, and, body temperature and vital signs should be measured.\", \"footnoteId\": \"f259342e-cea8-4b61-8767-5871a75ba784\", \"structuredCondition\": \"frequency.unscheduled(as_needed)\", \"appliesToActivityIds\": [\"Physical examination\", \"Body temperature\", \"Vital signs\"], \"sourceText\": \"b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evalu\"}, {\"id\": \"f96ab69c-e74d-40e1-a088-8131130a356f\", \"conditionType\": \"general\", \"text\": \"c At the EOS, the participants who have completed the study and remain on IMP will be offered participation in a long-term safety study. Follow-up visit assessment only performed for those participants who are not willing to take part in the long-term safety study. For other situations where a follow-up visit is needed, please see Section 7.1 and the Study Manual.\", \"footnoteId\": \"b2d81bfc-9c9b-4d42-81dd-ccf38d92f369\", \"structuredCondition\": \"eligibility.not_enrolled(Long-term safety study)\", \"appliesToActivityIds\": [\"afa51bac-cc9d-46d1-bcc2-3816a6882d81\"], \"sourceText\": \"c At the EOS, the participants who have completed the study and remain on IMP will be offered partic\"}, {\"id\": \"bfd1dd6b-a293-4636-8916-37e4504579fe\", \"conditionType\": \"general\", \"text\": \"d These visits may be done as home health visits (where applicable) or onsite visits (preferable that tests are performed at the central laboratory). In any situations where this is not possible (to be documented in source documents), the tests for these visits may be performed at a local laboratory.\", \"footnoteId\": \"9e2df569-4245-4cb9-aef7-7a8021ed7626\", \"structuredCondition\": \"location.preference(Central Lab, Home Health, Local Lab)\", \"appliesToActivityIds\": [\"Laboratory tests\"], \"sourceText\": \"d These visits may be done as home health visits (where applicable) or onsite visits (preferable tha\"}, {\"id\": \"2d0457f5-7228-4420-b65e-2c93e1fdf585\", \"conditionType\": \"sequence\", \"text\": \"e If a participant prematurely permanently discontinues treatment with IMP, the participant will undergo a premature EOT visit as soon as possible. Participants will then be asked to continue with the study visits as scheduled, until global EOS visit is reached. During these visits, all study procedures/assessments will be performed except IMP administration and blood sampling for biomarkers (NfL, Chi3L1, and Ig levels). MRI scans for these participants will only be performed annually (using the next annual visit as the starting point).\", \"footnoteId\": \"47a25e1e-69df-4167-a6c8-f1ce0bb75048\", \"structuredCondition\": \"if(treatment_discontinued).exclude(IMP administration, Biomarkers).frequency(MRI, P1Y)\", \"appliesToActivityIds\": [\"1dc9ad67-bfac-49bd-aaf9-0fda0c5f7c03\", \"df3107a0-a496-4a9f-8a78-550782733e37\"], \"sourceText\": \"e If a participant prematurely permanently discontinues treatment with IMP, the participant will und\"}, {\"id\": \"40638b9c-7133-44b4-9fc9-583653b68e82\", \"conditionType\": \"general\", \"text\": \"f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected to be reached. The timing and window of this visit will be communicated to sites.\", \"footnoteId\": \"8f191265-c2ce-4bb3-bf37-83759e313d26\", \"sourceText\": \"f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected t\"}, {\"id\": \"dc64a076-23e1-4350-9808-60bb113fd692\", \"conditionType\": \"timing_before\", \"text\": \"g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need to be reported in the CRF; other prior medications will be reported for the period of 6 months prior to signing the ICF.\", \"footnoteId\": \"ca7e3bb5-9feb-44e3-9118-b72d7195746a\", \"structuredCondition\": \"history.report(DMT, all_prior); history.report(other, P6M).before(ICF)\", \"appliesToActivityIds\": [\"Prior medications\"], \"sourceText\": \"g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need \"}, {\"id\": \"1ee95c47-2f61-46ca-81c9-aa3529aaa41c\", \"conditionType\": \"eligibility_conditional\", \"text\": \"h Additional safety assessments can be performed if required by local regulations; such testing may be performed locally. Additional visits may be added if required by local regulations.\", \"footnoteId\": \"9a589c83-f860-4118-9a91-c651d78dfead\", \"sourceText\": \"h Additional safety assessments can be performed if required by local regulations; such testing may \"}, {\"id\": \"dfa73aa0-56a2-4068-a1ba-0ee37ecb0a48\", \"conditionType\": \"timing_after\", \"text\": \"i Complete physical examination due at screening, baseline, yearly and EOS. Brief physical examination is sufficient for the rest of the visits (complete and brief physical examination will include neurological examination and collection of the following vital signs: arterial blood pressure, heart rate, and temperature).\", \"footnoteId\": \"079a924e-432b-42ac-9050-e0b0ad4b01ea\", \"structuredCondition\": \"if(Screening, Baseline, Yearly, EOS).type(Complete); else.type(Brief)\", \"appliesToActivityIds\": [\"1dc9ad67-bfac-49bd-aaf9-0fda0c5f7c03\"], \"sourceText\": \"i Complete physical examination due at screening, baseline, yearly and EOS. Brief physical examinati\"}, {\"id\": \"bfb3e0de-9ee1-4b3c-8786-10b66cb0635e\", \"conditionType\": \"general\", \"text\": \"j To be performed at screening for all participants. To be repeated based on clinical judgment, borderline results, or clinical suspicion of TB infection. Screening tests for TB are described in Appendix 2 (Section 10.2).\", \"footnoteId\": \"eb6372c1-e8de-48fe-8c26-deecb5d91aae\", \"sourceText\": \"j To be performed at screening for all participants. To be repeated based on clinical judgment, bord\"}, {\"id\": \"4135eecb-45fd-439c-a43c-bc13b8aaf28e\", \"conditionType\": \"sequence\", \"text\": \"k Hematology (platelet count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, reticulocytes, white blood cell count with differential: neutrophils, lymphocytes, monocytes, eosinophils, basophils). Biochemistry (blood urea nitrogen [BUN], creatinine, glucose, potassium, sodium, chloride, bicarbonate, calcium; liver function tests [AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein; creatine phosphokinase], lipase at Screening Visit, then quarterly). Monthly visits (M1, M2, M4, M5) will include hematology and full liver panel only. Additional safety assessments can be performed if required by local regulations. Such testing shall be performed at local laboratories. Note: a one-time retest at screening may be performed if an abnormal laboratory test value is considered temporary. Additional visits may be added if required by local regulations.\", \"footnoteId\": \"ad1194eb-cee6-4e18-8014-d50ff79614a7\", \"structuredCondition\": \"if(M1, M2, M4, M5).subset(Hematology, Liver Panel); if(Screening).add(Lipase); else.frequency(Lipase, P3M)\", \"appliesToActivityIds\": [\"1dc9ad67-bfac-49bd-aaf9-0fda0c5f7c03\"], \"sourceText\": \"k Hematology (platelet count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume,\"}, {\"id\": \"42370122-b18e-4db6-b5d0-cf6f1637a73d\", \"conditionType\": \"general\", \"text\": \"l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver function tests will be collected (AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein) and creatine phosphokinase; these can be performed at central laboratory (preferred, as on-site visits or home nursing as applicable for the site) or at local laboratory.\", \"footnoteId\": \"f003f225-db55-449c-8650-3b2739839f38\", \"sourceText\": \"l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver fu\"}, {\"id\": \"b0ea2995-be26-45da-8c92-fafc88e1bb0a\", \"conditionType\": \"timing_before\", \"text\": \"m Serum \\u03b2-HCG pregnancy test at central laboratory at screening and urine pregnancy tests within 24 hours before the first dose of IMP and at scheduled times during study. Additional serum or urine pregnancy tests may be performed, as determined necessary by the Investigator or required by local regulation, to establish the absence of pregnancy at any time during the participant's participation in the study. Communication by phone of the result of a pregnancy test performed at home to the site is allowed. See also Appendix 4 (Section 10.4).\", \"footnoteId\": \"10e9062f-1b8d-4fb8-9421-5c656ad4e905\", \"structuredCondition\": \"timing.before(the first dose of imp and at scheduled times during study. additional serum or urine pregnancy tests may be performed, as determined necessary by the investigator or required by local regulation, to establish the absence of pregnancy at any time during the participant's participation in the study. communication by phone of the result of a pregnancy test performed at home to the site is allowed. see also appendix 4 (section 10.4)., PT24M)\", \"appliesToActivityIds\": [\"cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a\"], \"timingConstraint\": \"PT24H\", \"sourceText\": \"m Serum \\u03b2-HCG pregnancy test at central laboratory at screening and urine pregnancy tests within 24 \"}, {\"id\": \"3b43d65d-fa5b-4b0a-b88a-999445647728\", \"conditionType\": \"general\", \"text\": \"n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section 10.11.2]).\", \"footnoteId\": \"ed474953-c5d5-4046-beed-0ac7023eb5ae\", \"sourceText\": \"n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section \"}, {\"id\": \"db9aef8f-4767-46cb-af30-4f89b2ea2c01\", \"conditionType\": \"general\", \"text\": \"o Only in female participants, if needed to establish menopausal status.\", \"footnoteId\": \"876c3230-56bd-4c47-a48e-fbc514bd2bb5\", \"structuredCondition\": \"eligibility.sex(Female).and(status_unknown(Menopause))\", \"appliesToActivityIds\": [\"FSH/Hormone testing\"], \"sourceText\": \"o Only in female participants, if needed to establish menopausal status.\"}, {\"id\": \"b04407d8-4520-4bd4-a96c-e7d6ec1ff965\", \"conditionType\": \"sequence\", \"text\": \"p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not available at a given site due to reasons such as lack of translation, local certification, etc, then only the SDMT will be assessed for that participant.\", \"footnoteId\": \"4cfb581e-fe4c-4fa0-9587-26477bd98e06\", \"sourceText\": \"p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not availab\"}, {\"id\": \"1c3ae05a-264b-48a9-8d0a-13c73dda946c\", \"conditionType\": \"timing_before\", \"text\": \"q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further details will be defined in a separate central MRI manual. For systemic corticosteroids and adrenocorticotropic hormone, 1 month washout is required prior to the MRI scans. A visit window of \\u00b121 days is acceptable for MRIs performed after D1. The screening MRI scan should be performed as close as possible before the start of IMP. As much as possible, the MRI scan should be performed during the screening period after it has been established that the participant meets all inclusion and no exclusion criteria.\", \"footnoteId\": \"3991a220-74c9-4108-972c-a20cc9196b68\", \"structuredCondition\": \"timing.washout(Corticosteroids, P1M).before(MRI); timing.window(MRI, P21D).after(D1)\", \"appliesToActivityIds\": [\"MRI scans\"], \"sourceText\": \"q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further d\"}, {\"id\": \"beb7d9b6-7ca3-4b8d-b995-7e091ef27867\", \"conditionType\": \"timing_before\", \"text\": \"r When available, clinical outcome assessments are to be completed by the participant prior to discussing their health status and prior to study treatment administration or other study-related procedures.\", \"footnoteId\": \"e6be3874-b0e7-4009-afa1-b1c70e7945fa\", \"structuredCondition\": \"sequence.before(Health_status_discussion, IMP_administration, Procedures)\", \"appliesToActivityIds\": [\"Clinical outcome assessments\"], \"sourceText\": \"r When available, clinical outcome assessments are to be completed by the participant prior to discu\"}, {\"id\": \"4875fe04-bd55-4401-babd-e5329303ff15\", \"conditionType\": \"general\", \"text\": \"t Pharmacodynamics/biomarkers samples collected are not timed samples.\", \"footnoteId\": \"3536d968-4b58-4f84-927c-797c601761d7\", \"sourceText\": \"t Pharmacodynamics/biomarkers samples collected are not timed samples.\", \"appliesToActivityIds\": [\"d29e8c36-3a34-4b61-b22e-db135ecb4620\", \"cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a\", \"0c2933ca-1e7d-4754-b38c-3b8ceffc17dd\"]}, {\"id\": \"5eb7d209-5986-4d2b-aad8-cb073438fbe1\", \"conditionType\": \"timing_after\", \"text\": \"u The DNA testing may be done, if locally applicable, at any time after signature of consent (in case it could not be done for some reason at Day 1).\", \"footnoteId\": \"4db4da9c-7278-4b8d-9539-4bc89a934534\", \"sourceText\": \"u The DNA testing may be done, if locally applicable, at any time after signature of consent (in cas\"}, {\"id\": \"da10164c-0df5-41dc-9e6f-24505b765f26\", \"conditionType\": \"general\", \"text\": \"v This sample will be collected and stored for use if any unexpected safety issue occurs to ensure that a pre-dose baseline value is available for previously not assessed parameters (eg, serology) and for biomarkers research, if agreed.\", \"footnoteId\": \"5b75b11c-ea51-4261-8e64-845478c9e891\", \"sourceText\": \"v This sample will be collected and stored for use if any unexpected safety issue occurs to ensure t\", \"appliesToActivityIds\": [\"0c2933ca-1e7d-4754-b38c-3b8ceffc17dd\"]}, {\"id\": \"a01b7c7e-0719-4160-befc-1b08cb6d9726\", \"conditionType\": \"timing_before\", \"text\": \"w Samples for hematology and biochemistry tests on Day 1 (randomization) must be collected prior to administration of the first IMP dose.\", \"footnoteId\": \"26452e9b-6393-4573-97de-04243ac26f67\", \"structuredCondition\": \"timing.before(IMP_dose_1)\", \"appliesToActivityIds\": [\"cee4f5a8-116f-44f6-9bb1-6faa1cbd0b7a\", \"0c2933ca-1e7d-4754-b38c-3b8ceffc17dd\"], \"sourceText\": \"w Samples for hematology and biochemistry tests on Day 1 (randomization) must be collected prior to \"}]"
              },
              {
                "id": "b616e884-1764-44f5-a53b-ae8d74fd608f",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"794e3730-9561-4bec-9f00-a47f3f947396\", \"name\": \"Primary: Adjudicated Relapse Rate\", \"endpointType\": \"Primary\", \"inputs\": [\"Relapse events\", \"Adjudication status\", \"Time on study\"], \"timeWindow\": {\"reference\": \"Treatment period\", \"duration\": \"Study duration\"}, \"algorithm\": \"Total number of adjudicated relapses / Total person-years of exposure\", \"successCriteria\": \"Statistically significant reduction in annualized rate compared to control (alpha = 0.05)\", \"sourceText\": \"Adjudicated relapse rate is the primary endpoint in this trial, being a standard endpoint used in pivotal RMS clinical studies\"}, {\"id\": \"a064521c-1fa6-41ac-a971-ae47a80e74d7\", \"name\": \"Secondary: 6-month Confirmed Disability Worsening (CDW)\", \"endpointType\": \"Secondary\", \"inputs\": [\"EDSS score\", \"Relapse onset date\", \"Relapse resolution status\", \"Screening EDSS\"], \"timeWindow\": {\"reference\": \"Initial onset of disability worsening\", \"duration\": \"P6M\"}, \"algorithm\": \"Onset of EDSS increase maintained for >= 6 months. Confirmation EDSS must be > 30 days after a confirmed relapse and in the absence of ongoing relapse. Intervening EDSS scores must also maintain the minimum increase.\", \"successCriteria\": \"Maintenance of minimum EDSS increase from onset to 6-month confirmation visit\", \"sourceText\": \"Six-month confirmed disability worsening (CDW) is selected as the key secondary endpoint... for the purpose of confirmation, only EDSS score(s) measured more than 30 days after the onset of a confirme\"}, {\"id\": \"2d64705f-d0cc-4121-a5b8-fd47e768f694\", \"name\": \"Safety: Treatment-Emergent Adverse Events (TEAE)\", \"endpointType\": \"Secondary\", \"inputs\": [\"Adverse Event (AE) onset date\", \"AE severity\", \"Study intervention start date\"], \"timeWindow\": {\"reference\": \"Treatment period\", \"duration\": \"From first dose to end of treatment\"}, \"algorithm\": \"AEs that developed, or worsened, or became serious during the treatment period\", \"successCriteria\": \"Descriptive analysis; no formal statistical significance testing\", \"sourceText\": \"TEAEs are defined as AEs that developed, or worsened, or became serious during the treatment period.\"}]"
              },
              {
                "id": "5f3d407c-f818-41c9-b275-db7d85159b92",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"f9ffb806-f5cf-4da0-ba87-9b15c0bb6c7f\", \"name\": \"Annualized Adjudicated Relapse Rate (ARR)\", \"variableType\": \"Custom\", \"sourceVariables\": [\"Confirmed protocol-defined adjudicated relapses\", \"Randomization date\", \"Last contact date\", \"EOS date\"], \"derivationRule\": \"Total number of adjudicated relapses divided by observation duration (randomization to EOS or last contact date). Analyzed via negative binomial regression with log-transformed duration as offset.\", \"baselineDefinition\": \"Not applicable (rate over study period)\", \"analysisWindow\": \"Randomization to End-of-Study (EOS) or last contact date\", \"imputationRule\": \"No imputation for unobserved events after study discontinuation\", \"unit\": \"Relapses per year\"}, {\"id\": \"c48dcedf-dc28-4c02-ac00-681febebaa72\", \"name\": \"Time to onset of 6-month Confirmed Disability Worsening (CDW)\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"EDSS score\"], \"derivationRule\": \"Time from randomization to first EDSS increase (>=1.5 if baseline 0; >=1.0 if baseline 0.5-5.5; >=0.5 if baseline >5.5) confirmed at a scheduled visit at least 6 months later.\", \"baselineDefinition\": \"Baseline EDSS score\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Study duration until EOS\", \"imputationRule\": \"Kaplan-Meier estimates for censored data\", \"unit\": \"Days/Months\"}, {\"id\": \"6d86097c-1648-4ea6-81ac-ba8d7fec8d08\", \"name\": \"Total number of new and/or enlarging T2-hyperintense lesions\", \"variableType\": \"Composite\", \"sourceVariables\": [\"T2-hyperintense lesions\"], \"derivationRule\": \"Sum of the individual number of new and/or enlarging T2 lesions at all scheduled visits starting after baseline up to and including the EOS visit.\", \"baselineDefinition\": \"Baseline MRI scan\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Post-baseline visits through EOS\", \"imputationRule\": \"Not specified\", \"unit\": \"Count\"}, {\"id\": \"9451abdf-fbc9-43d3-82de-bf7c46e77fa0\", \"name\": \"Total number of new Gd-enhancing T1-hyperintense lesions\", \"variableType\": \"Composite\", \"sourceVariables\": [\"Gd-enhancing T1-hyperintense lesions\"], \"derivationRule\": \"Sum of the individual number of new Gd-enhancing T1-hyperintense lesions at all scheduled visits starting after baseline up to and including the EOS visit.\", \"baselineDefinition\": \"Baseline MRI scan\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Post-baseline visits through EOS\", \"imputationRule\": \"Not specified\", \"unit\": \"Count\"}, {\"id\": \"5300792c-4d82-49a9-b09c-63ae5c92923d\", \"name\": \"Time to Confirmed Disability Improvement (CDI)\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"EDSS score\"], \"derivationRule\": \"Time to a >=1.0 point decrease on the EDSS from the baseline EDSS score confirmed over at least 6 months.\", \"baselineDefinition\": \"Baseline EDSS score\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Study duration until EOS\", \"imputationRule\": \"Not specified\", \"unit\": \"Days/Months\"}, {\"id\": \"5383b686-1296-4197-afa4-2f664d637b8c\", \"name\": \"Percent change in brain volume loss\", \"variableType\": \"PercentChange\", \"sourceVariables\": [\"Brain volume\"], \"derivationRule\": \"((EOS_value - Month6_value) / Month6_value) * 100\", \"baselineDefinition\": \"Month 6 MRI scan (Reference point)\", \"baselineVisit\": \"Month 6\", \"analysisWindow\": \"Month 6 to EOS\", \"imputationRule\": \"Not specified\", \"unit\": \"%\"}, {\"id\": \"a0787d95-88dd-41ce-a59b-454e074ccad4\", \"name\": \"Change in cognitive function (SDMT)\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"Symbol Digit Modalities Test (SDMT) score\"], \"derivationRule\": \"EOS_score - baseline_score\", \"baselineDefinition\": \"Last non-missing value prior to randomization\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Baseline to EOS\", \"imputationRule\": \"Not specified\", \"unit\": \"Score\"}, {\"id\": \"2bffccad-1e16-47b0-ae21-487657d90123\", \"name\": \"Change in MSQoL-54 score\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"MSQoL-54 questionnaire score\"], \"derivationRule\": \"EOS_score - baseline_score\", \"baselineDefinition\": \"Last non-missing value prior to randomization\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Baseline to EOS\", \"imputationRule\": \"Not specified\", \"unit\": \"Score\"}]"
              },
              {
                "id": "5a3c2001-2e00-479d-a9e3-33c401f94d1e",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"bb230d20-f605-47ff-bf67-71f7cb4b213a\", \"initialState\": \"Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening\", \"Year 1 (M12)\", \"From M15 to EOS\", \"For all participants\", \"Only for participants who completed treatment to EOS but do not enter LTS\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening\", \"toState\": \"Year 1 (M12)\", \"trigger\": \"Progress to Year 1 (M12)\"}, {\"fromState\": \"Year 1 (M12)\", \"toState\": \"From M15 to EOS\", \"trigger\": \"Progress to From M15 to EOS\"}, {\"fromState\": \"From M15 to EOS\", \"toState\": \"For all participants\", \"trigger\": \"Progress to For all participants\"}, {\"fromState\": \"For all participants\", \"toState\": \"Only for participants who completed treatment to EOS but do not enter LTS\", \"trigger\": \"Progress to Only for participants who completed treatment to EOS but do not enter LTS\"}, {\"fromState\": \"Only for participants who completed treatment to EOS but do not enter LTS\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Screening\": \"epoch_1\", \"Year 1 (M12)\": \"epoch_3\", \"From M15 to EOS\": \"epoch_4\", \"For all participants\": \"epoch_6\", \"Only for participants who completed treatment to EOS but do not enter LTS\": \"epoch_7\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "e63023fb-f085-4a09-bae8-774d01c731df",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"83a717a1-d733-44c2-bfb3-d03e4d947ba1\", \"treatmentName\": \"SAR442168\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 60.0, \"unit\": \"mg\"}, {\"amount\": 14.0, \"unit\": \"mg\"}], \"durationDescription\": \"36 months\", \"sourceText\": \"ation on Day 1. Screening Period Treatment Period : approximately 18 to 36 months All patients continue in the study until Common Study End (EOS) 0 12 24 15 18 Months Teriflunomide 14 mg Oral N=450 SA\"}, {\"id\": \"f5fe9f58-2abd-4b04-892c-9469c2ca9ac4\", \"treatmentName\": \"SAR442168 (Tolebrutinib)\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 0.0, \"unit\": \"\", \"description\": \"Dose not specified in provided text snippet\"}], \"durationDescription\": \"Not specified in text\", \"doseModifications\": [\"Liver function test monitoring guidance included for dose management\"]}, {\"id\": \"7e7cad11-f9d0-4476-9a46-0c6d19f5af3d\", \"treatmentName\": \"Teriflunomide (Aubagio)\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 0.0, \"unit\": \"mg\", \"description\": \"Standard clinical dose\"}], \"durationDescription\": \"Not specified in text\"}, {\"id\": \"6de16ec2-9ce9-4409-af76-68d1d97e91fe\", \"treatmentName\": \"Placebo\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"durationDescription\": \"Not specified in text\"}]"
              },
              {
                "id": "d97063ac-7606-43c1-8d77-95f339b0150d",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"0a604d23-e223-4cc4-85d0-ec827e30a3d9\", \"visitName\": \"screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening\", \"sourceText\": \"(EDSS) score at screening (<4 versus \\u22654) and geographic region (US versus non-US). Study intervention(s) Investigational medicinal product\"}, {\"id\": \"734caf1c-148e-4984-a413-ea5cb6d941fa\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 2, \"sourceText\": \"10.6 Appendix 6: Liver and other safety: actions and follow-up assessments Liver function test monitoring guidance\"}, {\"id\": \"6e4f534d-8f1d-4e68-b1f0-2d14a8da537f\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 3, \"epoch\": \"Treatment\", \"sourceText\": \"- increase of \\u22651.5 points from the baseline Expanded Disability Status Scale (EDSS) score when the baseline score is 0, OR\"}, {\"id\": \"eef37c16-1391-4d01-ad10-84143272b70b\", \"visitName\": \"EOS\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 4, \"epoch\": \"Treatment\", \"sourceText\": \"Study (EOS) visit and number of new and/or enlarging T2-hyperintense lesions by visit over time \\u2022\"}, {\"id\": \"94ae4794-9b30-41c6-8246-aa99443ba43e\", \"visitName\": \"Month 6\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 5, \"epoch\": \"Treatment\", \"sourceText\": \"scans at the EOS compared to Month 6 \\u2022 Change in cognitive function at the EOS compared to baseline\"}, {\"id\": \"db43d034-9b4c-4b58-8f22-672b4e8ffd3b\", \"visitName\": \"Month 24\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 6, \"sourceText\": \"The proportion of participants with events at given time points (eg, Month 24) will be calculated using the Kaplan-Meier estimates. In this primary ITT analysis:\"}, {\"id\": \"6c261d08-d1a2-4357-bc10-5277f8e65d08\", \"visitName\": \"EOT\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 7, \"sourceText\": \"pEOTe EOSf \\u201cCommon\"}, {\"id\": \"1f26f312-0223-4edd-918d-6d45d3d9a80b\", \"visitName\": \"Visit 1\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 8, \"sourceText\": \"Visit number V1 V2\"}, {\"id\": \"bdda1b0e-0b0a-4c5c-9605-f73d036f8c1d\", \"visitName\": \"Visit 2\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 9, \"sourceText\": \"V2 V3\"}, {\"id\": \"d09afee1-cc69-421d-b813-f0a6340bfeb7\", \"visitName\": \"Visit 3\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 10, \"sourceText\": \"V3 V4\"}, {\"id\": \"70b71893-16d7-4ed2-8c07-02fb4e2289c2\", \"visitName\": \"Visit 4\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 11, \"sourceText\": \"V4 V5\"}, {\"id\": \"f3f0e9a9-b7e8-4de7-8ed9-094c00df09bc\", \"visitName\": \"Visit 5\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 12, \"sourceText\": \"V5 V6, V7\"}, {\"id\": \"7fafa452-77a2-433d-8820-352119b1814e\", \"visitName\": \"Visit 6\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 13, \"sourceText\": \"V6, V7 V8\"}, {\"id\": \"605243fb-6718-44fa-bb3d-3f10fab43912\", \"visitName\": \"Visit 7\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 14, \"sourceText\": \"V7 V8\"}, {\"id\": \"f5055b55-98f8-47a0-bbf1-4b9c7e966e9c\", \"visitName\": \"Visit 8\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 15, \"sourceText\": \"V8 V9\"}, {\"id\": \"625afb8d-80e5-43bf-b280-cb93e3a274f8\", \"visitName\": \"Visit 9\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 16, \"sourceText\": \"V9 V10\"}, {\"id\": \"ec6e3ace-0312-459d-983b-c095ab50a0cc\", \"visitName\": \"Visit 10\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 17, \"sourceText\": \"V10 V11, V12, V13, V14,\"}, {\"id\": \"1e7f410b-94bf-40f6-8054-67fa3c0fb6c7\", \"visitName\": \"Visit 11\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 18, \"sourceText\": \"V11, V12, V13, V14, V15, V16,\"}, {\"id\": \"2d8a15bd-c6b4-4bef-b8e0-2254c20c3c14\", \"visitName\": \"Visit 13\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 19, \"sourceText\": \"V13, V14, V15, V16, V17, V18\\u2026\"}, {\"id\": \"2e06f85b-480c-4c5a-934e-7c4f1a19ba76\", \"visitName\": \"Visit 15\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 20, \"sourceText\": \"V15, V16, V17, V18\\u2026 V12,\"}, {\"id\": \"c236c198-1084-4838-9544-eba8bc6fd134\", \"visitName\": \"Visit 17\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 21, \"sourceText\": \"V17, V18\\u2026 V12, V14,\"}, {\"id\": \"988c361d-f7fd-4183-8e4c-996befbe0401\", \"visitName\": \"Visit 12\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 22, \"sourceText\": \"V12, V14, V16,\"}, {\"id\": \"03d535c2-f2b3-4aee-80dc-80dcc12a3266\", \"visitName\": \"Visit 14\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 23, \"sourceText\": \"V14, V16, V18\\u2026\"}, {\"id\": \"4a215c7c-44f9-433d-9183-74ab3a04eb07\", \"visitName\": \"Visit 16\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 24, \"sourceText\": \"V16, V18\\u2026 pEOTe\"}, {\"id\": \"4ebfbed3-07d2-45c7-87c4-7c39877a7240\", \"visitName\": \"Visit 18\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 25, \"sourceText\": \"V18\\u2026 pEOTe EOS\"}, {\"id\": \"42520a59-2cce-485e-9dc2-383b17a52049\", \"visitName\": \"Randomization\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 26, \"sourceText\": \"SAR442168 tablet daily. Randomization will be stratified by the Expanded Disability Status Scale (EDSS) score at screening (<4 versus \\u22654) and geographic region (US versus non-US). Study intervention(s\"}, {\"id\": \"8ca22cce-af9a-4684-9d8b-93960e601cce\", \"visitName\": \"Week 3\", \"targetDay\": 15, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 27, \"targetWeek\": 3, \"epoch\": \"Treatment\", \"sourceText\": \"Week 3 added in the visit header and in footnote \\u2018l\\u2019. Update.\"}, {\"id\": \"063cb842-c547-4b4f-8a88-6ca8b8ece96b\", \"visitName\": \"Week 4\", \"targetDay\": 22, \"windowBefore\": 4, \"windowAfter\": 4, \"isRequired\": true, \"visitNumber\": 28, \"targetWeek\": 4, \"sourceText\": \"within 4 days and 1 during the 60 mg SAR442168 treatment period [at Week 4, 107 U/L (normal range 6 to 34 U/L)]. The participant in the 60 mg group had slightly elevated ALT at screening (48 U/L) and \"}, {\"id\": \"2a7b86c5-daca-493f-a01e-11b8a0254d2a\", \"visitName\": \"Week 8\", \"targetDay\": 50, \"windowBefore\": 4, \"windowAfter\": 4, \"isRequired\": true, \"visitNumber\": 29, \"targetWeek\": 8, \"sourceText\": \"period [at Week 8, 105 U/L (normal range 6 to 34 U/L)] that returned to normal range within 4 days and 1 during the 60 mg SAR442168 treatment period [at Week 4, 107 U/L (normal range 6 to 34 U/L)]. Th\"}, {\"id\": \"66b6f7e5-2c9b-4d25-b26b-5152ab83eb8a\", \"visitName\": \"Week 16\", \"targetDay\": 106, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 30, \"targetWeek\": 16, \"sourceText\": \"Week 16 in the SAR442168 30 mg group and 1 event on Day 1 in the SAR442168 60 mg group, with occult blood noted in urine) were reported during the treatment period in the SAR442168 Phase 2b trial. The\"}, {\"id\": \"af274d92-4559-441a-b740-ad8300fa24dc\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 31, \"sourceText\": \"and follow-up assessments Liver function test monitoring guidance provided.\"}]"
              },
              {
                "id": "47961986-11d8-47f3-a8ac-11c6053d4e41",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-randomizationScheme",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"b122be69-9ac8-42b3-a028-f203538df2f9\", \"ratio\": \"1:1\", \"method\": \"Stratified randomization\", \"centralRandomization\": true, \"stratificationFactors\": [{\"id\": \"27814f0f-c49d-42c1-b0d1-88f88bdd6441\", \"name\": \"Region\", \"categories\": [\"North America\", \"Europe\", \"Asia\", \"Rest of World\"], \"isBlocking\": false, \"sourceText\": \"the expanded disability status scale \\n(edss) score at screening (<4 versus \\u22654) and geographic region (us versus non-us)\"}, {\"id\": \"18571f3a-8a9b-4cf8-8fef-a35ff329618e\", \"name\": \"Expanded Disability Status Scale (EDSS) score at screening\", \"categories\": [\"<4\", \"\\u22654\"], \"isBlocking\": false}, {\"id\": \"d4513339-5a9e-406e-8a14-ea4a1aa550d2\", \"name\": \"Geographic region\", \"categories\": [\"US\", \"non-US\"], \"isBlocking\": false}], \"sourceText\": \"Amended Clinical Trial Protocol 11  \\n20-Dec-2023 \\nSAR442168-EFC16034 - tolebrutinib \\nVersion number: 1 \\nProperty of the Sanofi group - strictly confidential \\nPage 12 \\nObjectives \\nEndpoints \\n\\u2022 \\nTo eval\"}"
              },
              {
                "id": "ext_execution_model_3579658c-0e23-4582-851c-98ff35928fc7",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T04:59:51.406843",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "e2c5bd20-140d-46c1-9b04-9eedfaa4c4ac",
                        "definition": "First administration of investigational product",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 60,
                        "sourceText": "first dose",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "3b6a57cd-107d-48b6-bf3a-b926f34a3d20",
                        "definition": "Date of subject randomization",
                        "anchorType": "Randomization",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 40,
                        "sourceText": "Randomization visit",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "3be0d886-7787-4d46-827a-fabd8eeaea16",
                        "definition": "Screening visit",
                        "anchorType": "Screening",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 20,
                        "sourceText": "screening period",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "e4d54fbc-238a-4f1c-9941-db2bc2b8acc6",
                        "definition": "Informed consent obtained",
                        "anchorType": "InformedConsent",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 10,
                        "sourceText": "Informed \nconsent",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "dfccf554-c2b4-414d-baef-df3fbd789df2",
                        "definition": "Procedure",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 100,
                        "sourceText": "Procedure",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "9b563e26-94ca-4fec-83f9-ade5e8d38119",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "once daily"
                      },
                      {
                        "id": "f47ba148-3519-43b6-89b7-13d3338cb086",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "Once daily"
                      },
                      {
                        "id": "bb045e62-5631-4577-9619-4a99bb92645f",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "d66a8c7e-3406-430b-a42d-3b5e6ec3f70a",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "OD"
                      },
                      {
                        "id": "b02325d1-52e8-4dcd-b88e-226c8972749d",
                        "type": "Interval",
                        "sourceText": "tid"
                      },
                      {
                        "id": "41b10db5-a081-4d68-abb2-38d3c625167a",
                        "type": "Continuous",
                        "startOffset": "-P28D",
                        "endOffset": "-P1D",
                        "sourceText": "Day-28 to Day-1"
                      },
                      {
                        "id": "0a59707a-6f7d-49b0-bba6-668930b330b1",
                        "type": "Continuous",
                        "startOffset": "-P28D",
                        "endOffset": "-P1D",
                        "sourceText": "Day -28 to Day -1"
                      },
                      {
                        "id": "350cb697-f942-43cb-a64a-c63f5cc39336",
                        "type": "Continuous",
                        "sourceText": "screening period"
                      },
                      {
                        "id": "e22cf613-3b7c-44ad-950f-b56529699a38",
                        "type": "Continuous",
                        "sourceText": "Screening \nPeriod"
                      },
                      {
                        "id": "1fd12671-fd33-47f3-99b5-1eb77ffd3cae",
                        "type": "Continuous",
                        "sourceText": "Screening period"
                      },
                      {
                        "id": "0f644d8f-0af8-4cf4-8f3f-0cd034520c9e",
                        "type": "Continuous",
                        "sourceText": "Screening Period"
                      },
                      {
                        "id": "8a73cb71-4b1a-4b1b-986b-8372ec1be7c2",
                        "type": "Continuous",
                        "sourceText": "Washout period"
                      },
                      {
                        "id": "448fdbe5-b52f-4907-b2ad-903eeeee8cfd",
                        "type": "Continuous",
                        "sourceText": "washout period"
                      },
                      {
                        "id": "0363fd6f-59b3-4317-9c5b-edf161d47b15",
                        "type": "Continuous",
                        "sourceText": "treatment period"
                      },
                      {
                        "id": "158a1c87-cbc4-4f61-bf44-2149c3d64133",
                        "type": "Continuous",
                        "sourceText": "Treatment Period"
                      },
                      {
                        "id": "95b379e6-7173-471e-ba30-783047a81bb5",
                        "type": "Continuous",
                        "sourceText": "observation \nperiod"
                      },
                      {
                        "id": "8bee80aa-5dee-4fef-890e-11c298249f84",
                        "type": "Continuous",
                        "sourceText": "follow-up period"
                      },
                      {
                        "id": "144f8388-c485-417b-9143-118113a0cab5",
                        "type": "Continuous",
                        "sourceText": "7 days pre"
                      },
                      {
                        "id": "caefe85f-3573-4899-af40-103975f8aa61",
                        "type": "Continuous",
                        "sourceText": "24 hours before"
                      },
                      {
                        "id": "0880a0fd-8363-4c8e-b950-daa0342a4393",
                        "type": "Continuous",
                        "sourceText": "8 days before"
                      },
                      {
                        "id": "d3dc00bd-b99d-4469-b531-90a839d125c9",
                        "type": "Daily",
                        "startOffset": "P0D",
                        "interval": "P1D",
                        "minObservations": 1,
                        "exitCondition": "End of study period",
                        "sourceText": "To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio)"
                      },
                      {
                        "id": "ae7a3153-17c6-492f-b8c7-62b77d67cabf",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "minObservations": 1,
                        "exitCondition": "End of study period",
                        "sourceText": "ARR during the study period assessed by confirmed protocol-defined adjudicated relapses"
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "86036aa9-c2de-4c6f-8237-1c64414e9704",
                        "requiredSequence": [
                          "epoch_1",
                          "epoch_3",
                          "epoch_4",
                          "epoch_6",
                          "epoch_7"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "7cfab4a0-7b22-4ed5-87d4-456bf222ad5c"
                        ],
                        "mandatoryVisits": [
                          "Day 1",
                          "End of Study",
                          "Screening"
                        ],
                        "sourceText": "[{'condition': 'If subject experiences AE requiring discontinuation', 'path': ['DEFINITIVE_DISCONTINUATION', 'EARLY_TERMINATION_VISIT', 'SAFETY_FOLLOW_UP']}, {'condition': 'Temporary discontinuation', 'path': ['TEMPORARY_DISCONTINUATION', 'RECHALLENGE', 'RESUME_TREATMENT']}, {'condition': 'Suspected MS relapse', 'path': ['UNSCHEDULED_ASSESSMENT_VISIT']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Blood Sample",
                        "executionType": "Recurring",
                        "rationale": "RECURRING signals: 1"
                      },
                      {
                        "activityId": "Vital Signs",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Electrocardiogram",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Ae",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Concomitant \nMedications",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 3"
                      },
                      {
                        "activityId": "Laboratory Assessments",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pharmacodynamic",
                        "executionType": "Recurring",
                        "rationale": "RECURRING signals: 1"
                      },
                      {
                        "activityId": "Imaging",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Questionnaire",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Liver function test monitoring",
                        "executionType": "Episode",
                        "rationale": "Appendix 6 describes actions and follow-up assessments based on specific liver safety criteria and decision points."
                      },
                      {
                        "activityId": "Week 3 Visit",
                        "executionType": "Single",
                        "rationale": "The amendment adds a specific one-time visit header at Week 3."
                      },
                      {
                        "activityId": "Schedule of Activities (SoA)",
                        "executionType": "Recurring",
                        "rationale": "The SoA outlines assessments that are repeated across multiple study visits throughout the Phase 3 trial."
                      },
                      {
                        "activityId": "CYP3A and CYP2C8 inhibitor monitoring",
                        "executionType": "Window",
                        "rationale": "The protocol requires continuous restriction and monitoring of prohibited medications (e.g., grapefruit juice) throughout the treatment period."
                      }
                    ],
                    "footnoteConditions": [
                      {
                        "id": "3ee2fd2b-9af9-4483-87b3-d007008df39d",
                        "conditionType": "eligibility_conditional",
                        "text": "a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs are available at site. The interval between screening and randomization visits can range from 11 days (minimum) to 28 days (maximum). However, if required, the randomization visit can be performed earlier than 11 days upon IMP receipt at the site, assuming the participant is eligible for randomization. In case the screening MRI must be rescheduled (eg, technical issues) or repeated, an additional 1 week (7 days) is allowed.",
                        "footnoteId": "a42e01f3-b62a-4d2b-8bcd-6e6a28142334",
                        "structuredCondition": "duration.between(Screening, Randomization).min(P11D).max(P28D)",
                        "appliesToActivityIds": [
                          "Randomization"
                        ],
                        "sourceText": "a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs a"
                      },
                      {
                        "id": "cacc1fa6-47ee-4bab-bcd8-5daa9e6a07d4",
                        "conditionType": "general",
                        "text": "b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evaluation of an adverse event). Assessments may be done as needed to evaluate the participant in accordance with the Investigator's best judgment and in line with the study protocol. At a minimum, a physical examination should be performed, and, body temperature and vital signs should be measured.",
                        "footnoteId": "f259342e-cea8-4b61-8767-5871a75ba784",
                        "structuredCondition": "frequency.unscheduled(as_needed)",
                        "appliesToActivityIds": [
                          "Physical examination",
                          "Body temperature",
                          "Vital signs"
                        ],
                        "sourceText": "b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evalu"
                      },
                      {
                        "id": "f96ab69c-e74d-40e1-a088-8131130a356f",
                        "conditionType": "general",
                        "text": "c At the EOS, the participants who have completed the study and remain on IMP will be offered participation in a long-term safety study. Follow-up visit assessment only performed for those participants who are not willing to take part in the long-term safety study. For other situations where a follow-up visit is needed, please see Section 7.1 and the Study Manual.",
                        "footnoteId": "b2d81bfc-9c9b-4d42-81dd-ccf38d92f369",
                        "structuredCondition": "eligibility.not_enrolled(Long-term safety study)",
                        "appliesToActivityIds": [
                          "afa51bac-cc9d-46d1-bcc2-3816a6882d81"
                        ],
                        "sourceText": "c At the EOS, the participants who have completed the study and remain on IMP will be offered partic"
                      },
                      {
                        "id": "bfd1dd6b-a293-4636-8916-37e4504579fe",
                        "conditionType": "general",
                        "text": "d These visits may be done as home health visits (where applicable) or onsite visits (preferable that tests are performed at the central laboratory). In any situations where this is not possible (to be documented in source documents), the tests for these visits may be performed at a local laboratory.",
                        "footnoteId": "9e2df569-4245-4cb9-aef7-7a8021ed7626",
                        "structuredCondition": "location.preference(Central Lab, Home Health, Local Lab)",
                        "appliesToActivityIds": [
                          "Laboratory tests"
                        ],
                        "sourceText": "d These visits may be done as home health visits (where applicable) or onsite visits (preferable tha"
                      },
                      {
                        "id": "2d0457f5-7228-4420-b65e-2c93e1fdf585",
                        "conditionType": "sequence",
                        "text": "e If a participant prematurely permanently discontinues treatment with IMP, the participant will undergo a premature EOT visit as soon as possible. Participants will then be asked to continue with the study visits as scheduled, until global EOS visit is reached. During these visits, all study procedures/assessments will be performed except IMP administration and blood sampling for biomarkers (NfL, Chi3L1, and Ig levels). MRI scans for these participants will only be performed annually (using the next annual visit as the starting point).",
                        "footnoteId": "47a25e1e-69df-4167-a6c8-f1ce0bb75048",
                        "structuredCondition": "if(treatment_discontinued).exclude(IMP administration, Biomarkers).frequency(MRI, P1Y)",
                        "appliesToActivityIds": [
                          "IMP administration",
                          "Blood sampling for biomarkers",
                          "MRI scans"
                        ],
                        "sourceText": "e If a participant prematurely permanently discontinues treatment with IMP, the participant will und"
                      },
                      {
                        "id": "40638b9c-7133-44b4-9fc9-583653b68e82",
                        "conditionType": "general",
                        "text": "f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected to be reached. The timing and window of this visit will be communicated to sites.",
                        "footnoteId": "8f191265-c2ce-4bb3-bf37-83759e313d26",
                        "sourceText": "f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected t"
                      },
                      {
                        "id": "dc64a076-23e1-4350-9808-60bb113fd692",
                        "conditionType": "timing_before",
                        "text": "g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need to be reported in the CRF; other prior medications will be reported for the period of 6 months prior to signing the ICF.",
                        "footnoteId": "ca7e3bb5-9feb-44e3-9118-b72d7195746a",
                        "structuredCondition": "history.report(DMT, all_prior); history.report(other, P6M).before(ICF)",
                        "appliesToActivityIds": [
                          "Prior medications"
                        ],
                        "sourceText": "g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need "
                      },
                      {
                        "id": "1ee95c47-2f61-46ca-81c9-aa3529aaa41c",
                        "conditionType": "eligibility_conditional",
                        "text": "h Additional safety assessments can be performed if required by local regulations; such testing may be performed locally. Additional visits may be added if required by local regulations.",
                        "footnoteId": "9a589c83-f860-4118-9a91-c651d78dfead",
                        "sourceText": "h Additional safety assessments can be performed if required by local regulations; such testing may "
                      },
                      {
                        "id": "dfa73aa0-56a2-4068-a1ba-0ee37ecb0a48",
                        "conditionType": "timing_after",
                        "text": "i Complete physical examination due at screening, baseline, yearly and EOS. Brief physical examination is sufficient for the rest of the visits (complete and brief physical examination will include neurological examination and collection of the following vital signs: arterial blood pressure, heart rate, and temperature).",
                        "footnoteId": "079a924e-432b-42ac-9050-e0b0ad4b01ea",
                        "structuredCondition": "if(Screening, Baseline, Yearly, EOS).type(Complete); else.type(Brief)",
                        "appliesToActivityIds": [
                          "Physical examination"
                        ],
                        "sourceText": "i Complete physical examination due at screening, baseline, yearly and EOS. Brief physical examinati"
                      },
                      {
                        "id": "bfb3e0de-9ee1-4b3c-8786-10b66cb0635e",
                        "conditionType": "general",
                        "text": "j To be performed at screening for all participants. To be repeated based on clinical judgment, borderline results, or clinical suspicion of TB infection. Screening tests for TB are described in Appendix 2 (Section 10.2).",
                        "footnoteId": "eb6372c1-e8de-48fe-8c26-deecb5d91aae",
                        "sourceText": "j To be performed at screening for all participants. To be repeated based on clinical judgment, bord"
                      },
                      {
                        "id": "4135eecb-45fd-439c-a43c-bc13b8aaf28e",
                        "conditionType": "sequence",
                        "text": "k Hematology (platelet count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, reticulocytes, white blood cell count with differential: neutrophils, lymphocytes, monocytes, eosinophils, basophils). Biochemistry (blood urea nitrogen [BUN], creatinine, glucose, potassium, sodium, chloride, bicarbonate, calcium; liver function tests [AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein; creatine phosphokinase], lipase at Screening Visit, then quarterly). Monthly visits (M1, M2, M4, M5) will include hematology and full liver panel only. Additional safety assessments can be performed if required by local regulations. Such testing shall be performed at local laboratories. Note: a one-time retest at screening may be performed if an abnormal laboratory test value is considered temporary. Additional visits may be added if required by local regulations.",
                        "footnoteId": "ad1194eb-cee6-4e18-8014-d50ff79614a7",
                        "structuredCondition": "if(M1, M2, M4, M5).subset(Hematology, Liver Panel); if(Screening).add(Lipase); else.frequency(Lipase, P3M)",
                        "appliesToActivityIds": [
                          "Hematology",
                          "Biochemistry",
                          "Lipase"
                        ],
                        "sourceText": "k Hematology (platelet count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume,"
                      },
                      {
                        "id": "42370122-b18e-4db6-b5d0-cf6f1637a73d",
                        "conditionType": "general",
                        "text": "l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver function tests will be collected (AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein) and creatine phosphokinase; these can be performed at central laboratory (preferred, as on-site visits or home nursing as applicable for the site) or at local laboratory.",
                        "footnoteId": "f003f225-db55-449c-8650-3b2739839f38",
                        "sourceText": "l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver fu"
                      },
                      {
                        "id": "b0ea2995-be26-45da-8c92-fafc88e1bb0a",
                        "conditionType": "timing_before",
                        "text": "m Serum Î²-HCG pregnancy test at central laboratory at screening and urine pregnancy tests within 24 hours before the first dose of IMP and at scheduled times during study. Additional serum or urine pregnancy tests may be performed, as determined necessary by the Investigator or required by local regulation, to establish the absence of pregnancy at any time during the participant's participation in the study. Communication by phone of the result of a pregnancy test performed at home to the site is allowed. See also Appendix 4 (Section 10.4).",
                        "footnoteId": "10e9062f-1b8d-4fb8-9421-5c656ad4e905",
                        "structuredCondition": "timing.before(the first dose of imp and at scheduled times during study. additional serum or urine pregnancy tests may be performed, as determined necessary by the investigator or required by local regulation, to establish the absence of pregnancy at any time during the participant's participation in the study. communication by phone of the result of a pregnancy test performed at home to the site is allowed. see also appendix 4 (section 10.4)., PT24M)",
                        "appliesToActivityIds": [
                          "Urine pregnancy test"
                        ],
                        "timingConstraint": "PT24H",
                        "sourceText": "m Serum Î²-HCG pregnancy test at central laboratory at screening and urine pregnancy tests within 24 "
                      },
                      {
                        "id": "3b43d65d-fa5b-4b0a-b88a-999445647728",
                        "conditionType": "general",
                        "text": "n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section 10.11.2]).",
                        "footnoteId": "ed474953-c5d5-4046-beed-0ac7023eb5ae",
                        "sourceText": "n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section "
                      },
                      {
                        "id": "db9aef8f-4767-46cb-af30-4f89b2ea2c01",
                        "conditionType": "general",
                        "text": "o Only in female participants, if needed to establish menopausal status.",
                        "footnoteId": "876c3230-56bd-4c47-a48e-fbc514bd2bb5",
                        "structuredCondition": "eligibility.sex(Female).and(status_unknown(Menopause))",
                        "appliesToActivityIds": [
                          "FSH/Hormone testing"
                        ],
                        "sourceText": "o Only in female participants, if needed to establish menopausal status."
                      },
                      {
                        "id": "b04407d8-4520-4bd4-a96c-e7d6ec1ff965",
                        "conditionType": "sequence",
                        "text": "p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not available at a given site due to reasons such as lack of translation, local certification, etc, then only the SDMT will be assessed for that participant.",
                        "footnoteId": "4cfb581e-fe4c-4fa0-9587-26477bd98e06",
                        "sourceText": "p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not availab"
                      },
                      {
                        "id": "1c3ae05a-264b-48a9-8d0a-13c73dda946c",
                        "conditionType": "timing_before",
                        "text": "q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further details will be defined in a separate central MRI manual. For systemic corticosteroids and adrenocorticotropic hormone, 1 month washout is required prior to the MRI scans. A visit window of Â±21 days is acceptable for MRIs performed after D1. The screening MRI scan should be performed as close as possible before the start of IMP. As much as possible, the MRI scan should be performed during the screening period after it has been established that the participant meets all inclusion and no exclusion criteria.",
                        "footnoteId": "3991a220-74c9-4108-972c-a20cc9196b68",
                        "structuredCondition": "timing.washout(Corticosteroids, P1M).before(MRI); timing.window(MRI, P21D).after(D1)",
                        "appliesToActivityIds": [
                          "MRI scans"
                        ],
                        "sourceText": "q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further d"
                      },
                      {
                        "id": "beb7d9b6-7ca3-4b8d-b995-7e091ef27867",
                        "conditionType": "timing_before",
                        "text": "r When available, clinical outcome assessments are to be completed by the participant prior to discussing their health status and prior to study treatment administration or other study-related procedures.",
                        "footnoteId": "e6be3874-b0e7-4009-afa1-b1c70e7945fa",
                        "structuredCondition": "sequence.before(Health_status_discussion, IMP_administration, Procedures)",
                        "appliesToActivityIds": [
                          "Clinical outcome assessments"
                        ],
                        "sourceText": "r When available, clinical outcome assessments are to be completed by the participant prior to discu"
                      },
                      {
                        "id": "4875fe04-bd55-4401-babd-e5329303ff15",
                        "conditionType": "general",
                        "text": "t Pharmacodynamics/biomarkers samples collected are not timed samples.",
                        "footnoteId": "3536d968-4b58-4f84-927c-797c601761d7",
                        "sourceText": "t Pharmacodynamics/biomarkers samples collected are not timed samples."
                      },
                      {
                        "id": "5eb7d209-5986-4d2b-aad8-cb073438fbe1",
                        "conditionType": "timing_after",
                        "text": "u The DNA testing may be done, if locally applicable, at any time after signature of consent (in case it could not be done for some reason at Day 1).",
                        "footnoteId": "4db4da9c-7278-4b8d-9539-4bc89a934534",
                        "sourceText": "u The DNA testing may be done, if locally applicable, at any time after signature of consent (in cas"
                      },
                      {
                        "id": "da10164c-0df5-41dc-9e6f-24505b765f26",
                        "conditionType": "general",
                        "text": "v This sample will be collected and stored for use if any unexpected safety issue occurs to ensure that a pre-dose baseline value is available for previously not assessed parameters (eg, serology) and for biomarkers research, if agreed.",
                        "footnoteId": "5b75b11c-ea51-4261-8e64-845478c9e891",
                        "sourceText": "v This sample will be collected and stored for use if any unexpected safety issue occurs to ensure t"
                      },
                      {
                        "id": "a01b7c7e-0719-4160-befc-1b08cb6d9726",
                        "conditionType": "timing_before",
                        "text": "w Samples for hematology and biochemistry tests on Day 1 (randomization) must be collected prior to administration of the first IMP dose.",
                        "footnoteId": "26452e9b-6393-4573-97de-04243ac26f67",
                        "structuredCondition": "timing.before(IMP_dose_1)",
                        "appliesToActivityIds": [
                          "Hematology",
                          "Biochemistry"
                        ],
                        "sourceText": "w Samples for hematology and biochemistry tests on Day 1 (randomization) must be collected prior to "
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "794e3730-9561-4bec-9f00-a47f3f947396",
                        "name": "Primary: Adjudicated Relapse Rate",
                        "endpointType": "Primary",
                        "inputs": [
                          "Relapse events",
                          "Adjudication status",
                          "Time on study"
                        ],
                        "timeWindow": {
                          "reference": "Treatment period",
                          "duration": "Study duration"
                        },
                        "algorithm": "Total number of adjudicated relapses / Total person-years of exposure",
                        "successCriteria": "Statistically significant reduction in annualized rate compared to control (alpha = 0.05)",
                        "sourceText": "Adjudicated relapse rate is the primary endpoint in this trial, being a standard endpoint used in pivotal RMS clinical studies"
                      },
                      {
                        "id": "a064521c-1fa6-41ac-a971-ae47a80e74d7",
                        "name": "Secondary: 6-month Confirmed Disability Worsening (CDW)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "EDSS score",
                          "Relapse onset date",
                          "Relapse resolution status",
                          "Screening EDSS"
                        ],
                        "timeWindow": {
                          "reference": "Initial onset of disability worsening",
                          "duration": "P6M"
                        },
                        "algorithm": "Onset of EDSS increase maintained for >= 6 months. Confirmation EDSS must be > 30 days after a confirmed relapse and in the absence of ongoing relapse. Intervening EDSS scores must also maintain the minimum increase.",
                        "successCriteria": "Maintenance of minimum EDSS increase from onset to 6-month confirmation visit",
                        "sourceText": "Six-month confirmed disability worsening (CDW) is selected as the key secondary endpoint... for the purpose of confirmation, only EDSS score(s) measured more than 30 days after the onset of a confirme"
                      },
                      {
                        "id": "2d64705f-d0cc-4121-a5b8-fd47e768f694",
                        "name": "Safety: Treatment-Emergent Adverse Events (TEAE)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "Adverse Event (AE) onset date",
                          "AE severity",
                          "Study intervention start date"
                        ],
                        "timeWindow": {
                          "reference": "Treatment period",
                          "duration": "From first dose to end of treatment"
                        },
                        "algorithm": "AEs that developed, or worsened, or became serious during the treatment period",
                        "successCriteria": "Descriptive analysis; no formal statistical significance testing",
                        "sourceText": "TEAEs are defined as AEs that developed, or worsened, or became serious during the treatment period."
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "f9ffb806-f5cf-4da0-ba87-9b15c0bb6c7f",
                        "name": "Annualized Adjudicated Relapse Rate (ARR)",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "Confirmed protocol-defined adjudicated relapses",
                          "Randomization date",
                          "Last contact date",
                          "EOS date"
                        ],
                        "derivationRule": "Total number of adjudicated relapses divided by observation duration (randomization to EOS or last contact date). Analyzed via negative binomial regression with log-transformed duration as offset.",
                        "baselineDefinition": "Not applicable (rate over study period)",
                        "analysisWindow": "Randomization to End-of-Study (EOS) or last contact date",
                        "imputationRule": "No imputation for unobserved events after study discontinuation",
                        "unit": "Relapses per year"
                      },
                      {
                        "id": "c48dcedf-dc28-4c02-ac00-681febebaa72",
                        "name": "Time to onset of 6-month Confirmed Disability Worsening (CDW)",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "EDSS score"
                        ],
                        "derivationRule": "Time from randomization to first EDSS increase (>=1.5 if baseline 0; >=1.0 if baseline 0.5-5.5; >=0.5 if baseline >5.5) confirmed at a scheduled visit at least 6 months later.",
                        "baselineDefinition": "Baseline EDSS score",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Study duration until EOS",
                        "imputationRule": "Kaplan-Meier estimates for censored data",
                        "unit": "Days/Months"
                      },
                      {
                        "id": "6d86097c-1648-4ea6-81ac-ba8d7fec8d08",
                        "name": "Total number of new and/or enlarging T2-hyperintense lesions",
                        "variableType": "Composite",
                        "sourceVariables": [
                          "T2-hyperintense lesions"
                        ],
                        "derivationRule": "Sum of the individual number of new and/or enlarging T2 lesions at all scheduled visits starting after baseline up to and including the EOS visit.",
                        "baselineDefinition": "Baseline MRI scan",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Post-baseline visits through EOS",
                        "imputationRule": "Not specified",
                        "unit": "Count"
                      },
                      {
                        "id": "9451abdf-fbc9-43d3-82de-bf7c46e77fa0",
                        "name": "Total number of new Gd-enhancing T1-hyperintense lesions",
                        "variableType": "Composite",
                        "sourceVariables": [
                          "Gd-enhancing T1-hyperintense lesions"
                        ],
                        "derivationRule": "Sum of the individual number of new Gd-enhancing T1-hyperintense lesions at all scheduled visits starting after baseline up to and including the EOS visit.",
                        "baselineDefinition": "Baseline MRI scan",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Post-baseline visits through EOS",
                        "imputationRule": "Not specified",
                        "unit": "Count"
                      },
                      {
                        "id": "5300792c-4d82-49a9-b09c-63ae5c92923d",
                        "name": "Time to Confirmed Disability Improvement (CDI)",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "EDSS score"
                        ],
                        "derivationRule": "Time to a >=1.0 point decrease on the EDSS from the baseline EDSS score confirmed over at least 6 months.",
                        "baselineDefinition": "Baseline EDSS score",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Study duration until EOS",
                        "imputationRule": "Not specified",
                        "unit": "Days/Months"
                      },
                      {
                        "id": "5383b686-1296-4197-afa4-2f664d637b8c",
                        "name": "Percent change in brain volume loss",
                        "variableType": "PercentChange",
                        "sourceVariables": [
                          "Brain volume"
                        ],
                        "derivationRule": "((EOS_value - Month6_value) / Month6_value) * 100",
                        "baselineDefinition": "Month 6 MRI scan (Reference point)",
                        "baselineVisit": "Month 6",
                        "analysisWindow": "Month 6 to EOS",
                        "imputationRule": "Not specified",
                        "unit": "%"
                      },
                      {
                        "id": "a0787d95-88dd-41ce-a59b-454e074ccad4",
                        "name": "Change in cognitive function (SDMT)",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "Symbol Digit Modalities Test (SDMT) score"
                        ],
                        "derivationRule": "EOS_score - baseline_score",
                        "baselineDefinition": "Last non-missing value prior to randomization",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Baseline to EOS",
                        "imputationRule": "Not specified",
                        "unit": "Score"
                      },
                      {
                        "id": "2bffccad-1e16-47b0-ae21-487657d90123",
                        "name": "Change in MSQoL-54 score",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "MSQoL-54 questionnaire score"
                        ],
                        "derivationRule": "EOS_score - baseline_score",
                        "baselineDefinition": "Last non-missing value prior to randomization",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Baseline to EOS",
                        "imputationRule": "Not specified",
                        "unit": "Score"
                      }
                    ],
                    "stateMachine": {
                      "id": "bb230d20-f605-47ff-bf67-71f7cb4b213a",
                      "initialState": "Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening",
                        "Year 1 (M12)",
                        "From M15 to EOS",
                        "For all participants",
                        "Only for participants who completed treatment to EOS but do not enter LTS",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening",
                          "toState": "Year 1 (M12)",
                          "trigger": "Progress to Year 1 (M12)"
                        },
                        {
                          "fromState": "Year 1 (M12)",
                          "toState": "From M15 to EOS",
                          "trigger": "Progress to From M15 to EOS"
                        },
                        {
                          "fromState": "From M15 to EOS",
                          "toState": "For all participants",
                          "trigger": "Progress to For all participants"
                        },
                        {
                          "fromState": "For all participants",
                          "toState": "Only for participants who completed treatment to EOS but do not enter LTS",
                          "trigger": "Progress to Only for participants who completed treatment to EOS but do not enter LTS"
                        },
                        {
                          "fromState": "Only for participants who completed treatment to EOS but do not enter LTS",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Screening": "epoch_1",
                        "Year 1 (M12)": "epoch_3",
                        "From M15 to EOS": "epoch_4",
                        "For all participants": "epoch_6",
                        "Only for participants who completed treatment to EOS but do not enter LTS": "epoch_7",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "83a717a1-d733-44c2-bfb3-d03e4d947ba1",
                        "treatmentName": "SAR442168",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 60.0,
                            "unit": "mg"
                          },
                          {
                            "amount": 14.0,
                            "unit": "mg"
                          }
                        ],
                        "durationDescription": "36 months",
                        "sourceText": "ation on Day 1. Screening Period Treatment Period : approximately 18 to 36 months All patients continue in the study until Common Study End (EOS) 0 12 24 15 18 Months Teriflunomide 14 mg Oral N=450 SA"
                      },
                      {
                        "id": "3e2b12e0-60d2-435b-930e-83c5ebb998ac",
                        "treatmentName": "the SAR442168",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 30.0,
                            "unit": "mg"
                          },
                          {
                            "amount": 60.0,
                            "unit": "mg"
                          }
                        ],
                        "sourceText": "ug by the Investigators. Both participants completed the DRI15928 study and successfully rolled over to the LTS follow-up study. â€¢ One event of mild petechia in a female participant (at Week 8 in the "
                      },
                      {
                        "id": "f5fe9f58-2abd-4b04-892c-9469c2ca9ac4",
                        "treatmentName": "SAR442168 (Tolebrutinib)",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 0.0,
                            "unit": "",
                            "description": "Dose not specified in provided text snippet"
                          }
                        ],
                        "durationDescription": "Not specified in text",
                        "doseModifications": [
                          "Liver function test monitoring guidance included for dose management"
                        ]
                      },
                      {
                        "id": "7e7cad11-f9d0-4476-9a46-0c6d19f5af3d",
                        "treatmentName": "Teriflunomide (Aubagio)",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 0.0,
                            "unit": "mg",
                            "description": "Standard clinical dose"
                          }
                        ],
                        "durationDescription": "Not specified in text"
                      },
                      {
                        "id": "6de16ec2-9ce9-4409-af76-68d1d97e91fe",
                        "treatmentName": "Placebo",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "durationDescription": "Not specified in text"
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "0a604d23-e223-4cc4-85d0-ec827e30a3d9",
                        "visitName": "screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening",
                        "sourceText": "(EDSS) score at screening (<4 versus â‰¥4) and geographic region (US versus non-US). Study intervention(s) Investigational medicinal product"
                      },
                      {
                        "id": "734caf1c-148e-4984-a413-ea5cb6d941fa",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2,
                        "sourceText": "10.6 Appendix 6: Liver and other safety: actions and follow-up assessments Liver function test monitoring guidance"
                      },
                      {
                        "id": "6e4f534d-8f1d-4e68-b1f0-2d14a8da537f",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 3,
                        "epoch": "Treatment",
                        "sourceText": "- increase of â‰¥1.5 points from the baseline Expanded Disability Status Scale (EDSS) score when the baseline score is 0, OR"
                      },
                      {
                        "id": "eef37c16-1391-4d01-ad10-84143272b70b",
                        "visitName": "EOS",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 4,
                        "epoch": "Treatment",
                        "sourceText": "Study (EOS) visit and number of new and/or enlarging T2-hyperintense lesions by visit over time â€¢"
                      },
                      {
                        "id": "94ae4794-9b30-41c6-8246-aa99443ba43e",
                        "visitName": "Month 6",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 5,
                        "epoch": "Treatment",
                        "sourceText": "scans at the EOS compared to Month 6 â€¢ Change in cognitive function at the EOS compared to baseline"
                      },
                      {
                        "id": "db43d034-9b4c-4b58-8f22-672b4e8ffd3b",
                        "visitName": "Month 24",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 6,
                        "sourceText": "The proportion of participants with events at given time points (eg, Month 24) will be calculated using the Kaplan-Meier estimates. In this primary ITT analysis:"
                      },
                      {
                        "id": "6c261d08-d1a2-4357-bc10-5277f8e65d08",
                        "visitName": "EOT",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 7,
                        "sourceText": "pEOTe EOSf â€œCommon"
                      },
                      {
                        "id": "1f26f312-0223-4edd-918d-6d45d3d9a80b",
                        "visitName": "Visit 1",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 8,
                        "sourceText": "Visit number V1 V2"
                      },
                      {
                        "id": "bdda1b0e-0b0a-4c5c-9605-f73d036f8c1d",
                        "visitName": "Visit 2",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 9,
                        "sourceText": "V2 V3"
                      },
                      {
                        "id": "d09afee1-cc69-421d-b813-f0a6340bfeb7",
                        "visitName": "Visit 3",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 10,
                        "sourceText": "V3 V4"
                      },
                      {
                        "id": "70b71893-16d7-4ed2-8c07-02fb4e2289c2",
                        "visitName": "Visit 4",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 11,
                        "sourceText": "V4 V5"
                      },
                      {
                        "id": "f3f0e9a9-b7e8-4de7-8ed9-094c00df09bc",
                        "visitName": "Visit 5",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 12,
                        "sourceText": "V5 V6, V7"
                      },
                      {
                        "id": "7fafa452-77a2-433d-8820-352119b1814e",
                        "visitName": "Visit 6",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 13,
                        "sourceText": "V6, V7 V8"
                      },
                      {
                        "id": "605243fb-6718-44fa-bb3d-3f10fab43912",
                        "visitName": "Visit 7",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 14,
                        "sourceText": "V7 V8"
                      },
                      {
                        "id": "f5055b55-98f8-47a0-bbf1-4b9c7e966e9c",
                        "visitName": "Visit 8",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 15,
                        "sourceText": "V8 V9"
                      },
                      {
                        "id": "625afb8d-80e5-43bf-b280-cb93e3a274f8",
                        "visitName": "Visit 9",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 16,
                        "sourceText": "V9 V10"
                      },
                      {
                        "id": "ec6e3ace-0312-459d-983b-c095ab50a0cc",
                        "visitName": "Visit 10",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 17,
                        "sourceText": "V10 V11, V12, V13, V14,"
                      },
                      {
                        "id": "1e7f410b-94bf-40f6-8054-67fa3c0fb6c7",
                        "visitName": "Visit 11",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 18,
                        "sourceText": "V11, V12, V13, V14, V15, V16,"
                      },
                      {
                        "id": "2d8a15bd-c6b4-4bef-b8e0-2254c20c3c14",
                        "visitName": "Visit 13",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 19,
                        "sourceText": "V13, V14, V15, V16, V17, V18â€¦"
                      },
                      {
                        "id": "2e06f85b-480c-4c5a-934e-7c4f1a19ba76",
                        "visitName": "Visit 15",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 20,
                        "sourceText": "V15, V16, V17, V18â€¦ V12,"
                      },
                      {
                        "id": "c236c198-1084-4838-9544-eba8bc6fd134",
                        "visitName": "Visit 17",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 21,
                        "sourceText": "V17, V18â€¦ V12, V14,"
                      },
                      {
                        "id": "988c361d-f7fd-4183-8e4c-996befbe0401",
                        "visitName": "Visit 12",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 22,
                        "sourceText": "V12, V14, V16,"
                      },
                      {
                        "id": "03d535c2-f2b3-4aee-80dc-80dcc12a3266",
                        "visitName": "Visit 14",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 23,
                        "sourceText": "V14, V16, V18â€¦"
                      },
                      {
                        "id": "4a215c7c-44f9-433d-9183-74ab3a04eb07",
                        "visitName": "Visit 16",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 24,
                        "sourceText": "V16, V18â€¦ pEOTe"
                      },
                      {
                        "id": "4ebfbed3-07d2-45c7-87c4-7c39877a7240",
                        "visitName": "Visit 18",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 25,
                        "sourceText": "V18â€¦ pEOTe EOS"
                      },
                      {
                        "id": "42520a59-2cce-485e-9dc2-383b17a52049",
                        "visitName": "Randomization",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 26,
                        "sourceText": "SAR442168 tablet daily. Randomization will be stratified by the Expanded Disability Status Scale (EDSS) score at screening (<4 versus â‰¥4) and geographic region (US versus non-US). Study intervention(s"
                      },
                      {
                        "id": "8ca22cce-af9a-4684-9d8b-93960e601cce",
                        "visitName": "Week 3",
                        "targetDay": 15,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 27,
                        "targetWeek": 3,
                        "epoch": "Treatment",
                        "sourceText": "Week 3 added in the visit header and in footnote â€˜lâ€™. Update."
                      },
                      {
                        "id": "063cb842-c547-4b4f-8a88-6ca8b8ece96b",
                        "visitName": "Week 4",
                        "targetDay": 22,
                        "windowBefore": 4,
                        "windowAfter": 4,
                        "isRequired": true,
                        "visitNumber": 28,
                        "targetWeek": 4,
                        "sourceText": "within 4 days and 1 during the 60 mg SAR442168 treatment period [at Week 4, 107 U/L (normal range 6 to 34 U/L)]. The participant in the 60 mg group had slightly elevated ALT at screening (48 U/L) and "
                      },
                      {
                        "id": "2a7b86c5-daca-493f-a01e-11b8a0254d2a",
                        "visitName": "Week 8",
                        "targetDay": 50,
                        "windowBefore": 4,
                        "windowAfter": 4,
                        "isRequired": true,
                        "visitNumber": 29,
                        "targetWeek": 8,
                        "sourceText": "period [at Week 8, 105 U/L (normal range 6 to 34 U/L)] that returned to normal range within 4 days and 1 during the 60 mg SAR442168 treatment period [at Week 4, 107 U/L (normal range 6 to 34 U/L)]. Th"
                      },
                      {
                        "id": "66b6f7e5-2c9b-4d25-b26b-5152ab83eb8a",
                        "visitName": "Week 16",
                        "targetDay": 106,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 30,
                        "targetWeek": 16,
                        "sourceText": "Week 16 in the SAR442168 30 mg group and 1 event on Day 1 in the SAR442168 60 mg group, with occult blood noted in urine) were reported during the treatment period in the SAR442168 Phase 2b trial. The"
                      },
                      {
                        "id": "af274d92-4559-441a-b740-ad8300fa24dc",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 31,
                        "sourceText": "and follow-up assessments Liver function test monitoring guidance provided."
                      }
                    ],
                    "randomizationScheme": {
                      "id": "b122be69-9ac8-42b3-a028-f203538df2f9",
                      "ratio": "1:1",
                      "method": "Stratified randomization",
                      "centralRandomization": true,
                      "stratificationFactors": [
                        {
                          "id": "27814f0f-c49d-42c1-b0d1-88f88bdd6441",
                          "name": "Region",
                          "categories": [
                            "North America",
                            "Europe",
                            "Asia",
                            "Rest of World"
                          ],
                          "isBlocking": false,
                          "sourceText": "the expanded disability status scale \n(edss) score at screening (<4 versus â‰¥4) and geographic region (us versus non-us)"
                        },
                        {
                          "id": "18571f3a-8a9b-4cf8-8fef-a35ff329618e",
                          "name": "Expanded Disability Status Scale (EDSS) score at screening",
                          "categories": [
                            "<4",
                            "â‰¥4"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "d4513339-5a9e-406e-8a14-ea4a1aa550d2",
                          "name": "Geographic region",
                          "categories": [
                            "US",
                            "non-US"
                          ],
                          "isBlocking": false
                        }
                      ],
                      "sourceText": "Amended Clinical Trial Protocol 11  \n20-Dec-2023 \nSAR442168-EFC16034 - tolebrutinib \nVersion number: 1 \nProperty of the Sanofi group - strictly confidential \nPage 12 \nObjectives \nEndpoints \nâ€¢ \nTo eval"
                    }
                  }
                }
              },
              {
                "id": "e35b0dcb-d9da-4ce0-a493-37822e4eb04f",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a Screening period can range from D-28 to D-1; Randomization visit can be performed only once IMPs are available at site. The interval between screening and randomization visits can range from 11 days (minimum) to 28 days (maximum). However, if required, the randomization visit can be performed earlier than 11 days upon IMP receipt at the site, assuming the participant is eligible for randomization. In case the screening MRI must be rescheduled (eg, technical issues) or repeated, an additional 1 week (7 days) is allowed.\", \"b From D1 to EOS, unscheduled visits may be performed at any time by the Investigator (eg, for evaluation of an adverse event). Assessments may be done as needed to evaluate the participant in accordance with the Investigator's best judgment and in line with the study protocol. At a minimum, a physical examination should be performed, and, body temperature and vital signs should be measured.\", \"c At the EOS, the participants who have completed the study and remain on IMP will be offered participation in a long-term safety study. Follow-up visit assessment only performed for those participants who are not willing to take part in the long-term safety study. For other situations where a follow-up visit is needed, please see Section 7.1 and the Study Manual.\", \"d These visits may be done as home health visits (where applicable) or onsite visits (preferable that tests are performed at the central laboratory). In any situations where this is not possible (to be documented in source documents), the tests for these visits may be performed at a local laboratory.\", \"e If a participant prematurely permanently discontinues treatment with IMP, the participant will undergo a premature EOT visit as soon as possible. Participants will then be asked to continue with the study visits as scheduled, until global EOS visit is reached. During these visits, all study procedures/assessments will be performed except IMP administration and blood sampling for biomarkers (NfL, Chi3L1, and Ig levels). MRI scans for these participants will only be performed annually (using the next annual visit as the starting point).\", \"f Common EOS visit will be done when the prespecified number of events for 6-month CDW is expected to be reached. The timing and window of this visit will be communicated to sites.\", \"g Any disease-modifying therapy for MS taken at any time prior to signing the informed consent need to be reported in the CRF; other prior medications will be reported for the period of 6 months prior to signing the ICF.\", \"h Additional safety assessments can be performed if required by local regulations; such testing may be performed locally. Additional visits may be added if required by local regulations.\", \"i Complete physical examination due at screening, baseline, yearly and EOS. Brief physical examination is sufficient for the rest of the visits (complete and brief physical examination will include neurological examination and collection of the following vital signs: arterial blood pressure, heart rate, and temperature).\", \"j To be performed at screening for all participants. To be repeated based on clinical judgment, borderline results, or clinical suspicion of TB infection. Screening tests for TB are described in Appendix 2 (Section 10.2).\", \"k Hematology (platelet count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, reticulocytes, white blood cell count with differential: neutrophils, lymphocytes, monocytes, eosinophils, basophils). Biochemistry (blood urea nitrogen [BUN], creatinine, glucose, potassium, sodium, chloride, bicarbonate, calcium; liver function tests [AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein; creatine phosphokinase], lipase at Screening Visit, then quarterly). Monthly visits (M1, M2, M4, M5) will include hematology and full liver panel only. Additional safety assessments can be performed if required by local regulations. Such testing shall be performed at local laboratories. Note: a one-time retest at screening may be performed if an abnormal laboratory test value is considered temporary. Additional visits may be added if required by local regulations.\", \"l At intermediate timepoints (W2, W3, W5, W6, W7, W9, W10, W11, M7, M8, M10, and M11), only liver function tests will be collected (AST, ALT, albumin, alkaline phosphatase, total and direct bilirubin, total protein) and creatine phosphokinase; these can be performed at central laboratory (preferred, as on-site visits or home nursing as applicable for the site) or at local laboratory.\", \"m Serum \\u03b2-HCG pregnancy test at central laboratory at screening and urine pregnancy tests within 24 hours before the first dose of IMP and at scheduled times during study. Additional serum or urine pregnancy tests may be performed, as determined necessary by the Investigator or required by local regulation, to establish the absence of pregnancy at any time during the participant's participation in the study. Communication by phone of the result of a pregnancy test performed at home to the site is allowed. See also Appendix 4 (Section 10.4).\", \"n Pregnancy tests will be performed monthly in all concerned EU countries (See Appendix 9, [Section 10.11.2]).\", \"o Only in female participants, if needed to establish menopausal status.\", \"p SDMT and CVLT-II will be performed in all participants. If for some reason, CVLT-II is not available at a given site due to reasons such as lack of translation, local certification, etc, then only the SDMT will be assessed for that participant.\", \"q A subset of sites that have 3T MRI capacity will perform additional sequences (eg, SWI). Further details will be defined in a separate central MRI manual. For systemic corticosteroids and adrenocorticotropic hormone, 1 month washout is required prior to the MRI scans. A visit window of \\u00b121 days is acceptable for MRIs performed after D1. The screening MRI scan should be performed as close as possible before the start of IMP. As much as possible, the MRI scan should be performed during the screening period after it has been established that the participant meets all inclusion and no exclusion criteria.\", \"r When available, clinical outcome assessments are to be completed by the participant prior to discussing their health status and prior to study treatment administration or other study-related procedures.\", \"s Where available per local regulations.\", \"t Pharmacodynamics/biomarkers samples collected are not timed samples.\", \"u The DNA testing may be done, if locally applicable, at any time after signature of consent (in case it could not be done for some reason at Day 1).\", \"v This sample will be collected and stored for use if any unexpected safety issue occurs to ensure that a pre-dose baseline value is available for previously not assessed parameters (eg, serology) and for biomarkers research, if agreed.\", \"w Samples for hematology and biochemistry tests on Day 1 (randomization) must be collected prior to administration of the first IMP dose.\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "c6db2baf-fa91-4a06-82d6-6d3cd1bbe411",
                "name": "SAR442168 Administration",
                "instanceType": "Administration",
                "dose": "60.0 mg / 14.0 mg",
                "doseFrequency": "QD",
                "route": {
                  "id": "690b92cb-a347-4acf-9140-4bc3c11b6186",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "36 months",
                "description": "ation on Day 1. Screening Period Treatment Period : approximately 18 to 36 months All patients continue in the study until Common Study End (EOS) 0 12 24 15 18 Months Teriflunomide 14 mg Oral N=450 SA"
              },
              {
                "id": "1bafe8d3-00a6-49ab-b577-f224cd2edf1a",
                "name": "the SAR442168 Administration",
                "instanceType": "Administration",
                "dose": "30.0 mg / 60.0 mg",
                "doseFrequency": "QD",
                "route": {
                  "id": "158e771a-90af-463a-b352-1734b3317782",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "description": "ug by the Investigators. Both participants completed the DRI15928 study and successfully rolled over to the LTS follow-up study. â€¢ One event of mild petechia in a female participant (at Week 8 in the "
              },
              {
                "id": "ec15042f-fb01-4c00-b92f-3eb9b881fa76",
                "name": "SAR442168 (Tolebrutinib) Administration",
                "instanceType": "Administration",
                "dose": "0.0 ",
                "doseFrequency": "QD",
                "route": {
                  "id": "b911f28d-0610-43c1-9a0a-a7b3baa74c4b",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "Not specified in text"
              },
              {
                "id": "2ff27d18-ff2c-49ec-9cb8-5d1f2d4befff",
                "name": "Teriflunomide (Aubagio) Administration",
                "instanceType": "Administration",
                "dose": "0.0 mg",
                "doseFrequency": "QD",
                "route": {
                  "id": "3813504c-a798-423e-93d1-3a69de39c2d5",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "Not specified in text"
              },
              {
                "id": "cfa94a7e-6ead-49b7-8521-e3e2bc2c8a34",
                "name": "Placebo Administration",
                "instanceType": "Administration",
                "doseFrequency": "QD",
                "route": {
                  "id": "7aa27279-8654-42f7-bb83-8918dcced0d3",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "Not specified in text"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "d7172e67-ecf3-487d-b5a3-42c4ac79d3fa",
            "text": "A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (AubagioÂ®) in participants with relapsing forms of multiple sclerosis (GEMINI 2)",
            "type": {
              "id": "1fde4cb4-c0f4-48d5-9924-feef000b910a",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "7dd03a76-2546-40c5-bc92-bb9a1a737a28",
            "text": "RMS study of BTK inhibitor tolebrutinib (SAR442168) (GEMINI 2)",
            "type": {
              "id": "e53d80f7-38dd-436a-a501-23105e885974",
              "code": "Brief Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Brief Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "65064799-f94f-4c1a-a335-bc45bdc26765",
            "text": "GEMINI 2",
            "type": {
              "id": "da4c4996-b272-4453-a3fc-908e1cc8b8f6",
              "code": "Study Acronym",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Acronym",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "709546c9-e5e4-4e23-af1d-7cdbb7b052c6",
            "text": "NCT04410991",
            "instanceType": "StudyIdentifier",
            "scopeId": "8e62c1f0-ef97-4eee-a4b1-bd03b8d79f2e",
            "type": {
              "code": "C172240",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinicaltrials.gov Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "a5a5a2d1-3762-4a5c-ab32-b3e56828cefb",
            "text": "EFC16034",
            "instanceType": "StudyIdentifier",
            "scopeId": "6cb0915e-8f71-4df9-9e12-b15199ac87e1",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "831a7a17-6ac5-4ceb-8fdc-c700f52d5fec",
            "text": "2020-000644-55",
            "instanceType": "StudyIdentifier",
            "scopeId": "fb07cc97-1f5c-42b2-ae05-98c0e229010e",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "4a6f7bf5-015c-4e3c-adeb-e8eaad3a8d25",
            "text": "140884",
            "instanceType": "StudyIdentifier",
            "scopeId": "d2cb75a6-261b-41b2-9a5e-1200d91c8a89",
            "type": {
              "code": "C218685",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "US FDA Investigational New Drug Application Number",
              "instanceType": "Code"
            }
          },
          {
            "id": "a9707404-24bd-4151-9dbc-da909b4f5f68",
            "text": "U1111-1238-1373",
            "instanceType": "StudyIdentifier",
            "scopeId": "51b26056-874b-49a2-a3f0-1820c17c9dff",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "e15d5f7a-0251-47f3-ab89-2cce09f7b0b1",
            "text": "VV-CLIN-0579233",
            "instanceType": "StudyIdentifier",
            "scopeId": "8e19c56e-1b0f-4a77-94e2-6615a455f965",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "6cb0915e-8f71-4df9-9e12-b15199ac87e1",
            "name": "Genzyme Corporation",
            "type": {
              "id": "3ec9448f-09ae-4689-adb8-61130bf12ca9",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Genzyme Corporation",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "8e19c56e-1b0f-4a77-94e2-6615a455f965",
            "name": "Sanofi",
            "type": {
              "id": "ce397136-e3ce-4a08-b6bd-a6ec2064bd75",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Sanofi",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "d2cb75a6-261b-41b2-9a5e-1200d91c8a89",
            "name": "FDA",
            "type": {
              "id": "d1deabb4-440a-4f62-8940-1febd93b0920",
              "code": "C25461",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Regulatory Agency",
              "instanceType": "Code"
            },
            "identifier": "FDA",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "6cb0915e-8f71-4df9-9e12-b15199ac87e1",
            "name": "North Central Neurology Associates, PC-Site Number:8400009",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "b9a39940-a760-49f8-9de1-2355a59a5990",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8e19c56e-1b0f-4a77-94e2-6615a455f965",
            "name": "Center for Neurology and Spine-Site Number:8400089",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "050cd47a-4e7d-4d3e-abbf-2bc0a81f363e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d2cb75a6-261b-41b2-9a5e-1200d91c8a89",
            "name": "Arcadia Neurology Center-Site Number:8400070",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "8ab2fd43-db8f-4f70-ba3b-1b79ee591f3c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3eeca508-7bf6-4fc2-bec0-5025096ef9c4",
            "name": "Multiple Sclerosis Center of California-Site Number:8400135",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "eec0c73a-92ff-4158-aec0-cec1917e038a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3dffeb90-95d8-4a6a-9f2a-a74450396f72",
            "name": "Harbor UCLA-Site Number:8400088",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "17aea6c3-9470-40f4-99f6-41221306ea88",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d103af87-edec-4b8c-a5f4-a58f5395928e",
            "name": "Mountain Neurological Research Center, Inc.-Site Number:8400128",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "1dcf76ff-1503-4008-9bf8-ac0be8f5a602",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "55789d35-d97f-49e6-b6c9-ea0b0c297f03",
            "name": "Advanced Neurosciences Research-Site Number:8400025",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "87bd71f8-b078-46cb-9c7d-fc88e1ea176c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "03b6510b-a5f2-431b-8192-ac0461904fe0",
            "name": "South Florida Neurology Associates-Site Number:8400029",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "58baa86e-7f17-40a1-8cec-b261f10d4fb4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2c949af8-7f0a-494f-a61c-4912de35701a",
            "name": "University of Florida Health-Site Number:8400159",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "410d7141-4778-4173-aefc-2c7a0f6d62b1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "35edb884-9065-4d10-91bc-3010becfd93a",
            "name": "Neurology Associates, PA-Site Number:8400004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "3bf4cb5b-d283-4ede-b337-497b5549403f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cddc602a-fa63-4187-bf7f-db5754af0e4f",
            "name": "University of Miami-Site Number:8400063",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "eaa89cdc-a26c-494c-b0e8-d3efdd542ab2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d9f9f643-778a-49cd-85cd-19230b0387fa",
            "name": "Infinity Clinical Research-Site Number:8400008",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "ab146a4c-bb40-4b82-a7d1-aebacd87c077",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f34740ec-b84b-4375-b5ee-f25b5e56a0aa",
            "name": "University of South Florida-Site Number:8400006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "55c68887-ca0c-44a1-908f-6237da4f8f61",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1967bd44-5efc-4a52-ba0a-6d6405e51bf9",
            "name": "Meridian Clinical Research-Site Number:8400003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "31dba00b-41b9-4492-b0c9-aea8e774eb08",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "64facd45-c978-4810-a649-aa8c5dd4d5f4",
            "name": "Consultants In Neurology-Site Number:8400011",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "f8e51b1e-d6d6-41f6-ae8e-9a7a989b79e9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3e5441f7-27e5-4a82-b988-524f6a7e8740",
            "name": "Prairie Education and Research Cooperative-Site Number:8400071",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "41cf51c2-4e7d-4067-93d0-c0359516198c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9f61eb99-35d2-4d01-a765-89a05cd765e1",
            "name": "Fort Wayne Neurological Center-Site Number:8400039",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "316a0d16-058d-4d38-b893-9116b9bf0a09",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8f69b607-84a7-47d2-a9ce-7eefe7043e59",
            "name": "CHI Saint Joseph Medical Group Neurology-Site Number:8400110",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "e8989613-17fe-4e0e-b9d4-f5b57beb62b9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1d1727da-0432-482e-be76-f78beed49559",
            "name": "University of Kentucky-Site Number:8400106",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "d820a719-4959-4285-b16b-cf02e9c4b6b9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2d5dac55-ae56-4a8f-885d-66c98d18e13f",
            "name": "Norton Neurology MS Services-Site Number:8400127",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "689ddc55-594a-400e-8540-1dbf79ac29fb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e80fc21b-b13f-44a9-8c9d-c07ad5629b85",
            "name": "The NeuroMedical Center-Site Number:8400057",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "72df1351-8b42-4cb2-814e-57405207b4cc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0bac265d-5088-4c40-8d14-831ab0be277c",
            "name": "International Neurorehabilitation Institute-Site Number:8400034",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "796943b7-d01b-47e4-b9c6-ef5c95c4ab46",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "52fa54da-2fa2-44ae-bd4e-6dec55721802",
            "name": "Wayne State University-Site Number:8400046",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "620ba45e-e0ca-4591-972a-59ea71993377",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3bc0291a-d4fa-43f4-8f47-6bcdf9945137",
            "name": "Minneapolis Clinic of Neurology-Site Number:8400051",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "4bcb5d60-26e6-494f-ada3-b9d0c35c1d6a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a3953972-c0d5-4722-a437-9d77951ee3a1",
            "name": "Saint Luke's Hospital-Site Number:8400153",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "f344a91e-407a-42a0-bc92-ce2f5e976a26",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "48ae3d39-ff20-4453-be05-94e0d93a6667",
            "name": "West Omaha Family Physicians-Site Number:8400139",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "a6e47c41-4862-47de-8a8f-df76f88561f5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e6d48366-126c-4539-9aa6-983876c1f470",
            "name": "University Of Nebraska-Site Number:8400129",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "84c7ca09-d274-4843-b5b3-482b357abf6e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e44c1040-e84b-49fa-9861-2fc5262e5341",
            "name": "Hackensack University Hospital-Site Number:8400047",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "c6aab21f-89f8-441f-8f0c-be4c02e3316c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b42b75de-0d84-423b-babc-3edb27a16c05",
            "name": "University of New Mexico-Site Number:8400032",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "95cb7254-3a97-4a8c-b03c-ad0ad9e88818",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f27be633-9522-42a1-8dc0-a64f9dc89c22",
            "name": "South Shore Neurologic Associates-Site Number:8400100",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "dd0b600c-ea8b-4bde-9e34-b07047de33e8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f9bebd15-9dc0-4c3e-a69d-cf830e8053bd",
            "name": "Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "2433b474-cce2-4601-8c9d-fd9dc16658d0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "05a82b6d-ecce-407b-8c4f-f9f9b7654975",
            "name": "Meridian Clinical Research, LLC-Site Number:8400005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "03586fae-8a6d-41d2-a5eb-f09d57146795",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0f2459ec-78cf-4dcb-89c4-bb297b46ed5d",
            "name": "Sanford Brain & Spine Center-Site Number:8400126",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "069bfd12-3358-4d99-aef2-b8c533941af2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "eb14bba8-e129-4a79-8f50-323126a5e72f",
            "name": "Dayton Center for Neurological Disorders-Site Number:8400081",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "74b24d1d-d1d4-4732-ac82-986cb08363bb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f26a2557-9f04-4af1-bd6f-27e7d183f25e",
            "name": "Jefferson Neurology Associates-Site Number:8400016",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "737111ac-3899-4d5b-a977-354fbefefea5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "934feb4c-93ab-469b-a28b-402865fba72e",
            "name": "Premier Neurology-Site Number:8400069",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "867aa3de-15be-4073-a4c5-bf350b236d2a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6030e5c6-5a94-49ec-93ba-4dec445dfd11",
            "name": "Advanced Neuroscience Center-Site Number:8400035",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "6db19d34-9a5a-4948-8a09-d096313f9212",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d3b63639-2168-4bc7-a0ba-d7534f5d2c37",
            "name": "Sibyl Wray, MD, Neurology, PC-Site Number:8400007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "dbf4cf2e-d003-495a-aabe-4dec91e6d8d7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "df26d784-b456-4149-8529-0673270e785f",
            "name": "Mt Olympus Medical Research-Site Number:8400163",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "8bee4a9a-1b25-4ebb-9a79-759a00e91b41",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "10216084-19d0-4e7b-b0b4-6b6029167957",
            "name": "Neurology Center of San Antonio-Site Number:8400036",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "c5063a7c-dee4-4aff-94f0-0c6f0fc6e640",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b01c47c7-141a-48a5-930e-4df9b67eea83",
            "name": "Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "41",
            "type": {
              "id": "53723a10-81c1-4119-b643-4ecab9ad556e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1fc1d33b-1f0f-465c-9498-697b54bc76d6",
            "name": "Neurological Associates-Site Number:8400097",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "42",
            "type": {
              "id": "ee942e15-92ef-4f1f-aa3f-46a884352e13",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c92ac317-3233-49a4-b972-f9b9af40efaf",
            "name": "Wheaton Franciscan Healthcare-Site Number:8400022",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "43",
            "type": {
              "id": "1b57716b-48b1-47b1-be6b-4fac9c0ddd25",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4d62d939-cec2-4c16-a8af-dd97a224b009",
            "name": "Investigational Site Number :0320004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "44",
            "type": {
              "id": "0009fff5-0f51-411c-bf14-ccef738b96fd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "994e40ef-d251-4540-9b6e-8fdfc2be6862",
            "name": "Investigational Site Number :0320002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "45",
            "type": {
              "id": "debdc16b-524a-45ff-8147-6c736e5d20b5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6075a72a-f70d-4e25-8f83-30c4a65b8caa",
            "name": "Investigational Site Number :0320001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "46",
            "type": {
              "id": "7e2562c5-c833-41de-ae3b-c4da86786dae",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fb41c990-182f-4cc9-81b4-c2652b168b28",
            "name": "Investigational Site Number :0320003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "47",
            "type": {
              "id": "f10b4e78-d341-41b8-bf95-bcf9c5a726ee",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5446dc92-544a-44d5-adf0-a08633f6dc33",
            "name": "Investigational Site Number :0320005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "48",
            "type": {
              "id": "598f6269-e500-4d03-ae28-4e662a27d300",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ceaf9114-45e8-4908-a026-fbde4c6c9f76",
            "name": "Investigational Site Number :0560005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "49",
            "type": {
              "id": "d3d750a2-0431-4837-a3ec-8d8331889ef6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "60142b92-de43-4dfe-a74a-e873c2e2f1d2",
            "name": "Investigational Site Number :0560004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "50",
            "type": {
              "id": "706b5bb0-84a8-496e-bb68-fd9c1bff2d9a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6fb86db2-5694-457f-bbe0-a08446fd1e5d",
            "name": "Investigational Site Number :0560002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "51",
            "type": {
              "id": "f9a715b8-e73f-4d6e-ab44-2105de4ec4d4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "762a26a1-f5f6-4077-98a9-31ae5906eb7a",
            "name": "Investigational Site Number :0560001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "52",
            "type": {
              "id": "b9da3c5a-7d96-4fd9-8a19-d99c53c978d9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3ef906b8-2f58-475c-a04e-3a642c6a7a5d",
            "name": "Investigational Site Number :0760001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "53",
            "type": {
              "id": "1e966147-680d-4ed5-9d56-f010ad580bfb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ef0ef553-3a94-4847-9df2-5826250a6fd8",
            "name": "Investigational Site Number :0760002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "54",
            "type": {
              "id": "383847aa-ff2c-474b-a45b-91a85e48bf4f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1c2eb71d-8c1a-4512-9413-e1f5097f2eba",
            "name": "Investigational Site Number :0760007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "55",
            "type": {
              "id": "302e2003-d9bb-4c1f-8f8d-776ae9b6b54b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2964f659-9466-4969-ab78-bd763bebdc92",
            "name": "Investigational Site Number :1240002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "56",
            "type": {
              "id": "71d573ba-7b27-46fb-afd2-a0ac5f3ab7f2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3a63e641-43c5-4e7c-ada8-386e7d30ce8d",
            "name": "Investigational Site Number : 1240012",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "57",
            "type": {
              "id": "99df3542-b1b3-4d00-8833-e0ed81a915d2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "71840b3e-7c19-4d31-82e5-054d7bb8d7a8",
            "name": "Investigational Site Number :1240014",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "58",
            "type": {
              "id": "fd1edee4-ae3d-405f-9d8f-5042466aff89",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3e66cc50-09b1-4da1-b09d-b0b5da6804c9",
            "name": "Investigational Site Number :1240005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "59",
            "type": {
              "id": "2bd94a0a-3c74-4d7e-ba20-1f83dcb93ceb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "177f46b5-dc33-49c7-806d-25c9cd2f0d68",
            "name": "Investigational Site Number :1240006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "60",
            "type": {
              "id": "2b60d0ab-2ff9-4e3b-8639-addfe16a31bd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dc962cbe-93b0-487a-ab6e-1f2ae7df15d3",
            "name": "Investigational Site Number :1240021",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "61",
            "type": {
              "id": "f0615532-2019-40fd-889b-8c5394427027",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c4f35ae8-a449-4f1e-bf92-c77f0c53ed9b",
            "name": "Investigational Site Number :1520002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "62",
            "type": {
              "id": "df508810-e281-42a0-8237-ff9e91d1321f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e5239829-1fec-4c22-9c88-ace940b903a7",
            "name": "Investigational Site Number :1520005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "63",
            "type": {
              "id": "42c45b66-856e-45b2-a8ee-43815f566807",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4fed151d-989e-4a45-ac1f-e54e296c836c",
            "name": "Investigational Site Number :1520001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "64",
            "type": {
              "id": "ca385a57-4ee3-4439-a7b2-59b68123b71b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fd3b4588-f5a3-41a5-a831-0ca8b68abc7b",
            "name": "Investigational Site Number :1520003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "65",
            "type": {
              "id": "9262fdb5-b2d2-4a96-b6f1-30660f175459",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a4fb15d7-2ee6-479b-ba3c-052786366d44",
            "name": "Investigational Site Number :1520006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "66",
            "type": {
              "id": "605d5b01-931b-47b4-8e66-b8a10eadf85c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ef2a177b-1957-4eee-8046-1a20756df63b",
            "name": "Investigational Site Number :1520004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "67",
            "type": {
              "id": "5232fd26-c9c9-4685-9484-a536448e664e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b70befb3-b45f-455f-988b-1e8daa5f7056",
            "name": "Investigational Site Number :1910001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "68",
            "type": {
              "id": "dce3c2f9-0489-4d33-9c62-09762e707afb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7d0a2089-e2dc-409e-a1b5-735333a9bc96",
            "name": "Investigational Site Number :1910002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "69",
            "type": {
              "id": "97721eb8-6629-45b6-9ec2-07e5cc178d0c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5dc1c2c4-2a04-42d6-8986-01b25dc435ec",
            "name": "Investigational Site Number :1910003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "70",
            "type": {
              "id": "cead5116-3de2-4181-99e9-6ebae116666e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c24230b2-039a-438a-8a20-b6cb3c2cd486",
            "name": "Investigational Site Number :2030002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "71",
            "type": {
              "id": "dfc6110d-ef9b-4916-8da8-d6829bf09e34",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e76ebce5-a71d-405b-9400-5a967cc13510",
            "name": "Investigational Site Number :2030011",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "72",
            "type": {
              "id": "226b3bb9-de0a-46df-b480-4175b5bdeb77",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7c43d38f-87e4-4761-9c43-fa7e50e6a279",
            "name": "Investigational Site Number :2030001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "73",
            "type": {
              "id": "2e7d9c79-118e-49d2-8cb0-d5b0edcc35a1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4f2f463e-8c6f-470f-9a53-762d418d1be4",
            "name": "Investigational Site Number :2030008",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "74",
            "type": {
              "id": "389fc739-ac3b-457c-95fa-735227d30d28",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "44fd72a6-91ed-42e7-ad48-12ac895e5aae",
            "name": "Investigational Site Number :2030005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "75",
            "type": {
              "id": "8a5ee111-9e1f-48ad-a932-01057ff20ea0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c50691f2-e49d-4c90-9a2c-bc05b0f35d06",
            "name": "Investigational Site Number :2500019",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "76",
            "type": {
              "id": "4def02da-3851-46ba-b92b-0d10b3a28fdf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "52163d6c-b034-4382-becf-110e249e4880",
            "name": "Investigational Site Number :2500018",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "77",
            "type": {
              "id": "cc309e93-18e4-44a1-87c1-ab0531b58e59",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "85f8205c-e645-48a8-b3ae-84adce5acff3",
            "name": "Investigational Site Number :2500011",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "78",
            "type": {
              "id": "00e10861-efe7-4763-8216-51265e7f301e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d1fc4caf-3e15-4ba1-bfbe-1dbf2bbc4590",
            "name": "Investigational Site Number :2500005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "79",
            "type": {
              "id": "88169d47-0b98-403f-83da-23ac3d69cccf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "01e6cbc9-9125-405c-a26d-55996ae76208",
            "name": "Investigational Site Number :2500006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "80",
            "type": {
              "id": "66f5db37-4d87-4470-b486-b07a4e0714ea",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4aafda55-2ff7-4ef0-976d-9bcfad2fce5d",
            "name": "Investigational Site Number :2500010",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "81",
            "type": {
              "id": "c4e5a436-a120-430e-a2ae-9b809b436c85",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f9834175-94c4-4b96-afdb-2cd220d141ad",
            "name": "Investigational Site Number :2500002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "82",
            "type": {
              "id": "48b8c38f-25b6-419d-97fa-3512f8d64586",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "60becd8e-5f1d-4204-9316-031ef19432ca",
            "name": "Investigational Site Number :2500017",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "83",
            "type": {
              "id": "0a5f66e3-77a3-4bcc-8bef-2873cb15fe9a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "683aaaa9-4203-4e46-a57a-4a979d34f2d3",
            "name": "Investigational Site Number :2500007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "84",
            "type": {
              "id": "4135342e-a006-41fd-9fda-136f0ed144f9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5be5f3b7-421a-4130-b79e-f45ebd122250",
            "name": "Investigational Site Number :2500004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "85",
            "type": {
              "id": "251a87fd-8578-43e3-b45a-ed944ec35207",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f3160375-fdb7-4401-bb0b-8b17a77d5c5d",
            "name": "Investigational Site Number :2500003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "86",
            "type": {
              "id": "c03f35dc-fb59-4381-9f0d-afae2adc8a23",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7b4b0f82-33b6-41df-94fb-8ddd95e0e2bc",
            "name": "Investigational Site Number :2500001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "87",
            "type": {
              "id": "d02c17a3-2a29-49f6-b17f-ebd5b94fa00f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1020286a-692c-4016-b0ae-5f16cb043f7c",
            "name": "Investigational Site Number :2760005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "88",
            "type": {
              "id": "c051e31f-cbdb-4659-bce8-d26b5c53d80f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "da4bf05b-920c-4b24-9f31-7b8c6742ee82",
            "name": "Investigational Site Number :2760015",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "89",
            "type": {
              "id": "80404124-dea5-4272-a606-6bc4ae3506ca",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "18260bfa-b973-4346-8a77-64507dda99f9",
            "name": "Investigational Site Number :2760014",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "90",
            "type": {
              "id": "d284291f-824d-4d67-8f2c-b802981f62e1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "404e692a-dd37-4e66-997c-4f58b09ad209",
            "name": "Investigational Site Number :2760020",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "91",
            "type": {
              "id": "d87b5f31-6e49-452d-827f-2007bddbd805",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8913feb9-2c96-4383-b2e6-93e97430ac2e",
            "name": "Investigational Site Number :2760012",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "92",
            "type": {
              "id": "66c64aa9-438f-45cd-b1ab-bdd1426c11bb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "960d5a17-f1a4-4b55-86a0-6f332e2711fd",
            "name": "Investigational Site Number :2760003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "93",
            "type": {
              "id": "901ce552-edeb-4a08-b614-4eb4fdb08c71",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "67fd9487-65ab-4e36-82c2-9fbf70818b26",
            "name": "Investigational Site Number :3000001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "94",
            "type": {
              "id": "0363150d-f1fb-430a-8a57-4cab0d6a8a6e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b73f0721-2a0e-4823-8b85-63d767cc1559",
            "name": "Investigational Site Number :3000006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "95",
            "type": {
              "id": "32073a55-b30e-4232-be80-8c93fe7eaa9b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "18ef153a-7353-43ac-a8d7-a437df02741a",
            "name": "Investigational Site Number :3000002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "96",
            "type": {
              "id": "b9bb9bd8-6694-4e32-b5ad-33c1bbbc78e4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0ef3ba49-ab7b-4834-8049-0c6eab064ae6",
            "name": "Investigational Site Number :3000007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "97",
            "type": {
              "id": "88361775-d497-446a-85e3-48cfaedf22cc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c1b8aa9f-27ff-4174-9b91-eaaa59971301",
            "name": "Investigational Site Number :3000009",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "98",
            "type": {
              "id": "cd53881d-aa53-4dec-a13b-854bd9f09f14",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3e6175c6-39ea-4afe-911d-198a20ede311",
            "name": "Investigational Site Number :3000004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "99",
            "type": {
              "id": "4dbd5c07-3dfb-455e-9827-14099f859785",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6f18e36b-5669-4d46-b46c-00e5c835d7fa",
            "name": "Investigational Site Number :3000003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "100",
            "type": {
              "id": "a6ab9f50-c3ce-4b1d-aa17-2ed86ffb3896",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f52dafe9-e955-4b59-93e8-8e1102ec71df",
            "name": "Investigational Site Number :3480105",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "101",
            "type": {
              "id": "b71aafb5-65db-48b0-b0ae-d0a2877f95fe",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5ef328b9-f4b8-4f48-beab-b43e8a323737",
            "name": "Investigational Site Number :3480102",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "102",
            "type": {
              "id": "b00a548c-648b-4a58-885e-974aa323f8c6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "13704691-d471-4b50-8ae2-43980bcea50e",
            "name": "Investigational Site Number :3480106",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "103",
            "type": {
              "id": "0af45e61-f717-4577-b63b-6c07ba9bcae8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c4b89350-f88d-46e2-bacc-8f329ba3d8a4",
            "name": "Investigational Site Number :3480103",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "104",
            "type": {
              "id": "7dc5c279-7dd4-42c8-a797-7be73213b4a4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "697771ff-72e2-4656-ab79-04ed301a0b75",
            "name": "Investigational Site Number :3560005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "105",
            "type": {
              "id": "3c16441a-9938-4841-bf52-987d83b0b88b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3e540d16-8440-4863-8a44-0d29bbe8b156",
            "name": "Investigational Site Number :3560007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "106",
            "type": {
              "id": "367ce047-92d2-499f-b39f-b09e7f85b739",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "33dbea1f-77f3-488c-aa3d-60abd98ef8b0",
            "name": "Investigational Site Number :3560008",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "107",
            "type": {
              "id": "6de660b2-15af-408f-869a-8b696f9d6f80",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5367a3b6-8901-4576-be21-76a9cedefdf8",
            "name": "Investigational Site Number :3560002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "108",
            "type": {
              "id": "ebeb8e90-75c3-4d02-b7ba-c3e3526f87da",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "33c533fc-bcc0-4a52-8bd6-ecfa129ed81b",
            "name": "Investigational Site Number :3560004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "109",
            "type": {
              "id": "722d1bdd-2cea-4a92-a0c4-cf8ebf65f08e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "edebe32f-99ce-477c-81ac-1e804a62ad16",
            "name": "Investigational Site Number :3760002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "110",
            "type": {
              "id": "1d3c8d6f-bc4c-4c96-bccb-4331321c46fd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "93522913-fa98-405d-919f-a85f5b763640",
            "name": "Investigational Site Number :3760003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "111",
            "type": {
              "id": "ab2bf16b-b5e7-495b-8e11-3b83cc7ca858",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cba63f1a-c6d8-4715-b080-76b5c6584b1c",
            "name": "Investigational Site Number :3760006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "112",
            "type": {
              "id": "d863e73e-7539-44bb-9b79-ae9cf46fc120",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7114310b-1c3c-4e6b-853f-539111ac4c01",
            "name": "Investigational Site Number :3760004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "113",
            "type": {
              "id": "9b8507c9-d8e8-46c8-9cbc-34433e0a9e10",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2e34d7a5-58a8-4e0d-9016-a45369c151e9",
            "name": "Investigational Site Number :3760001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "114",
            "type": {
              "id": "e94ba91f-a0cc-4016-a3c3-dd3f9f76cd7d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "12783a8b-867c-4613-8fe3-9f6584c188f9",
            "name": "Investigational Site Number :4280002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "115",
            "type": {
              "id": "47179678-5078-4e3d-a1f4-3472f217d9a6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "42df3892-5bd3-40e3-96a4-131bd7e3c504",
            "name": "Investigational Site Number :4280003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "116",
            "type": {
              "id": "373c0b72-0cb9-42da-b515-0d911761d7ee",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "73f1a114-3378-4bfa-bb3b-664216c1570b",
            "name": "Investigational Site Number :5280001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "117",
            "type": {
              "id": "40ccb53d-3aaa-4710-8dfe-9e97b0e4d09f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ef6c5137-c0f0-45f0-92ba-aee1e65c91c8",
            "name": "Investigational Site Number :5780002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "118",
            "type": {
              "id": "5e785cef-fb87-4874-8587-ecfd70d57f16",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b478cd0d-a059-4f96-9e6c-bd75fd8186e4",
            "name": "Investigational Site Number :5780001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "119",
            "type": {
              "id": "991709ef-c265-423b-adf4-bad642fbfa7a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dfd74492-1bf4-43c4-bf78-bae54b3ece81",
            "name": "Investigational Site Number :6200001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "120",
            "type": {
              "id": "1b648e7f-03b7-42a0-a129-a8a9e3563834",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5dba1bb1-4d43-47df-a1b6-13443e2b01e4",
            "name": "Investigational Site Number :6200005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "121",
            "type": {
              "id": "e7fd7db8-10db-41d2-84d6-43187e59db60",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "443a30fe-ef63-479c-b8e5-f97b359d5628",
            "name": "Investigational Site Number :6200011",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "122",
            "type": {
              "id": "1ac0ab26-4e38-4344-b2ac-0e0ba443fa64",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e2cabd3d-ac3c-42ca-bf9d-3bf6404f27d3",
            "name": "Investigational Site Number :6200006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "123",
            "type": {
              "id": "6c7a7aa6-5fec-442e-9161-1d5ca0dd41c7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f0b4b726-8202-4955-bdf4-20d0dd249b68",
            "name": "Investigational Site Number :6200002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "124",
            "type": {
              "id": "fb34592c-5cfc-4c81-80c3-1aeb3df23447",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "976637c1-b37c-44d6-8fbd-784c8178417d",
            "name": "Investigational Site Number :6200010",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "125",
            "type": {
              "id": "a116c111-f9ef-48a4-9e2f-1466ce2f4efd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "73040cea-90c5-40f2-b02a-a33047ba6ee7",
            "name": "Investigational Site Number :6200004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "126",
            "type": {
              "id": "d701bf8d-0470-4911-9b90-a1e4d726100a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1c3cbd26-0bc8-4736-ba95-c58b527ce49f",
            "name": "San Juan MS Center-Site Number:8400015",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "127",
            "type": {
              "id": "9452c706-5ade-4de5-9def-49f4e43b1165",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4293273e-7b78-4d9f-94bf-2199dbee4266",
            "name": "Investigational Site Number :6430006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "128",
            "type": {
              "id": "543be97e-bd07-4bbc-a32d-233105690421",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5a30e741-b6e8-4124-be9c-42d0f073e0a7",
            "name": "Investigational Site Number :6430013",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "129",
            "type": {
              "id": "0c11b0e7-af90-428b-90ab-b54f1bbb3ad6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "39b2333b-7075-42e6-888e-e94529f677f4",
            "name": "Investigational Site Number :6430001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "130",
            "type": {
              "id": "72a68404-aff0-4540-9a64-f417460672c0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "48d044a0-6205-4abb-a49d-ead738a955e1",
            "name": "Investigational Site Number :6430010",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "131",
            "type": {
              "id": "f869678a-255c-4103-8f29-47130762e16c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "db87785a-7968-4303-bf07-7a0d839b0d39",
            "name": "Investigational Site Number :6430007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "132",
            "type": {
              "id": "8d0a5ad8-97a8-478c-8dc5-b9ce13d038ae",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fd6e8d41-6156-4309-af80-a051e35d3dbd",
            "name": "Investigational Site Number :6430005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "133",
            "type": {
              "id": "77b6ecd2-bb24-4700-be5c-470a382fcb29",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0883197c-7491-441e-8596-600ffa5983a7",
            "name": "Investigational Site Number :6430003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "134",
            "type": {
              "id": "0ec065a1-9975-4288-aa4e-6aad99a48bd4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8d091fae-8ca0-4738-b59d-1468f256aa8e",
            "name": "Investigational Site Number :6430014",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "135",
            "type": {
              "id": "84e073c7-010d-4c8e-b024-7ed81f769207",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "15442c23-d050-4791-955c-8f0d72c94f2f",
            "name": "Investigational Site Number :6430004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "136",
            "type": {
              "id": "e5239944-1432-401a-acd3-c46e72d635ac",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cbba5303-6f25-4f40-8d0c-ce6a5b5d0a4f",
            "name": "Investigational Site Number :6430002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "137",
            "type": {
              "id": "f5c894aa-cee6-4a59-9f8e-a2d0cd0ee806",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ebb8fb30-9366-4a37-9796-9999888ba8d2",
            "name": "Investigational Site Number :6430011",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "138",
            "type": {
              "id": "1afef2d3-8b9a-46e4-b24d-e7a2ac71014a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "431c3571-db07-4b94-a874-2d0be8b55072",
            "name": "Investigational Site Number :6430012",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "139",
            "type": {
              "id": "fa68cb8b-f04c-4e53-b318-35c92e201c37",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4ec5c28a-d7b0-4b72-bec6-0c66585cb7bb",
            "name": "Investigational Site Number :6880001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "140",
            "type": {
              "id": "b00aadd5-88d3-4b6e-be3c-93ae118f60a5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b6acbb5f-0a65-488a-bcce-170f43c036a4",
            "name": "Investigational Site Number :6880003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "141",
            "type": {
              "id": "6e783873-3ed1-47d1-8567-ed07d4548ff2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b67f5df8-22a0-44a1-8702-e60daa3b30ea",
            "name": "Investigational Site Number :6880006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "142",
            "type": {
              "id": "c8d2c8c1-0ebd-48dd-a258-ae859cd9f093",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8273b8e6-db55-4161-89b9-d280178d7784",
            "name": "Investigational Site Number :6880002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "143",
            "type": {
              "id": "ab28cdb7-b739-488b-ba1b-997070cf4390",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "29756d1a-8332-40d3-95e7-c930dfbe47e2",
            "name": "Investigational Site Number :6880004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "144",
            "type": {
              "id": "0ccdf6af-e4f1-46ba-8ed0-17b42290b455",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "202c5a82-49d6-4f45-a288-e765f0065ced",
            "name": "Investigational Site Number :6880005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "145",
            "type": {
              "id": "beb9c3e1-3567-49d3-b560-c0102b78e2f0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fc64c130-73d8-45f4-885e-8d0cd8cdd40e",
            "name": "Investigational Site Number :7030001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "146",
            "type": {
              "id": "9afc87b4-2c69-44e3-97b6-b08575614f6f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "82c5b900-69c0-4b18-a70b-3abb85e67696",
            "name": "Investigational Site Number :7030002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "147",
            "type": {
              "id": "b186e45c-10b2-46ef-a61d-e13542286a68",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "01b524f0-3287-4e88-80cc-6f9f6a27fa90",
            "name": "Investigational Site Number :7030004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "148",
            "type": {
              "id": "9e1a32a8-34a3-4dc5-8e02-11f967fcfe7d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4966a44e-0f3c-42a3-8d27-6c928cf1ca9a",
            "name": "Investigational Site Number :4100001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "149",
            "type": {
              "id": "c0ec1502-9311-4ba5-be9c-59296e87e4e3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b5ebc3b9-9a31-40cb-9f3d-d52b6bfb9844",
            "name": "Investigational Site Number :4100003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "150",
            "type": {
              "id": "13630920-2c85-4249-b174-7887eeca00bc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a480b29d-9ae3-408b-8076-e86fd0eca4ae",
            "name": "Investigational Site Number :4100006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "151",
            "type": {
              "id": "c7692dff-f4a4-4618-9094-b5189ce412d9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a976fe13-6ca6-414e-bccd-3762a137ed86",
            "name": "Investigational Site Number :4100002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "152",
            "type": {
              "id": "5bbf13fd-4e56-4f4e-a7e7-df153eb75c1f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d918f3ba-d0a3-45a6-9421-11c9e3404c0d",
            "name": "Investigational Site Number :7240011",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "153",
            "type": {
              "id": "278c73e7-0b00-4ac9-aafe-3cb8e167c0e5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "911c0718-dd16-4669-8166-b3cd5bd2405d",
            "name": "Investigational Site Number :7240006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "154",
            "type": {
              "id": "0c329ff1-de8f-43c3-bbf7-4e5bef05012e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2c02ba7b-0520-40f0-88fd-c130b44600a9",
            "name": "Investigational Site Number :7240009",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "155",
            "type": {
              "id": "2762435f-dc2e-4c31-99ba-9a3fffa742a4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d085ddcf-68de-4db5-9607-a45c5efa3afc",
            "name": "Investigational Site Number :7240004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "156",
            "type": {
              "id": "9f83341b-4021-47e1-9d73-579035275079",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b613a846-2bde-42f8-a150-1cd616a96215",
            "name": "Investigational Site Number :7240013",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "157",
            "type": {
              "id": "08e54cd9-76f1-4890-a8d8-702ea4391f5c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "69d62598-a339-49be-85dc-b0ac49e6511f",
            "name": "Investigational Site Number :7240008",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "158",
            "type": {
              "id": "80bd083b-4f44-458e-949f-2c15e92b936a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "787186be-7c08-404c-8139-66fb14ff02fb",
            "name": "Investigational Site Number :7240007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "159",
            "type": {
              "id": "8601409a-bc1e-4062-b8be-e3c92c7a3cd4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b2a73256-c46a-4b5a-b41d-036f2559fcf6",
            "name": "Investigational Site Number :7240005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "160",
            "type": {
              "id": "32525cb0-c6f7-46f9-b915-bb11734e02bf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e7528012-324d-4f66-8f2d-13c33585f482",
            "name": "Investigational Site Number :7240003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "161",
            "type": {
              "id": "6ee77fcb-ad5f-4a63-80ef-0f0c885281db",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f5cdd9c3-a928-406b-bf2d-92b043bd0d2f",
            "name": "Investigational Site Number :7240001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "162",
            "type": {
              "id": "0593bfee-1ae4-46d3-b4d7-e5cf65d7cb11",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3de1a546-6943-4b52-a4ea-f17238ff00dd",
            "name": "Investigational Site Number :7240002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "163",
            "type": {
              "id": "d5528680-b0ea-477e-aeb6-e9cce1100323",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0b9db1e7-5214-48b4-bf57-22fef5951248",
            "name": "Investigational Site Number :7240010",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "164",
            "type": {
              "id": "6e431d6f-fcc7-45af-941d-abf4c1b1e92c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "62f03c0a-9ec2-41f8-b869-9c48ef41ce86",
            "name": "Investigational Site Number :7240012",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "165",
            "type": {
              "id": "734ee601-b044-49a4-8d56-ed215a4d89bb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "21721cdb-e654-42b2-8d22-f81a232c9827",
            "name": "Investigational Site Number :7560003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "166",
            "type": {
              "id": "764beb13-4778-43b0-9798-1cb9e5b4265a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e0819f88-f362-4f7e-b68f-250f32d510a5",
            "name": "Investigational Site Number :7560002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "167",
            "type": {
              "id": "ca87c7c4-c238-45ba-afb8-3f32b0b15478",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5aba3829-5e19-484a-a99b-5fafd4692021",
            "name": "Investigational Site Number :7560004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "168",
            "type": {
              "id": "84019aef-791a-40fa-997f-c10dfd0ab9d4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "22e7721d-bcea-47b5-8c69-82ef50aad302",
            "name": "Investigational Site Number :7920002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "169",
            "type": {
              "id": "14b2dcd5-adf9-4433-97ed-8fd2f4f9e5bd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9f86593d-bdde-41b3-9746-5b02b3f22501",
            "name": "Investigational Site Number :7920005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "170",
            "type": {
              "id": "d9e3693e-255a-4841-87f7-50914a1339ff",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4f538be1-bd44-41a6-8451-507e44d91aad",
            "name": "Investigational Site Number :7920006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "171",
            "type": {
              "id": "8887754c-9f49-4a0d-bd03-c7631729551d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ac8acbf8-dfb9-4a77-bcd8-ad7ba5bccafc",
            "name": "Investigational Site Number :7920004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "172",
            "type": {
              "id": "2b5c04da-51cb-4c51-b6cd-8a48a60a00ba",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "760911cd-6a72-42fb-ac85-1bc80299bf85",
            "name": "Investigational Site Number :7920001",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "173",
            "type": {
              "id": "6cae8048-f7cb-45ef-849a-f14aa915b935",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "46e6c1c6-7cb6-4cc0-b607-c586a1c02a77",
            "name": "Investigational Site Number :7920003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "174",
            "type": {
              "id": "1982eb51-4e46-4ce3-a800-e1708ae64061",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d30db27b-d464-412c-a77e-57d91f7005f5",
            "name": "Investigational Site Number :8040020",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "175",
            "type": {
              "id": "b1ecac30-9778-4421-a3c1-1e8b86c0f097",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9085c3f1-c281-4887-b4e7-b3a603efe095",
            "name": "Investigational Site Number :8040002",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "176",
            "type": {
              "id": "53c33253-2d95-49a6-b72a-c456c52dd0c4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a0031450-e0e2-4c9c-a90a-44310c6bd61c",
            "name": "Investigational Site Number :8040019",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "177",
            "type": {
              "id": "ebbf1724-4feb-44be-9bbc-7762d5e2c377",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "704f3d82-3036-4254-b34b-a2fde53307b4",
            "name": "Investigational Site Number :8040005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "178",
            "type": {
              "id": "7a17ae2d-0977-43e3-8f48-4e9b64b6a1fe",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2850b3f4-b506-4b0a-a6c4-a3f6bfc8969f",
            "name": "Investigational Site Number :8040022",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "179",
            "type": {
              "id": "fc39a01c-f26b-46c9-8ca8-76ce6fc9cd3b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a9dc36fe-3d95-4fb0-b1fc-63b8cbef8119",
            "name": "Investigational Site Number :8040018",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "180",
            "type": {
              "id": "ec7a0fef-e485-43a2-8ce6-14df5b2c0fb1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7e4911bd-b16e-4435-8407-c4851a3246d5",
            "name": "Investigational Site Number :8040007",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "181",
            "type": {
              "id": "8f1ae6bb-1bbb-43ff-8aa2-4bceb57f0bc9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0a15f614-1bef-4679-b72a-a47d344a56c4",
            "name": "Investigational Site Number :8040006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "182",
            "type": {
              "id": "4a962f47-93a0-4ab7-9508-0d7c9ac19db3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c1c3bdba-21a1-44b9-a474-40b96217ab1e",
            "name": "Investigational Site Number :8040003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "183",
            "type": {
              "id": "97d7e6ea-cfe3-4992-8a36-dbd9ce2dce73",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0ae39091-e8ba-4d4b-a00d-03407309197e",
            "name": "Investigational Site Number :8260003",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "184",
            "type": {
              "id": "332d8a1b-a66c-46bc-ba82-2f6893d9aa7e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4d025313-712b-4364-a9b4-834b18cda8f4",
            "name": "Investigational Site Number :8260016",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "185",
            "type": {
              "id": "4c3fb3e8-434e-48fc-8cca-f6e1edd5bc52",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fbb32e65-14bb-44aa-913b-9f4ecdf80933",
            "name": "Investigational Site Number :8260009",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "186",
            "type": {
              "id": "36224463-b4bb-4ede-845f-f33864f6625f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "dd31e8c2-fe99-4e11-9a96-b67af579bb6a",
          "code": "Phase3",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase3",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "99e152af-e3bc-48b3-a0d4-7fe1d362d0a8",
            "name": "Age requirement",
            "text": "The participant must be 18 to 55 years of age, inclusive, at the time of signing the informed consent.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "a0798009-75da-4cd5-bfd3-9a6c5ad60f41",
            "name": "RMS Diagnosis",
            "text": "The participant must have been diagnosed with RMS according to the 2017 revision of the McDonald diagnostic criteria (17).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "343f697e-6c41-42b0-80b0-1dd09f7e3cea",
            "name": "EDSS Score",
            "text": "The participant has an EDSS score â‰¤5.5 at the first visit (Screening Visit)",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5b87859f-6159-4dc8-822e-18731d66955a",
            "name": "Relapse or MRI Activity",
            "text": "The participant must have at least 1 of the following prior to screening: â‰¥1 documented relapse within the previous year OR â‰¥2 documented relapses within the previous 2 years, OR â‰¥1 documented Gd-enhancing lesion on an MRI scan within the previous year. Note: The initial clinical demyelinating episode of MS should be counted as a relapse for the first 2 criteria.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "af992d15-a8f7-4c31-b395-a435be4642d1",
            "name": "Sex and Contraception",
            "text": "Male or Female. Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies. Male participants wishing to conceive a child and female participants becoming pregnant or wishing to become pregnant must permanently discontinue the study intervention and follow the local teriflunomide label recommendation. Male participants are eligible to participate if they agree to refrain from donating sperm and be abstinent or use contraception. Female participants must not be pregnant or breastfeeding and must be non-WOCBP or agree to use highly effective contraception.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "28a6af55-cc9b-49da-95c1-61cbdeba413c",
            "name": "Informed Consent",
            "text": "The participant must have given written informed consent prior to undertaking any study-related procedure. This includes consent to comply with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "1a028804-0aa2-4bec-a0e3-87b61f2a4414",
            "name": "PPMS or nonrelapsing SPMS Diagnosis",
            "text": "The participant has been diagnosed with PPMS according to the 2017 revision of the McDonald diagnostic criteria (17) or with nonrelapsing SPMS (18).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "486ad176-f6a3-4c0c-8672-0354a5c5b874",
            "name": "Infection Risk",
            "text": "The participant has a history of infection or may be at risk for infection: history of T-lymphocyte vaccination/transplantation; received live vaccine within 2 months; lymphocyte count < LLN; history of PML; history of HIV; history of active or latent TB; persistent chronic or active recurring infection; fever within 4 weeks; risk of hepatitis B or C; or other active infections.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "05c52a97-8035-43c1-9ecb-95574d5cfc48",
            "name": "Psychiatric or Substance Abuse",
            "text": "The presence of psychiatric disturbance or substance abuse as evidenced by: history of psychiatric disease/depression requiring hospitalization within 2 years; documented history of attempted suicide or suicidal ideation (C-SSRS Category 4 or 5) over 6 months; active alcohol use disorder or drug abuse within 1 year; current alcohol intake >2 drinks/day for men and >1 drink/day for women.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b3d604e0-0b73-42e1-835d-fc7673b6671b",
            "name": "Clinically Significant Screening Findings",
            "text": "The following findings obtained during the Screening Visit considered in the Investigatorâ€™s judgment to be clinically significant in the context of this clinical trial: Any screening laboratory values outside normal limits; Abnormal ECG.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "70e9a3d1-e4a7-4f96-bfe8-e350f8c8015b",
            "name": "Bleeding Predisposition",
            "text": "Conditions that may predispose the participant to excessive bleeding: bleeding disorder or known platelet dysfunction; platelet count <150 000/Î¼L; major surgery within 4 weeks; history of significant bleeding event within 6 months (e.g., cerebral or gastrointestinal).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b8a9e5e2-e5ff-48be-a667-deaab56724ef",
            "name": "General Participation Contraindications",
            "text": "Conditions that would adversely affect participation in the study or make the primary efficacy endpoint non-evaluable: Sensitivity to study interventions; short life expectancy due to pre-existing health condition(s).",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "0d8a7fb2-bce1-4cef-9fc4-d70ac93c2f93",
            "name": "SAR442168",
            "type": {
              "id": "bc8508ab-02b8-4efd-bea0-c9843b237367",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "e42aeaff-f9f5-4513-b51b-b30d3598bca7",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Brain penetrant inhibitor of Brutonâ€™s tyrosine kinase (BTK) for relapsing forms of multiple sclerosis",
            "productIds": [
              "5a9b6e34-208a-4ecd-af3f-7bc6288de5da"
            ],
            "administrationIds": [
              "10f17ef5-90e6-4ef3-bf60-4dadf85146f9",
              "5c0f6179-363a-4051-bfbd-a9a1514c33a6",
              "ceb105f7-e4f9-46eb-a4fc-80774186c82b"
            ]
          },
          {
            "id": "41a97964-cf6f-45c3-bbb7-a10336db54c6",
            "name": "Teriflunomide",
            "type": {
              "id": "34674642-6627-4897-b432-e60f193bc0d4",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "70ce735f-b3c9-47ec-9add-cca97f3eea80",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Active comparator (Aubagio) for relapsing forms of multiple sclerosis",
            "productIds": [
              "119f876c-ad8d-41b3-8eca-1a6916a7b286"
            ],
            "administrationIds": [
              "0ea710aa-5640-4e92-8cbd-dfce06323a29",
              "e204c622-9f94-42c9-998d-c573fa227ab9"
            ]
          },
          {
            "id": "5136f188-1f94-47b8-a73f-f7cb0ac3e1ab",
            "name": "Placebo to match SAR442168",
            "type": {
              "id": "bdb358ed-f80e-4ce3-84cb-0967df3aeca7",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "role": {
              "id": "695266e2-aec6-4bf3-b6fe-6dd6b46d1213",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Matching placebo film-coated tablet for double-dummy design",
            "productIds": [
              "d219d87d-fd2b-4f3a-91d8-e0c1868dae4d"
            ],
            "administrationIds": [
              "5685298f-6c4e-48bd-98fe-e69aca241bbb",
              "48cd1f91-a654-4e24-a287-5be74cfc9bc5"
            ]
          },
          {
            "id": "ec9010e4-77f7-44c8-bf46-55f47f9190c0",
            "name": "Placebo to match teriflunomide",
            "type": {
              "id": "1afc9fcc-22fc-45b1-a7fc-b77c48c05b8f",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "role": {
              "id": "c9cf5ea3-89cc-4403-b6c1-2053afb74b62",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Matching placebo tablet for double-dummy design",
            "productIds": [
              "4e2cdab9-a379-47d8-abac-012191c339e1"
            ],
            "administrationIds": [
              "f7d86c91-b849-401c-8a88-f27c038c0ca4"
            ]
          },
          {
            "id": "34a3bb81-7c3d-4c10-b4d2-fbddf78bd5ce",
            "name": "MRI contrast-enhancing preparations",
            "type": {
              "id": "3fb03772-6d05-412d-ad82-aa79f97b7fd5",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "7ca83340-8624-4782-ae81-bb9ad72a9dcc",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Noninvestigational medicinal product for routine T1 contrast-enhanced sequences"
          },
          {
            "id": "6123901e-41aa-41b5-ab4f-35cd1274a162",
            "name": "Cholestyramine",
            "type": {
              "id": "5668395c-bc05-4fe3-8af6-e4346576e94f",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "996d86a0-8a0b-46ee-a965-9bf82b8db8f0",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Noninvestigational medicinal product used for accelerated elimination procedure of teriflunomide"
          },
          {
            "id": "8d0c5a2c-4205-4993-8f27-63413db93c6e",
            "name": "Systemic corticosteroids",
            "type": {
              "id": "e68b2f85-c2e0-49e9-8108-e70cb26dd6d2",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "176ded17-7f0f-44af-b3a1-fa86cd927be0",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Requires 1 month washout prior to screening MRI scan"
          },
          {
            "id": "4b55ed97-09fe-4f95-b297-8f96ab6039b3",
            "name": "Adrenocorticotropic hormone",
            "type": {
              "id": "2e41b507-909f-47ad-b5ac-cb173e508044",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "e075d78d-e7f9-4d80-8378-97275b5e894c",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Requires 1 month washout prior to screening MRI scan"
          }
        ],
        "administrableProducts": [
          {
            "id": "5a9b6e34-208a-4ecd-af3f-7bc6288de5da",
            "name": "SAR442168 film-coated tablet",
            "administrableDoseForm": {
              "id": "ab8adec4-2f3b-4592-a8d2-a609e5b80b0f",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "7d4a293e-74a4-4eec-943e-2fb879241c05",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "affb1fcf-de08-4477-972f-f3ee86b8e6fa",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "60 mg",
            "substanceIds": [
              "077e8fa1-c1ad-455a-ac3d-c170d9af8a34"
            ],
            "manufacturer": "Sanofi"
          },
          {
            "id": "119f876c-ad8d-41b3-8eca-1a6916a7b286",
            "name": "Teriflunomide tablet",
            "administrableDoseForm": {
              "id": "bab7db9a-15bb-458f-b569-20507919d36b",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "4e7221a1-9f40-466e-b1ba-8d5e4f327c2b",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "b9bd40db-b3f4-4c39-8d63-98487ff77e07",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "14 mg",
            "substanceIds": [
              "56a62e0e-3438-4ce9-a62c-96fe7724184c"
            ],
            "manufacturer": "Sanofi"
          },
          {
            "id": "d219d87d-fd2b-4f3a-91d8-e0c1868dae4d",
            "name": "Placebo to match SAR442168",
            "administrableDoseForm": {
              "id": "76fc8243-adbe-450f-977f-b8366908a942",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "f3309e34-d528-4aa7-859a-9afacea0b4e7",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "a6d7d944-b235-4f39-b29d-485aa369dc50",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "0 mg",
            "substanceIds": [
              "ebd87038-462b-47cc-8a64-efe66fa98478"
            ],
            "manufacturer": "Sanofi"
          },
          {
            "id": "4e2cdab9-a379-47d8-abac-012191c339e1",
            "name": "Placebo to match teriflunomide",
            "administrableDoseForm": {
              "id": "78f99c34-0762-4ae7-b5f2-e36692b1126f",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "b8d45f58-9154-4ff6-bb05-fedd16d4db51",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "bff3906a-6591-4a41-b6a5-cf1f17f613a4",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "0 mg",
            "manufacturer": "Sanofi"
          }
        ],
        "narrativeContents": [
          {
            "id": "8bf139a4-a427-4ead-971b-facb658e8d2f",
            "name": "PROTOCOL SUMMARY",
            "text": "PROTOCOL SUMMARY",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "PROTOCOL SUMMARY",
            "sectionType": {
              "id": "5681dff1-7b76-4612-be02-2c3e2c43c3df",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            },
            "childIds": [
              "09636162-f597-4108-a270-56299713d793",
              "52d2a0f9-61f2-48c8-8441-4a6b4459b021",
              "33010f6b-377f-408a-9fbd-c772d56f68cb"
            ]
          },
          {
            "id": "cb376be6-aca9-40dd-aabc-48c0c5d111bb",
            "name": "INTRODUCTION",
            "text": "INTRODUCTION",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "INTRODUCTION",
            "sectionType": {
              "id": "56465815-ce9c-446d-9a36-e0c78cd28f61",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "7c89dffe-a216-48d5-9af4-34e8213951a3",
              "caf461ad-eb94-4465-baa9-7fb924df0747",
              "10fc383d-436b-4ddc-9792-84166cb4b251"
            ]
          },
          {
            "id": "d15aa0d8-cb82-48be-910a-2e7f42d58b3e",
            "name": "OBJECTIVES AND ENDPOINTS",
            "text": "OBJECTIVES AND ENDPOINTS",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "OBJECTIVES AND ENDPOINTS",
            "sectionType": {
              "id": "161360eb-1b13-4590-891b-9048ca73f8c1",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            },
            "childIds": [
              "33304696-8759-429d-a72e-a7d12f5f5bb0"
            ]
          },
          {
            "id": "b0ac7f31-631c-4b36-90a8-38de32dd2335",
            "name": "STUDY DESIGN",
            "text": "STUDY DESIGN",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4",
            "sectionTitle": "STUDY DESIGN",
            "sectionType": {
              "id": "ec003675-a8b9-4d87-9e44-076054bb6380",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "49231bdd-c693-493a-aa20-53adc7459dee",
              "8db4f8e6-79a1-4ab2-b73b-77f0228834e5",
              "b86e816c-bceb-4e33-bef4-45d320a831f0",
              "a3b1e9e0-3585-496f-9b1f-5210978cfe1b"
            ]
          },
          {
            "id": "14374b30-a2b7-4d89-9af0-4bb4d1eab737",
            "name": "STUDY POPULATION",
            "text": "STUDY POPULATION",
            "order": 4,
            "instanceType": "NarrativeContent",
            "sectionNumber": "5",
            "sectionTitle": "STUDY POPULATION",
            "sectionType": {
              "id": "d26daf65-06a3-46d0-94d3-3b8e03fed46c",
              "code": "Study Population",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Population",
              "instanceType": "Code"
            },
            "childIds": [
              "4b2f6f8a-5d53-4821-828e-116616fa8cf2",
              "8f79f2aa-a62e-47f3-acbf-483ca0cfb088",
              "f881cce7-f5c7-4bd4-b2c4-a49498fbc7b1"
            ]
          },
          {
            "id": "2f837bd0-0273-45e4-8d7e-7cc2cbd53035",
            "name": "Appendix 6: Liver and other safety: actions and follow-up assessments",
            "text": "Appendix 6: Liver and other safety: actions and follow-up assessments",
            "order": 5,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.6",
            "sectionTitle": "Appendix 6: Liver and other safety: actions and follow-up assessments",
            "sectionType": {
              "id": "ba7af019-5de3-4b10-a96d-64af5cf906f5",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          },
          {
            "id": "bdcc93a8-eda3-4640-9fd1-25f8090e0759",
            "name": "Appendix 8A: Examples of drugs with a potential to change SAR442168 metabolism",
            "text": "Appendix 8A: Examples of drugs with a potential to change SAR442168 metabolism",
            "order": 6,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.8",
            "sectionTitle": "Appendix 8A: Examples of drugs with a potential to change SAR442168 metabolism",
            "sectionType": {
              "id": "aa276118-4a51-42cd-8b85-81e43089b3b9",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          },
          {
            "id": "39fab4e4-d8be-430e-a9c4-0ea602519688",
            "name": "Country-specific provisions for the US, Brazil, Israel, and sites following FDA partial clinical hold conditions",
            "text": "Country-specific provisions for the US, Brazil, Israel, and sites following FDA partial clinical hold conditions",
            "order": 7,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.11.4",
            "sectionTitle": "Country-specific provisions for the US, Brazil, Israel, and sites following FDA partial clinical hold conditions",
            "sectionType": {
              "id": "87e47f67-df8a-4891-b1f1-577a9340c4b2",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "15db8110-1358-4b03-97aa-afa0b97a8e7a",
            "name": "Appendix 12: Protocol amendment history",
            "text": "Appendix 12: Protocol amendment history",
            "order": 8,
            "instanceType": "NarrativeContent",
            "sectionNumber": "10.14",
            "sectionTitle": "Appendix 12: Protocol amendment history",
            "sectionType": {
              "id": "b1865e1c-7dd5-4bf6-bb09-d2af150e4819",
              "code": "Appendix",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Appendix",
              "instanceType": "Code"
            }
          }
        ],
        "narrativeContentItems": [
          {
            "id": "09636162-f597-4108-a270-56299713d793",
            "name": "SYNOPSIS",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.1",
            "sectionTitle": "SYNOPSIS"
          },
          {
            "id": "52d2a0f9-61f2-48c8-8441-4a6b4459b021",
            "name": "SCHEMA",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2",
            "sectionTitle": "SCHEMA"
          },
          {
            "id": "33010f6b-377f-408a-9fbd-c772d56f68cb",
            "name": "SCHEDULE OF ACTIVITIES (SOA)",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.3",
            "sectionTitle": "SCHEDULE OF ACTIVITIES (SOA)"
          },
          {
            "id": "7c89dffe-a216-48d5-9af4-34e8213951a3",
            "name": "STUDY RATIONALE",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "STUDY RATIONALE"
          },
          {
            "id": "caf461ad-eb94-4465-baa9-7fb924df0747",
            "name": "BACKGROUND",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "BACKGROUND"
          },
          {
            "id": "10fc383d-436b-4ddc-9792-84166cb4b251",
            "name": "BENEFIT/RISK ASSESSMENT",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.3",
            "sectionTitle": "BENEFIT/RISK ASSESSMENT"
          },
          {
            "id": "33304696-8759-429d-a72e-a7d12f5f5bb0",
            "name": "APPROPRIATENESS OF MEASUREMENTS",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.1",
            "sectionTitle": "APPROPRIATENESS OF MEASUREMENTS"
          },
          {
            "id": "49231bdd-c693-493a-aa20-53adc7459dee",
            "name": "OVERALL DESIGN",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.1",
            "sectionTitle": "OVERALL DESIGN"
          },
          {
            "id": "8db4f8e6-79a1-4ab2-b73b-77f0228834e5",
            "name": "SCIENTIFIC RATIONALE FOR STUDY DESIGN",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.2",
            "sectionTitle": "SCIENTIFIC RATIONALE FOR STUDY DESIGN"
          },
          {
            "id": "b86e816c-bceb-4e33-bef4-45d320a831f0",
            "name": "JUSTIFICATION FOR DOSE",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.3",
            "sectionTitle": "JUSTIFICATION FOR DOSE"
          },
          {
            "id": "a3b1e9e0-3585-496f-9b1f-5210978cfe1b",
            "name": "END OF STUDY DEFINITION",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.4",
            "sectionTitle": "END OF STUDY DEFINITION"
          },
          {
            "id": "4b2f6f8a-5d53-4821-828e-116616fa8cf2",
            "name": "INCLUSION CRITERIA",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.1",
            "sectionTitle": "INCLUSION CRITERIA"
          },
          {
            "id": "8f79f2aa-a62e-47f3-acbf-483ca0cfb088",
            "name": "EXCLUSION CRITERIA",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2",
            "sectionTitle": "EXCLUSION CRITERIA"
          },
          {
            "id": "f881cce7-f5c7-4bd4-b2c4-a49498fbc7b1",
            "name": "LIFESTYLE CONSIDERATIONS",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3",
            "sectionTitle": "LIFESTYLE CONSIDERATIONS"
          }
        ],
        "abbreviations": [
          {
            "id": "60d73160-906a-4eed-9ee7-6a779b9fbca6",
            "abbreviatedText": "SoA",
            "expandedText": "Schedule of activities",
            "instanceType": "Abbreviation"
          },
          {
            "id": "507ff636-8d39-48e6-b034-ec157a487592",
            "abbreviatedText": "CYP3A",
            "expandedText": "Cytochrome P450 3A",
            "instanceType": "Abbreviation"
          },
          {
            "id": "eb86f82c-ca5c-4ff6-b9e3-2630c78c550a",
            "abbreviatedText": "CYP2C8",
            "expandedText": "Cytochrome P450 2C8",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e5cae690-3d7e-41f4-a60b-5ac94cc3d65d",
            "abbreviatedText": "DDI",
            "expandedText": "Drug-drug interaction",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b37d8a9f-ef18-4f1f-a39e-a9d00ac6d64f",
            "abbreviatedText": "FDA",
            "expandedText": "Food and Drug Administration",
            "instanceType": "Abbreviation"
          },
          {
            "id": "690f4dea-3e69-4ddc-9185-30a6d85521f5",
            "abbreviatedText": "DMTs",
            "expandedText": "disease-modifying therapies",
            "instanceType": "Abbreviation"
          },
          {
            "id": "23dc78b9-b960-42c1-aa55-2956e2439e6b",
            "abbreviatedText": "RMS",
            "expandedText": "relapsing forms of multiple sclerosis",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cc64c53f-ea5c-4f45-8e98-9c881bbc596e",
            "abbreviatedText": "CNS",
            "expandedText": "central nervous system",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0fbd2440-807f-413a-8778-669933a741ad",
            "abbreviatedText": "MS",
            "expandedText": "multiple sclerosis",
            "instanceType": "Abbreviation"
          },
          {
            "id": "16dd9692-bad0-4432-9547-05026aed2e5e",
            "abbreviatedText": "MRI",
            "expandedText": "magnetic resonance imaging",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6f68955d-9658-4293-a7e3-67af09827ac9",
            "abbreviatedText": "BTK",
            "expandedText": "Brutonâ€™s tyrosine kinase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0e299f82-5c3c-409c-aeef-9aafa6e81751",
            "abbreviatedText": "Gd-",
            "expandedText": "gadolinium-",
            "instanceType": "Abbreviation"
          },
          {
            "id": "dca93348-b627-4e42-868c-138d8d8296be",
            "abbreviatedText": "EOS",
            "expandedText": "end of study",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9514dbe1-ae6e-405f-a0aa-cce5f13fe5db",
            "abbreviatedText": "R",
            "expandedText": "randomization",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0090173a-8d4b-4ca9-9aa1-3ea30dd91390",
            "abbreviatedText": "D-28",
            "expandedText": "Day-28",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0ed3d159-c86d-437f-99f4-2c96c2ee79b5",
            "abbreviatedText": "D-1",
            "expandedText": "Day-1",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cbec5acd-4c79-46e8-b2ae-3e083b3ca4cb",
            "abbreviatedText": "D1",
            "expandedText": "Day 1",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b756e56c-5b8e-4d7e-a8d7-27f74ee7fa7e",
            "abbreviatedText": "IMP",
            "expandedText": "Investigational Medicinal Product",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7712450c-8777-42e9-a3d9-877e475a17d8",
            "abbreviatedText": "M12",
            "expandedText": "Month 12",
            "instanceType": "Abbreviation"
          },
          {
            "id": "569738ef-4a0c-4993-9294-3b6b1d3c1cd6",
            "abbreviatedText": "LTS",
            "expandedText": "Long-term Safety Study",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9f3facaa-bf55-4c7f-9ff7-2696112877c8",
            "abbreviatedText": "pEOT",
            "expandedText": "prematurely discontinue IMP",
            "instanceType": "Abbreviation"
          },
          {
            "id": "d62cbcbf-accd-426e-9096-f8122133b9cf",
            "abbreviatedText": "FUV",
            "expandedText": "Follow-up visit",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "778a9b3b-322c-443d-85c6-34ae5dd8cf99",
            "number": "1",
            "name": "Amendment 1",
            "scope": {
              "id": "b54d00c7-3460-45a9-840d-12041c0b2a1d",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "0d7d7d24-0aa8-4a27-95ff-931e7e2074b6",
              "code": {
                "id": "b56d8142-232c-4380-be96-d157d17c3f5a",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "4f867e9f-5b92-4f44-92eb-cd03472db622",
                "type": {
                  "id": "b085e34c-2c8e-4fba-a088-451469b89aac",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary drivers for this amended protocol were to add exclusion criteria that were previously omitted and the regulatory requirement of a benefit/risk evaluation of the study in the context of the COVID-19 pandemic.",
            "effectiveDate": "2020-05-07",
            "reasonIds": [
              "ee8869bf-b17b-4cb8-a84b-0ff1fff925de",
              "0e3f2e1f-c346-4cc2-bdb0-49cda9ef17b1",
              "fcea0573-c506-4345-ac00-4a2ce30b724b"
            ],
            "previousVersion": "Original Protocol",
            "newVersion": "1"
          },
          {
            "id": "54b047e0-1a69-455f-a773-a9cd98bbeb1b",
            "number": "2",
            "name": "Amendment 2",
            "scope": {
              "id": "d9ddbde8-7a51-4cd7-9c27-b85baaefd2a3",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "10b89cf8-9baa-474b-bcfe-860a38d874fc",
              "code": {
                "id": "a16a0b97-6d33-4e1d-877d-d686730995de",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "689e0e8e-0924-4557-9ad4-33a1d05c1414",
                "type": {
                  "id": "9be4e760-13b8-44ff-8f44-0148a61365de",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary driver for this amended protocol was to respond to European Health Authoritiesâ€™ requests.",
            "effectiveDate": "2020-08-24",
            "reasonIds": [
              "5e980aeb-12cb-4e95-882d-4a083708d0d3",
              "0bb8f044-3fc6-4f49-be76-c2b03bb7d016",
              "699f9306-5978-439c-aac5-1580bf6d6819"
            ],
            "previousVersion": "1",
            "newVersion": "2"
          },
          {
            "id": "c876ee76-096d-4c38-ac40-48403a242cf1",
            "number": "3",
            "name": "Amendment 3",
            "scope": {
              "id": "bde76928-9a42-47e7-880b-491ba59ae3db",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "e4fd3315-4440-44f5-bff9-ff7c302a0230",
              "code": {
                "id": "da4adc43-39b7-4fab-8f4e-d86c9f7b2863",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "68b71c16-e984-4899-af96-dfbdb22d3964",
                "type": {
                  "id": "bda7869b-0756-4da9-a715-f0a9f21af065",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary driver for this amended protocol is to update the protocol for COVID-19-related contingencies.",
            "effectiveDate": "2020-09-28",
            "reasonIds": [
              "f3ab9cfb-3af7-4d08-8014-d31cecc92a8f",
              "f1e60dd6-5a9f-4d62-829c-bf585d320409"
            ],
            "previousVersion": "2",
            "newVersion": "3"
          },
          {
            "id": "76f11beb-219f-459c-88fa-2bb36d9adbb8",
            "number": "4",
            "name": "Amendment 4",
            "scope": {
              "id": "951a7b01-f33e-4b25-9d61-5f494bd2c0ba",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "511bcf5a-0be0-495b-822c-6a2d532f1600",
              "code": {
                "id": "15b46f6a-421e-4ab9-829f-b6e058e30d13",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "d6a54817-612d-4ad3-9ced-22b9c1c08398",
                "type": {
                  "id": "1240e830-4aee-4e9c-b08d-1305846d0e34",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary driver for this amended protocol was to update the liver function test frequency in the European Union (EU) countries in accordance with the updated teriflunomide (Aubagio) summary of product characteristics (SmPC). Alanine aminotransferase exclusion criterion was also updated to align with the Aubagio label.",
            "effectiveDate": "2021-04-14",
            "reasonIds": [
              "19d1bacf-eee6-49ad-8b84-020d82e01e79",
              "a987b0e7-32bb-41aa-80fd-f8272eba90eb"
            ],
            "previousVersion": "3",
            "newVersion": "4"
          },
          {
            "id": "c12e08b6-cc7b-4898-a2ea-fa929be024fa",
            "number": "5",
            "name": "Amendment 5",
            "scope": {
              "id": "40f12fc0-794b-40db-b162-003d9e97e693",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "dbc3c430-27a1-4a1b-a9dc-0275412397bd",
              "code": {
                "id": "037a1262-5212-427b-b59d-b470b919e022",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "d7319a93-50e9-448d-a238-4c77cd396007",
                "type": {
                  "id": "0e5bc350-8ee8-4de1-b3a1-11c379ff326a",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary driver for this amended protocol was to update the safety follow-up algorithms for ALT increase and thrombocytopenia and the platelet level threshold for definition of an AESI in order to harmonize them with the other studies in the Phase 3 program.",
            "effectiveDate": "2021-11-18",
            "reasonIds": [
              "98e27fe3-1522-40b9-b3c6-dc5c2be924a3",
              "c9d1ff2d-9e84-4699-ab4f-e69bd8e41a70"
            ],
            "previousVersion": "4",
            "newVersion": "5"
          },
          {
            "id": "fcdfb473-7e8a-4f62-907c-53e922f2face",
            "number": "6",
            "name": "Amendment 6",
            "scope": {
              "id": "7945aa6f-7f6c-4ba3-988d-9c6dfcc42690",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "dd3b4bda-fa71-4551-8c4e-88b63c98d8df",
              "code": {
                "id": "5f821206-2a04-4fac-a5a3-bcdf37317701",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "b07cfffa-5078-4ba3-82f9-563f1a0fe138",
                "type": {
                  "id": "660c398f-3d84-4f11-a1c9-64bffda46938",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary driver for this amended protocol is to update liver related exclusion criteria and monitoring to mitigate risk of drug-induced liver injury.",
            "effectiveDate": "2022-05-23",
            "reasonIds": [
              "3da09036-d861-4f96-ace5-afc11888e715"
            ],
            "previousVersion": "5",
            "newVersion": "6"
          },
          {
            "id": "04d32eb6-53a2-4ca3-ac7f-0c2c37f2ab4e",
            "number": "7",
            "name": "Amendment 7",
            "scope": {
              "id": "c8a69f85-9ff4-4c70-9dd9-800153a41b50",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "3900aa47-9f01-451f-adc4-dc3c81c0e370",
              "code": {
                "id": "f93fe0a9-7cb1-4928-b060-d4d2bc362b56",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "ff491da3-271f-4450-994a-a4de663f70b5",
                "type": {
                  "id": "fea0943e-36cb-4840-ae45-6099e6f577d0",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The rationale for this protocol amendment is to further reduce the risk of drug-induced liver injury (DILI) by increasing the intensity of liver monitoring.",
            "effectiveDate": "2022-09-13",
            "reasonIds": [
              "010b353b-a393-418f-8823-3738721ce108"
            ],
            "previousVersion": "6",
            "newVersion": "7"
          },
          {
            "id": "b2becc8c-8493-4d3c-a77b-7889d983e7cb",
            "number": "8",
            "name": "Amendment 8",
            "scope": {
              "id": "f4f2b754-23a5-48ca-bbe3-8754de5bdc13",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "07fb7ef7-81c9-4387-90f4-eec86ed0d652",
              "code": {
                "id": "331fbb86-6bcb-4fb1-b0a9-4558cbee8c0e",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "d073faeb-17e7-497e-9b15-2b23275865cc",
                "type": {
                  "id": "d3fb386c-bb16-4027-8269-361d65047cf5",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The rationale for this protocol amendment is to clarify information about drug-induced liver injury (DILI) and update the ALT increase algorithm in relation to the risk of DILI.",
            "effectiveDate": "2022-12-12",
            "reasonIds": [
              "29b60c39-049d-4a8f-953a-2884ab926b00",
              "46ae003e-d0a2-4847-b72b-952aa1c0fcbb"
            ],
            "previousVersion": "7",
            "newVersion": "8"
          },
          {
            "id": "c7ac84de-75e2-4c68-91fd-5a368a84cc42",
            "number": "9",
            "name": "Amendment 9",
            "scope": {
              "id": "50e1e055-27be-4475-a3c7-a1a1c073ecf5",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "2098ba36-5e2d-46bc-9dbc-8685319ec922",
              "code": {
                "id": "a6e41ddf-27e3-40a2-9c74-fbea635a19c2",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "89c76c3d-bec7-4804-aaa6-cae378d7bf48",
                "type": {
                  "id": "ce716f23-6630-4ad9-bb72-67b296dbc028",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The rationale for this protocol amendment is to incorporate country-specific guidelines for France.",
            "effectiveDate": "2023-07-12",
            "reasonIds": [
              "a21a92fd-cba0-4020-8b04-78c3686d5e9b"
            ],
            "previousVersion": "8",
            "newVersion": "9"
          },
          {
            "id": "131ddfb6-0209-4444-a46c-2b22ac1ec894",
            "number": "10",
            "name": "Amendment 10",
            "scope": {
              "id": "457b947c-698d-409d-9b83-60546f2308b5",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "307900c2-45f6-444f-8bc5-9a61bafcca12",
              "code": {
                "id": "65f6a9cb-f5c5-4d31-ab1a-df7abfc5c837",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "3fdccf0a-061d-4e18-aca4-9c250e0bb35a",
                "type": {
                  "id": "ec21c138-d1ad-49a7-a277-94c719055f6c",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The rationale for this protocol amendment is to update the testing requirements in the â€œIncrease in ALT algorithmâ€ as per Health Authority request.",
            "effectiveDate": "2023-11-17",
            "reasonIds": [
              "c7e0cc96-3588-454d-9620-1cda1ab312c4",
              "227ebd45-cdb7-4fcd-829c-f44527cab161"
            ],
            "previousVersion": "9",
            "newVersion": "10"
          },
          {
            "id": "0d071cfa-810f-4705-a44c-5480ff6b1033",
            "number": "11",
            "name": "Amendment 11",
            "scope": {
              "id": "72fb5fc9-d820-4464-863b-17314049bfa8",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "bebac45f-9ecb-4569-9bcd-f2d9b1b6dfbc",
              "code": {
                "id": "10e1528f-bacb-40d0-ae54-7e643bfeb002",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "1edb1af1-e35e-45b6-b6f8-d3ea95b2552f",
                "type": {
                  "id": "1939cb11-bccd-413d-9fad-b62b23a3a52a",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The rationale for this protocol amendment is to include liver function test monitoring guidance previously in the study manual and update the co-medication guidance as per Health Authority request.",
            "effectiveDate": "2023-12-20",
            "reasonIds": [
              "7094b892-e1fc-4e92-a2bd-226315ba083f",
              "c1f13440-0408-45c4-817f-eaca1100f9c0",
              "546752fe-3902-43bf-96de-e32931a4ab0e"
            ],
            "previousVersion": "10",
            "newVersion": "11"
          }
        ],
        "medicalDevices": [
          {
            "id": "647e95d1-91fb-4794-9556-ec0f3387dbd2",
            "name": "Magnetic Resonance Imaging Scanner",
            "instanceType": "MedicalDevice",
            "label": "MRI Machine",
            "description": "3T MRI capacity equipment for brain sequences",
            "deviceType": {
              "id": "6981b8b0-2017-44df-ab75-8a024c4d2d58",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "9283e79c-dcc5-4781-8982-16f05467682e",
            "name": "Electrocardiograph",
            "instanceType": "MedicalDevice",
            "label": "ECG Device",
            "description": "12-lead ECG recording equipment",
            "deviceType": {
              "id": "b7485eed-fb4e-4839-8ea0-527fc2fb1342",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "a7dcefce-ae63-42ab-8d5c-376bf572b97a",
            "name": "Intravenous Line",
            "instanceType": "MedicalDevice",
            "label": "IV Line",
            "description": "Venous access for MRI contrast administration",
            "deviceType": {
              "id": "978f8453-8a14-4b2a-b8d7-b7192f0368f7",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          }
        ],
        "conditions": [
          {
            "id": "d5656337-a974-4729-a539-f13ad1f36828",
            "name": "Liver Function Eligibility",
            "instanceType": "Condition",
            "description": "Screening lab thresholds for ALT, AST, and Bilirubin",
            "text": "ALT >1.5 x ULN, AST >1.5 x ULN, or Total Bilirubin >1.5 x ULN"
          },
          {
            "id": "fcb91a10-6be6-4f4a-9753-7e5fa9b83104",
            "name": "Suicidal Risk",
            "instanceType": "Condition",
            "description": "C-SSRS assessment criteria for intervention delay",
            "text": "Yes on items 4 or 5 of Suicidal Ideation or any item of Suicidal Behavior"
          },
          {
            "id": "55a30e59-aaf7-4df1-a978-5fe7a1304932",
            "name": "Cardiac Arrhythmia",
            "instanceType": "Condition",
            "description": "Grade 3 atrial fibrillation criteria",
            "text": "Symptomatic, urgent intervention indicated, or new onset"
          }
        ],
        "studySites": [
          {
            "id": "61e80677-2927-4097-a6fa-c265386c2874",
            "name": "North Central Neurology Associates, PC-Site Number:8400009",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "6cb0915e-8f71-4df9-9e12-b15199ac87e1",
            "country": "United States"
          },
          {
            "id": "b654b89a-4b13-4268-a52c-7194de1361a3",
            "name": "Center for Neurology and Spine-Site Number:8400089",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "8e19c56e-1b0f-4a77-94e2-6615a455f965",
            "country": "United States"
          },
          {
            "id": "cd1c6ab6-b562-428c-ac6a-57b45b9e841e",
            "name": "Arcadia Neurology Center-Site Number:8400070",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "d2cb75a6-261b-41b2-9a5e-1200d91c8a89",
            "country": "United States"
          },
          {
            "id": "43b9f5b8-b57d-4a53-88b8-3398e39818f2",
            "name": "Multiple Sclerosis Center of California-Site Number:8400135",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "3eeca508-7bf6-4fc2-bec0-5025096ef9c4",
            "country": "United States"
          },
          {
            "id": "9c19dcae-2f88-4c8d-b5d6-8e4e21a1fcfc",
            "name": "Harbor UCLA-Site Number:8400088",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "3dffeb90-95d8-4a6a-9f2a-a74450396f72",
            "country": "United States"
          },
          {
            "id": "c115d040-0003-4802-abb8-68a119a28956",
            "name": "Mountain Neurological Research Center, Inc.-Site Number:8400128",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "d103af87-edec-4b8c-a5f4-a58f5395928e",
            "country": "United States"
          },
          {
            "id": "83dccebc-3db9-472b-936b-36ac45f13f4d",
            "name": "Advanced Neurosciences Research-Site Number:8400025",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "55789d35-d97f-49e6-b6c9-ea0b0c297f03",
            "country": "United States"
          },
          {
            "id": "e0398ea7-cdad-4e13-b3c1-1a44a8a2dda1",
            "name": "South Florida Neurology Associates-Site Number:8400029",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "03b6510b-a5f2-431b-8192-ac0461904fe0",
            "country": "United States"
          },
          {
            "id": "715f13b5-61c4-4342-902c-587b260929de",
            "name": "University of Florida Health-Site Number:8400159",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "2c949af8-7f0a-494f-a61c-4912de35701a",
            "country": "United States"
          },
          {
            "id": "2ede291a-cb31-419a-ab69-1ec73e280d7b",
            "name": "Neurology Associates, PA-Site Number:8400004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "35edb884-9065-4d10-91bc-3010becfd93a",
            "country": "United States"
          },
          {
            "id": "4515c2de-7d48-4df7-bae2-63e26db0279f",
            "name": "University of Miami-Site Number:8400063",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "cddc602a-fa63-4187-bf7f-db5754af0e4f",
            "country": "United States"
          },
          {
            "id": "f039a981-c464-4c49-bb93-1ad4ccdec806",
            "name": "Infinity Clinical Research-Site Number:8400008",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "d9f9f643-778a-49cd-85cd-19230b0387fa",
            "country": "United States"
          },
          {
            "id": "d87b49b0-df84-422c-ac63-c19f6d37cf1e",
            "name": "University of South Florida-Site Number:8400006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "f34740ec-b84b-4375-b5ee-f25b5e56a0aa",
            "country": "United States"
          },
          {
            "id": "2ce612af-b093-4799-a9b4-d9219b8ecee6",
            "name": "Meridian Clinical Research-Site Number:8400003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "1967bd44-5efc-4a52-ba0a-6d6405e51bf9",
            "country": "United States"
          },
          {
            "id": "060fb7da-eb5f-40a8-9194-00822dc222dd",
            "name": "Consultants In Neurology-Site Number:8400011",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "64facd45-c978-4810-a649-aa8c5dd4d5f4",
            "country": "United States"
          },
          {
            "id": "7b843c76-2268-48a3-ac23-b82d909f2969",
            "name": "Prairie Education and Research Cooperative-Site Number:8400071",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "3e5441f7-27e5-4a82-b988-524f6a7e8740",
            "country": "United States"
          },
          {
            "id": "880de5e4-f461-48e9-b11d-b58a5471fc06",
            "name": "Fort Wayne Neurological Center-Site Number:8400039",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "9f61eb99-35d2-4d01-a765-89a05cd765e1",
            "country": "United States"
          },
          {
            "id": "204e9111-6666-4732-8d7b-dcc285ebc624",
            "name": "CHI Saint Joseph Medical Group Neurology-Site Number:8400110",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "8f69b607-84a7-47d2-a9ce-7eefe7043e59",
            "country": "United States"
          },
          {
            "id": "2e9bc7d9-d85d-45b2-ac5d-45679c566810",
            "name": "University of Kentucky-Site Number:8400106",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "1d1727da-0432-482e-be76-f78beed49559",
            "country": "United States"
          },
          {
            "id": "9380d376-44aa-4cdb-9fdd-c699aec336f6",
            "name": "Norton Neurology MS Services-Site Number:8400127",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "2d5dac55-ae56-4a8f-885d-66c98d18e13f",
            "country": "United States"
          },
          {
            "id": "63393425-e6c1-4507-beff-9ab4adab839e",
            "name": "The NeuroMedical Center-Site Number:8400057",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "e80fc21b-b13f-44a9-8c9d-c07ad5629b85",
            "country": "United States"
          },
          {
            "id": "e0eb6be3-4dda-4694-8375-395a598feaf5",
            "name": "International Neurorehabilitation Institute-Site Number:8400034",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "0bac265d-5088-4c40-8d14-831ab0be277c",
            "country": "United States"
          },
          {
            "id": "1405b4fa-cf2b-40f8-9e64-c00b2806e0cf",
            "name": "Wayne State University-Site Number:8400046",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "52fa54da-2fa2-44ae-bd4e-6dec55721802",
            "country": "United States"
          },
          {
            "id": "dddbb6d1-d06b-4b24-adcf-1efde6594d20",
            "name": "Minneapolis Clinic of Neurology-Site Number:8400051",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "3bc0291a-d4fa-43f4-8f47-6bcdf9945137",
            "country": "United States"
          },
          {
            "id": "3566c2e6-6b6e-4b5f-82a5-ab0f1754d347",
            "name": "Saint Luke's Hospital-Site Number:8400153",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "a3953972-c0d5-4722-a437-9d77951ee3a1",
            "country": "United States"
          },
          {
            "id": "24d643a2-0c25-475c-b05a-bd94073d0fab",
            "name": "West Omaha Family Physicians-Site Number:8400139",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "48ae3d39-ff20-4453-be05-94e0d93a6667",
            "country": "United States"
          },
          {
            "id": "a04eccce-53d0-4863-aceb-aaf7b72f81aa",
            "name": "University Of Nebraska-Site Number:8400129",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "e6d48366-126c-4539-9aa6-983876c1f470",
            "country": "United States"
          },
          {
            "id": "dd0b2456-7e3f-4e58-b85b-1a6376351eda",
            "name": "Hackensack University Hospital-Site Number:8400047",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "e44c1040-e84b-49fa-9861-2fc5262e5341",
            "country": "United States"
          },
          {
            "id": "6871fab1-9f82-4c9a-b15c-0c200edefdec",
            "name": "University of New Mexico-Site Number:8400032",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "b42b75de-0d84-423b-babc-3edb27a16c05",
            "country": "United States"
          },
          {
            "id": "de08e399-ecee-46a9-a417-88c548e1a0f5",
            "name": "South Shore Neurologic Associates-Site Number:8400100",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "f27be633-9522-42a1-8dc0-a64f9dc89c22",
            "country": "United States"
          },
          {
            "id": "9d877dd3-84a0-4cef-b782-f42582b61b8b",
            "name": "Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "f9bebd15-9dc0-4c3e-a69d-cf830e8053bd",
            "country": "United States"
          },
          {
            "id": "d1b5d842-ec1a-45e4-a50c-1466c51f7d9a",
            "name": "Meridian Clinical Research, LLC-Site Number:8400005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "05a82b6d-ecce-407b-8c4f-f9f9b7654975",
            "country": "United States"
          },
          {
            "id": "d2abca27-f032-4687-b755-249229625e3e",
            "name": "Sanford Brain & Spine Center-Site Number:8400126",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "0f2459ec-78cf-4dcb-89c4-bb297b46ed5d",
            "country": "United States"
          },
          {
            "id": "c710f415-5b27-439a-8142-67adc455905d",
            "name": "Dayton Center for Neurological Disorders-Site Number:8400081",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "eb14bba8-e129-4a79-8f50-323126a5e72f",
            "country": "United States"
          },
          {
            "id": "5cb167a9-7089-493b-84c9-601454cd99a5",
            "name": "Jefferson Neurology Associates-Site Number:8400016",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "f26a2557-9f04-4af1-bd6f-27e7d183f25e",
            "country": "United States"
          },
          {
            "id": "3ba8577e-abed-423c-8344-cb70b060c7d6",
            "name": "Premier Neurology-Site Number:8400069",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "934feb4c-93ab-469b-a28b-402865fba72e",
            "country": "United States"
          },
          {
            "id": "98a27cf6-63f3-4c21-866e-525accdf7ec9",
            "name": "Advanced Neuroscience Center-Site Number:8400035",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "6030e5c6-5a94-49ec-93ba-4dec445dfd11",
            "country": "United States"
          },
          {
            "id": "fc0833fa-1260-404d-8128-0e7f99d440dc",
            "name": "Sibyl Wray, MD, Neurology, PC-Site Number:8400007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "d3b63639-2168-4bc7-a0ba-d7534f5d2c37",
            "country": "United States"
          },
          {
            "id": "7198ded7-ef88-4f83-9710-09173d56516c",
            "name": "Mt Olympus Medical Research-Site Number:8400163",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "df26d784-b456-4149-8529-0673270e785f",
            "country": "United States"
          },
          {
            "id": "a3c270a9-ede7-4353-9f9a-5623dd498040",
            "name": "Neurology Center of San Antonio-Site Number:8400036",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "10216084-19d0-4e7b-b0b4-6b6029167957",
            "country": "United States"
          },
          {
            "id": "2e1eb805-387d-46f1-8337-fe1c3b76e7c6",
            "name": "Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "41",
            "organizationId": "b01c47c7-141a-48a5-930e-4df9b67eea83",
            "country": "United States"
          },
          {
            "id": "71573d1e-4e59-468e-aa05-2d52a4e59639",
            "name": "Neurological Associates-Site Number:8400097",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "42",
            "organizationId": "1fc1d33b-1f0f-465c-9498-697b54bc76d6",
            "country": "United States"
          },
          {
            "id": "1143cfe3-4c3b-4ea4-80f0-5038a382109e",
            "name": "Wheaton Franciscan Healthcare-Site Number:8400022",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "43",
            "organizationId": "c92ac317-3233-49a4-b972-f9b9af40efaf",
            "country": "United States"
          },
          {
            "id": "d89b2a1a-bc26-4186-8475-df52576035d7",
            "name": "Investigational Site Number :0320004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "44",
            "organizationId": "4d62d939-cec2-4c16-a8af-dd97a224b009",
            "country": "Argentina"
          },
          {
            "id": "ac16cc9f-6010-4c5b-86f7-2dc6f5d2b933",
            "name": "Investigational Site Number :0320002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "45",
            "organizationId": "994e40ef-d251-4540-9b6e-8fdfc2be6862",
            "country": "Argentina"
          },
          {
            "id": "c53180ce-ee67-4727-9aad-957bf1db5ede",
            "name": "Investigational Site Number :0320001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "46",
            "organizationId": "6075a72a-f70d-4e25-8f83-30c4a65b8caa",
            "country": "Argentina"
          },
          {
            "id": "c73d8807-0efc-4671-8e82-2815c40b7281",
            "name": "Investigational Site Number :0320003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "47",
            "organizationId": "fb41c990-182f-4cc9-81b4-c2652b168b28",
            "country": "Argentina"
          },
          {
            "id": "d428e514-3827-4cb2-ad9b-6109ea5e5c64",
            "name": "Investigational Site Number :0320005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "48",
            "organizationId": "5446dc92-544a-44d5-adf0-a08633f6dc33",
            "country": "Argentina"
          },
          {
            "id": "b94bbc56-f364-4e86-9833-a00461100dbf",
            "name": "Investigational Site Number :0560005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "49",
            "organizationId": "ceaf9114-45e8-4908-a026-fbde4c6c9f76",
            "country": "Belgium"
          },
          {
            "id": "89053496-db96-4f09-8073-0a95712bb370",
            "name": "Investigational Site Number :0560004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "50",
            "organizationId": "60142b92-de43-4dfe-a74a-e873c2e2f1d2",
            "country": "Belgium"
          },
          {
            "id": "3ee9c25c-8fd1-4f22-8ec3-bc2f6fbfbd07",
            "name": "Investigational Site Number :0560002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "51",
            "organizationId": "6fb86db2-5694-457f-bbe0-a08446fd1e5d",
            "country": "Belgium"
          },
          {
            "id": "0edce4ab-98f6-467c-acf2-db40eff0f1af",
            "name": "Investigational Site Number :0560001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "52",
            "organizationId": "762a26a1-f5f6-4077-98a9-31ae5906eb7a",
            "country": "Belgium"
          },
          {
            "id": "136a0891-80a8-4d6f-9985-98f2834072d7",
            "name": "Investigational Site Number :0760001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "53",
            "organizationId": "3ef906b8-2f58-475c-a04e-3a642c6a7a5d",
            "country": "Brazil"
          },
          {
            "id": "a71e91ee-3c97-42e3-8efd-d03eceb8914e",
            "name": "Investigational Site Number :0760002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "54",
            "organizationId": "ef0ef553-3a94-4847-9df2-5826250a6fd8",
            "country": "Brazil"
          },
          {
            "id": "e7175c70-1cb1-4f50-8055-5c7d7a1c6760",
            "name": "Investigational Site Number :0760007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "55",
            "organizationId": "1c2eb71d-8c1a-4512-9413-e1f5097f2eba",
            "country": "Brazil"
          },
          {
            "id": "cc025446-5eb9-4460-88c2-834e96a95264",
            "name": "Investigational Site Number :1240002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "56",
            "organizationId": "2964f659-9466-4969-ab78-bd763bebdc92",
            "country": "Canada"
          },
          {
            "id": "437f1d8a-af20-4844-94cf-680313d39a61",
            "name": "Investigational Site Number : 1240012",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "57",
            "organizationId": "3a63e641-43c5-4e7c-ada8-386e7d30ce8d",
            "country": "Canada"
          },
          {
            "id": "d7fffa39-b3d4-478a-beb1-9822dc46ece2",
            "name": "Investigational Site Number :1240014",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "58",
            "organizationId": "71840b3e-7c19-4d31-82e5-054d7bb8d7a8",
            "country": "Canada"
          },
          {
            "id": "9a4bb8f0-328f-4db3-8971-065cd3f05571",
            "name": "Investigational Site Number :1240005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "59",
            "organizationId": "3e66cc50-09b1-4da1-b09d-b0b5da6804c9",
            "country": "Canada"
          },
          {
            "id": "d633f3c9-30e0-4257-81cf-d1fab8d20ac8",
            "name": "Investigational Site Number :1240006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "60",
            "organizationId": "177f46b5-dc33-49c7-806d-25c9cd2f0d68",
            "country": "Canada"
          },
          {
            "id": "49b8bbd4-f3f0-4956-a2f4-97560fc70d05",
            "name": "Investigational Site Number :1240021",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "61",
            "organizationId": "dc962cbe-93b0-487a-ab6e-1f2ae7df15d3",
            "country": "Canada"
          },
          {
            "id": "9b8dd609-28b7-47c5-b51b-cc534f828f7e",
            "name": "Investigational Site Number :1520002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "62",
            "organizationId": "c4f35ae8-a449-4f1e-bf92-c77f0c53ed9b",
            "country": "Chile"
          },
          {
            "id": "df72a88d-d8d4-4f21-bd2a-d881e08ccc0f",
            "name": "Investigational Site Number :1520005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "63",
            "organizationId": "e5239829-1fec-4c22-9c88-ace940b903a7",
            "country": "Chile"
          },
          {
            "id": "bdcbc268-cd7f-4943-8ede-7482443cf12c",
            "name": "Investigational Site Number :1520001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "64",
            "organizationId": "4fed151d-989e-4a45-ac1f-e54e296c836c",
            "country": "Chile"
          },
          {
            "id": "00ee0cae-9cc2-46c0-9608-626463d17f7c",
            "name": "Investigational Site Number :1520003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "65",
            "organizationId": "fd3b4588-f5a3-41a5-a831-0ca8b68abc7b",
            "country": "Chile"
          },
          {
            "id": "6048f301-c192-4786-9d21-f6cd038a5f32",
            "name": "Investigational Site Number :1520006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "66",
            "organizationId": "a4fb15d7-2ee6-479b-ba3c-052786366d44",
            "country": "Chile"
          },
          {
            "id": "c3fc0847-c72a-47ff-a4d1-5719ed7aeb51",
            "name": "Investigational Site Number :1520004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "67",
            "organizationId": "ef2a177b-1957-4eee-8046-1a20756df63b",
            "country": "Chile"
          },
          {
            "id": "02c3cebc-9e12-4ef8-9ac4-3d9e8c62d4dd",
            "name": "Investigational Site Number :1910001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "68",
            "organizationId": "b70befb3-b45f-455f-988b-1e8daa5f7056",
            "country": "Croatia"
          },
          {
            "id": "a8777b33-356e-47e1-8807-fe3d01fb3b23",
            "name": "Investigational Site Number :1910002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "69",
            "organizationId": "7d0a2089-e2dc-409e-a1b5-735333a9bc96",
            "country": "Croatia"
          },
          {
            "id": "4d2dd5a9-560a-4a9d-9e00-9bad5f2ef0a4",
            "name": "Investigational Site Number :1910003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "70",
            "organizationId": "5dc1c2c4-2a04-42d6-8986-01b25dc435ec",
            "country": "Croatia"
          },
          {
            "id": "df4b684b-1c8f-47f4-b602-f19e7d50f8b3",
            "name": "Investigational Site Number :2030002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "71",
            "organizationId": "c24230b2-039a-438a-8a20-b6cb3c2cd486",
            "country": "Czechia"
          },
          {
            "id": "bdd529ab-c22a-4501-9f79-6084400345e5",
            "name": "Investigational Site Number :2030011",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "72",
            "organizationId": "e76ebce5-a71d-405b-9400-5a967cc13510",
            "country": "Czechia"
          },
          {
            "id": "e8eda3e7-0a7e-4389-9647-0de3b6435d3b",
            "name": "Investigational Site Number :2030001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "73",
            "organizationId": "7c43d38f-87e4-4761-9c43-fa7e50e6a279",
            "country": "Czechia"
          },
          {
            "id": "98dffa98-3f9d-4a89-a2b9-2abed8a208eb",
            "name": "Investigational Site Number :2030008",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "74",
            "organizationId": "4f2f463e-8c6f-470f-9a53-762d418d1be4",
            "country": "Czechia"
          },
          {
            "id": "61cffed8-951e-4f41-8544-7d70f181606c",
            "name": "Investigational Site Number :2030005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "75",
            "organizationId": "44fd72a6-91ed-42e7-ad48-12ac895e5aae",
            "country": "Czechia"
          },
          {
            "id": "7004d12a-8946-4ae1-93d5-d8f57f75b77c",
            "name": "Investigational Site Number :2500019",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "76",
            "organizationId": "c50691f2-e49d-4c90-9a2c-bc05b0f35d06",
            "country": "France"
          },
          {
            "id": "8eb770e6-4687-47c3-9942-e7e3b3f8013d",
            "name": "Investigational Site Number :2500018",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "77",
            "organizationId": "52163d6c-b034-4382-becf-110e249e4880",
            "country": "France"
          },
          {
            "id": "0d0ad32e-52c5-49a0-87b0-fcbbe1cd1867",
            "name": "Investigational Site Number :2500011",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "78",
            "organizationId": "85f8205c-e645-48a8-b3ae-84adce5acff3",
            "country": "France"
          },
          {
            "id": "b9ac0e99-d1a9-478c-b16f-2427f1253608",
            "name": "Investigational Site Number :2500005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "79",
            "organizationId": "d1fc4caf-3e15-4ba1-bfbe-1dbf2bbc4590",
            "country": "France"
          },
          {
            "id": "2be62826-afc5-40c7-856f-0bbf19cfc71a",
            "name": "Investigational Site Number :2500006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "80",
            "organizationId": "01e6cbc9-9125-405c-a26d-55996ae76208",
            "country": "France"
          },
          {
            "id": "3352ebc8-84da-4cb5-ab2a-1e5abfaeff9e",
            "name": "Investigational Site Number :2500010",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "81",
            "organizationId": "4aafda55-2ff7-4ef0-976d-9bcfad2fce5d",
            "country": "France"
          },
          {
            "id": "1d34d0d5-4dbe-47c9-af61-6b6520f33627",
            "name": "Investigational Site Number :2500002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "82",
            "organizationId": "f9834175-94c4-4b96-afdb-2cd220d141ad",
            "country": "France"
          },
          {
            "id": "32252342-5c0d-4cf5-9bd2-b7386bc8491d",
            "name": "Investigational Site Number :2500017",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "83",
            "organizationId": "60becd8e-5f1d-4204-9316-031ef19432ca",
            "country": "France"
          },
          {
            "id": "0ff24bbd-68dc-46d9-befe-8291ecd02e11",
            "name": "Investigational Site Number :2500007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "84",
            "organizationId": "683aaaa9-4203-4e46-a57a-4a979d34f2d3",
            "country": "France"
          },
          {
            "id": "c1ea0a27-459e-47c5-b5de-b386db19ff2a",
            "name": "Investigational Site Number :2500004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "85",
            "organizationId": "5be5f3b7-421a-4130-b79e-f45ebd122250",
            "country": "France"
          },
          {
            "id": "474a6d0e-78ef-49de-8f5d-bbd82157cb7a",
            "name": "Investigational Site Number :2500003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "86",
            "organizationId": "f3160375-fdb7-4401-bb0b-8b17a77d5c5d",
            "country": "France"
          },
          {
            "id": "8f4bb49f-90ef-4bfd-9162-d3ba01f113b0",
            "name": "Investigational Site Number :2500001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "87",
            "organizationId": "7b4b0f82-33b6-41df-94fb-8ddd95e0e2bc",
            "country": "France"
          },
          {
            "id": "7dab395c-dcb1-40a1-bc0d-37182ac063f6",
            "name": "Investigational Site Number :2760005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "88",
            "organizationId": "1020286a-692c-4016-b0ae-5f16cb043f7c",
            "country": "Germany"
          },
          {
            "id": "9ddebe66-5f41-4703-8549-b565f93351af",
            "name": "Investigational Site Number :2760015",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "89",
            "organizationId": "da4bf05b-920c-4b24-9f31-7b8c6742ee82",
            "country": "Germany"
          },
          {
            "id": "494cabf5-7cef-410e-88b0-070fbb89148b",
            "name": "Investigational Site Number :2760014",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "90",
            "organizationId": "18260bfa-b973-4346-8a77-64507dda99f9",
            "country": "Germany"
          },
          {
            "id": "8e3c2d33-03a7-4eeb-bf4e-2aa7e6e33eca",
            "name": "Investigational Site Number :2760020",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "91",
            "organizationId": "404e692a-dd37-4e66-997c-4f58b09ad209",
            "country": "Germany"
          },
          {
            "id": "5f5ccbfb-d7d0-42a7-b8a2-eca535537ac3",
            "name": "Investigational Site Number :2760012",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "92",
            "organizationId": "8913feb9-2c96-4383-b2e6-93e97430ac2e",
            "country": "Germany"
          },
          {
            "id": "5868c537-befa-4458-98ab-169a584a336f",
            "name": "Investigational Site Number :2760003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "93",
            "organizationId": "960d5a17-f1a4-4b55-86a0-6f332e2711fd",
            "country": "Germany"
          },
          {
            "id": "5b24f3ab-ea66-4c96-826f-4a4c2794eab8",
            "name": "Investigational Site Number :3000001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "94",
            "organizationId": "67fd9487-65ab-4e36-82c2-9fbf70818b26",
            "country": "Greece"
          },
          {
            "id": "2111e629-dbd1-4b1b-9b92-d66ae6deab24",
            "name": "Investigational Site Number :3000006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "95",
            "organizationId": "b73f0721-2a0e-4823-8b85-63d767cc1559",
            "country": "Greece"
          },
          {
            "id": "e572fb9f-0c99-41a9-b5f3-539945b8e11b",
            "name": "Investigational Site Number :3000002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "96",
            "organizationId": "18ef153a-7353-43ac-a8d7-a437df02741a",
            "country": "Greece"
          },
          {
            "id": "a6157c03-8ba9-48c4-b3a4-2710a73c4e98",
            "name": "Investigational Site Number :3000007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "97",
            "organizationId": "0ef3ba49-ab7b-4834-8049-0c6eab064ae6",
            "country": "Greece"
          },
          {
            "id": "8b69483a-a753-4ab9-be74-ac1e3b08910c",
            "name": "Investigational Site Number :3000009",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "98",
            "organizationId": "c1b8aa9f-27ff-4174-9b91-eaaa59971301",
            "country": "Greece"
          },
          {
            "id": "7cac338d-9ca8-4988-9148-2bbcabcded30",
            "name": "Investigational Site Number :3000004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "99",
            "organizationId": "3e6175c6-39ea-4afe-911d-198a20ede311",
            "country": "Greece"
          },
          {
            "id": "6b095446-c6cf-417f-a783-5cf671a93f9b",
            "name": "Investigational Site Number :3000003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "100",
            "organizationId": "6f18e36b-5669-4d46-b46c-00e5c835d7fa",
            "country": "Greece"
          },
          {
            "id": "ba763612-50f1-4ce8-b2f0-464db7f6c79c",
            "name": "Investigational Site Number :3480105",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "101",
            "organizationId": "f52dafe9-e955-4b59-93e8-8e1102ec71df",
            "country": "Hungary"
          },
          {
            "id": "0462c444-d4b6-490f-93a1-91a8dbad0d65",
            "name": "Investigational Site Number :3480102",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "102",
            "organizationId": "5ef328b9-f4b8-4f48-beab-b43e8a323737",
            "country": "Hungary"
          },
          {
            "id": "97ec6c90-c74c-4a0d-b2ae-7e59dd2f8253",
            "name": "Investigational Site Number :3480106",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "103",
            "organizationId": "13704691-d471-4b50-8ae2-43980bcea50e",
            "country": "Hungary"
          },
          {
            "id": "f16b26f1-6ee3-44ff-8463-fe6e21c12c3b",
            "name": "Investigational Site Number :3480103",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "104",
            "organizationId": "c4b89350-f88d-46e2-bacc-8f329ba3d8a4",
            "country": "Hungary"
          },
          {
            "id": "73e94090-574e-47d1-814b-7c576a376c9b",
            "name": "Investigational Site Number :3560005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "105",
            "organizationId": "697771ff-72e2-4656-ab79-04ed301a0b75",
            "country": "India"
          },
          {
            "id": "a11d7828-a7ee-4872-8d4c-48204944792d",
            "name": "Investigational Site Number :3560007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "106",
            "organizationId": "3e540d16-8440-4863-8a44-0d29bbe8b156",
            "country": "India"
          },
          {
            "id": "90953076-235d-4f4d-87e3-05dab57bbe7f",
            "name": "Investigational Site Number :3560008",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "107",
            "organizationId": "33dbea1f-77f3-488c-aa3d-60abd98ef8b0",
            "country": "India"
          },
          {
            "id": "966c07d6-56ef-4424-8213-0c7e4c3fb0f9",
            "name": "Investigational Site Number :3560002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "108",
            "organizationId": "5367a3b6-8901-4576-be21-76a9cedefdf8",
            "country": "India"
          },
          {
            "id": "18e47878-3b2a-4a4d-bcec-3046e7c3f9fd",
            "name": "Investigational Site Number :3560004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "109",
            "organizationId": "33c533fc-bcc0-4a52-8bd6-ecfa129ed81b",
            "country": "India"
          },
          {
            "id": "3f4ee0c3-9831-4c1d-a9d9-087fc7f6867e",
            "name": "Investigational Site Number :3760002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "110",
            "organizationId": "edebe32f-99ce-477c-81ac-1e804a62ad16",
            "country": "Israel"
          },
          {
            "id": "72e7fc6e-1dfe-4839-84a5-9c2d04c16f93",
            "name": "Investigational Site Number :3760003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "111",
            "organizationId": "93522913-fa98-405d-919f-a85f5b763640",
            "country": "Israel"
          },
          {
            "id": "7d5b819b-dec1-404a-87e2-e375b7220389",
            "name": "Investigational Site Number :3760006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "112",
            "organizationId": "cba63f1a-c6d8-4715-b080-76b5c6584b1c",
            "country": "Israel"
          },
          {
            "id": "1fb07a48-8670-4894-81c0-7909329208f9",
            "name": "Investigational Site Number :3760004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "113",
            "organizationId": "7114310b-1c3c-4e6b-853f-539111ac4c01",
            "country": "Israel"
          },
          {
            "id": "c173c837-03b1-4638-b242-b7c85d13a1c9",
            "name": "Investigational Site Number :3760001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "114",
            "organizationId": "2e34d7a5-58a8-4e0d-9016-a45369c151e9",
            "country": "Israel"
          },
          {
            "id": "11d22dc9-45cc-443d-8574-04ff322e7ab7",
            "name": "Investigational Site Number :4280002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "115",
            "organizationId": "12783a8b-867c-4613-8fe3-9f6584c188f9",
            "country": "Latvia"
          },
          {
            "id": "dd8b985c-a647-4286-96e2-0092455b8c0d",
            "name": "Investigational Site Number :4280003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "116",
            "organizationId": "42df3892-5bd3-40e3-96a4-131bd7e3c504",
            "country": "Latvia"
          },
          {
            "id": "db4c1fca-36c6-4e4c-8da0-ec704ab57135",
            "name": "Investigational Site Number :5280001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "117",
            "organizationId": "73f1a114-3378-4bfa-bb3b-664216c1570b",
            "country": "Netherlands"
          },
          {
            "id": "19b2d29b-903e-42a6-ae6d-af6fa798c62a",
            "name": "Investigational Site Number :5780002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "118",
            "organizationId": "ef6c5137-c0f0-45f0-92ba-aee1e65c91c8",
            "country": "Norway"
          },
          {
            "id": "d8405cfd-544c-4b79-88a9-b0ef540a719e",
            "name": "Investigational Site Number :5780001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "119",
            "organizationId": "b478cd0d-a059-4f96-9e6c-bd75fd8186e4",
            "country": "Norway"
          },
          {
            "id": "89860f9a-2c74-4492-88fd-9d366333bf16",
            "name": "Investigational Site Number :6200001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "120",
            "organizationId": "dfd74492-1bf4-43c4-bf78-bae54b3ece81",
            "country": "Portugal"
          },
          {
            "id": "90fea6fc-9f4d-4412-a483-b21b552e2905",
            "name": "Investigational Site Number :6200005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "121",
            "organizationId": "5dba1bb1-4d43-47df-a1b6-13443e2b01e4",
            "country": "Portugal"
          },
          {
            "id": "96612f1d-60ec-414c-819e-26a2e3cd089c",
            "name": "Investigational Site Number :6200011",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "122",
            "organizationId": "443a30fe-ef63-479c-b8e5-f97b359d5628",
            "country": "Portugal"
          },
          {
            "id": "86d5c335-b521-43eb-b9d4-b9ca8ecf39d2",
            "name": "Investigational Site Number :6200006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "123",
            "organizationId": "e2cabd3d-ac3c-42ca-bf9d-3bf6404f27d3",
            "country": "Portugal"
          },
          {
            "id": "34fdb516-6f23-45ad-8fd6-8b95cae5ca61",
            "name": "Investigational Site Number :6200002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "124",
            "organizationId": "f0b4b726-8202-4955-bdf4-20d0dd249b68",
            "country": "Portugal"
          },
          {
            "id": "42d7977b-7456-4dfa-857d-00fb1961c67f",
            "name": "Investigational Site Number :6200010",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "125",
            "organizationId": "976637c1-b37c-44d6-8fbd-784c8178417d",
            "country": "Portugal"
          },
          {
            "id": "c503102e-35b8-4016-b446-ada5d1165877",
            "name": "Investigational Site Number :6200004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "126",
            "organizationId": "73040cea-90c5-40f2-b02a-a33047ba6ee7",
            "country": "Portugal"
          },
          {
            "id": "3fa4a213-f1b5-4e82-beb9-db9bd5cf3a4c",
            "name": "San Juan MS Center-Site Number:8400015",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "127",
            "organizationId": "1c3cbd26-0bc8-4736-ba95-c58b527ce49f",
            "country": "Puerto Rico"
          },
          {
            "id": "6e4759fc-fc0b-46bc-96dc-df9814f20136",
            "name": "Investigational Site Number :6430006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "128",
            "organizationId": "4293273e-7b78-4d9f-94bf-2199dbee4266",
            "country": "Russia"
          },
          {
            "id": "9bcd803c-fe03-46b3-a694-97f2531d9b11",
            "name": "Investigational Site Number :6430013",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "129",
            "organizationId": "5a30e741-b6e8-4124-be9c-42d0f073e0a7",
            "country": "Russia"
          },
          {
            "id": "ae324758-8d56-4c84-8a0b-008951f20652",
            "name": "Investigational Site Number :6430001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "130",
            "organizationId": "39b2333b-7075-42e6-888e-e94529f677f4",
            "country": "Russia"
          },
          {
            "id": "20745594-6922-4f9a-9009-ec311e03aaae",
            "name": "Investigational Site Number :6430010",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "131",
            "organizationId": "48d044a0-6205-4abb-a49d-ead738a955e1",
            "country": "Russia"
          },
          {
            "id": "9c9f84ef-09b4-4a98-81ed-fd61d2832d63",
            "name": "Investigational Site Number :6430007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "132",
            "organizationId": "db87785a-7968-4303-bf07-7a0d839b0d39",
            "country": "Russia"
          },
          {
            "id": "57bf2f36-4133-4814-8422-fca4bb98563b",
            "name": "Investigational Site Number :6430005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "133",
            "organizationId": "fd6e8d41-6156-4309-af80-a051e35d3dbd",
            "country": "Russia"
          },
          {
            "id": "e7d0261d-be4b-462a-b6e8-eb22d25f9a9d",
            "name": "Investigational Site Number :6430003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "134",
            "organizationId": "0883197c-7491-441e-8596-600ffa5983a7",
            "country": "Russia"
          },
          {
            "id": "b90039af-7088-4526-83d7-8aa85da0937c",
            "name": "Investigational Site Number :6430014",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "135",
            "organizationId": "8d091fae-8ca0-4738-b59d-1468f256aa8e",
            "country": "Russia"
          },
          {
            "id": "6b247308-9dae-42f5-9505-04667a1cbd4e",
            "name": "Investigational Site Number :6430004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "136",
            "organizationId": "15442c23-d050-4791-955c-8f0d72c94f2f",
            "country": "Russia"
          },
          {
            "id": "d43abb8c-6d13-4f78-9504-802377658e51",
            "name": "Investigational Site Number :6430002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "137",
            "organizationId": "cbba5303-6f25-4f40-8d0c-ce6a5b5d0a4f",
            "country": "Russia"
          },
          {
            "id": "9b891e56-8a93-4231-9698-633f7dede5a1",
            "name": "Investigational Site Number :6430011",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "138",
            "organizationId": "ebb8fb30-9366-4a37-9796-9999888ba8d2",
            "country": "Russia"
          },
          {
            "id": "6a74c1bd-d4ad-40ac-82db-6d0a54dfb52a",
            "name": "Investigational Site Number :6430012",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "139",
            "organizationId": "431c3571-db07-4b94-a874-2d0be8b55072",
            "country": "Russia"
          },
          {
            "id": "1e708ffa-5a5b-4f05-9259-2797d5ed4d6c",
            "name": "Investigational Site Number :6880001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "140",
            "organizationId": "4ec5c28a-d7b0-4b72-bec6-0c66585cb7bb",
            "country": "Serbia"
          },
          {
            "id": "f9bf6865-9c23-4dae-8199-a06d0b62dae1",
            "name": "Investigational Site Number :6880003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "141",
            "organizationId": "b6acbb5f-0a65-488a-bcce-170f43c036a4",
            "country": "Serbia"
          },
          {
            "id": "ae46a130-7fd8-4bdb-922d-fa2a36ae8c11",
            "name": "Investigational Site Number :6880006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "142",
            "organizationId": "b67f5df8-22a0-44a1-8702-e60daa3b30ea",
            "country": "Serbia"
          },
          {
            "id": "d55590bc-edab-436e-94b0-f9c544c54f7e",
            "name": "Investigational Site Number :6880002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "143",
            "organizationId": "8273b8e6-db55-4161-89b9-d280178d7784",
            "country": "Serbia"
          },
          {
            "id": "7492cc61-de99-442c-851a-da0f8bc2ac62",
            "name": "Investigational Site Number :6880004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "144",
            "organizationId": "29756d1a-8332-40d3-95e7-c930dfbe47e2",
            "country": "Serbia"
          },
          {
            "id": "7b593a6d-8479-4d33-8f61-aca901c6fec2",
            "name": "Investigational Site Number :6880005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "145",
            "organizationId": "202c5a82-49d6-4f45-a288-e765f0065ced",
            "country": "Serbia"
          },
          {
            "id": "01d4f2ed-048b-4165-9a31-554fd37c6edc",
            "name": "Investigational Site Number :7030001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "146",
            "organizationId": "fc64c130-73d8-45f4-885e-8d0cd8cdd40e",
            "country": "Slovakia"
          },
          {
            "id": "7d67abba-db47-4dcb-ae14-797a153a1868",
            "name": "Investigational Site Number :7030002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "147",
            "organizationId": "82c5b900-69c0-4b18-a70b-3abb85e67696",
            "country": "Slovakia"
          },
          {
            "id": "80ac6801-2318-4fb6-8d19-05ba6d37ba1d",
            "name": "Investigational Site Number :7030004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "148",
            "organizationId": "01b524f0-3287-4e88-80cc-6f9f6a27fa90",
            "country": "Slovakia"
          },
          {
            "id": "a274d94f-d947-4dfb-afa9-cd7f279d0280",
            "name": "Investigational Site Number :4100001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "149",
            "organizationId": "4966a44e-0f3c-42a3-8d27-6c928cf1ca9a",
            "country": "South Korea"
          },
          {
            "id": "d0b1a858-6076-475c-bceb-e58f007d2ef8",
            "name": "Investigational Site Number :4100003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "150",
            "organizationId": "b5ebc3b9-9a31-40cb-9f3d-d52b6bfb9844",
            "country": "South Korea"
          },
          {
            "id": "eca2d50b-e6f5-4800-a400-2a478d3e36f2",
            "name": "Investigational Site Number :4100006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "151",
            "organizationId": "a480b29d-9ae3-408b-8076-e86fd0eca4ae",
            "country": "South Korea"
          },
          {
            "id": "5cdcdc6d-0af8-418c-9a03-eca66df1312d",
            "name": "Investigational Site Number :4100002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "152",
            "organizationId": "a976fe13-6ca6-414e-bccd-3762a137ed86",
            "country": "South Korea"
          },
          {
            "id": "a5c112bf-2387-4aca-adca-9c4b7f8531ae",
            "name": "Investigational Site Number :7240011",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "153",
            "organizationId": "d918f3ba-d0a3-45a6-9421-11c9e3404c0d",
            "country": "Spain"
          },
          {
            "id": "2791fb7c-3360-4054-ae49-4b6d1a472596",
            "name": "Investigational Site Number :7240006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "154",
            "organizationId": "911c0718-dd16-4669-8166-b3cd5bd2405d",
            "country": "Spain"
          },
          {
            "id": "8eff0399-1f57-47e5-950c-18a56e41b517",
            "name": "Investigational Site Number :7240009",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "155",
            "organizationId": "2c02ba7b-0520-40f0-88fd-c130b44600a9",
            "country": "Spain"
          },
          {
            "id": "7abc0713-5473-47de-8561-2fc724dd9a9f",
            "name": "Investigational Site Number :7240004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "156",
            "organizationId": "d085ddcf-68de-4db5-9607-a45c5efa3afc",
            "country": "Spain"
          },
          {
            "id": "f775e8d5-684a-4e96-8a02-6f5210a31ef1",
            "name": "Investigational Site Number :7240013",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "157",
            "organizationId": "b613a846-2bde-42f8-a150-1cd616a96215",
            "country": "Spain"
          },
          {
            "id": "e66cada2-af07-46bd-98dc-270bf4ca9fd4",
            "name": "Investigational Site Number :7240008",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "158",
            "organizationId": "69d62598-a339-49be-85dc-b0ac49e6511f",
            "country": "Spain"
          },
          {
            "id": "ffb2b830-a3e5-46a1-8169-e2b33d9c2ae3",
            "name": "Investigational Site Number :7240007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "159",
            "organizationId": "787186be-7c08-404c-8139-66fb14ff02fb",
            "country": "Spain"
          },
          {
            "id": "52ec4f12-d45d-4525-a963-0ee5ac2bf3af",
            "name": "Investigational Site Number :7240005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "160",
            "organizationId": "b2a73256-c46a-4b5a-b41d-036f2559fcf6",
            "country": "Spain"
          },
          {
            "id": "50b6d7af-73ba-446e-8445-88f93e982b85",
            "name": "Investigational Site Number :7240003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "161",
            "organizationId": "e7528012-324d-4f66-8f2d-13c33585f482",
            "country": "Spain"
          },
          {
            "id": "b1ba5620-95f0-499c-be28-927f993214f8",
            "name": "Investigational Site Number :7240001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "162",
            "organizationId": "f5cdd9c3-a928-406b-bf2d-92b043bd0d2f",
            "country": "Spain"
          },
          {
            "id": "50f39425-ae64-48c7-9d09-716d88c3f6af",
            "name": "Investigational Site Number :7240002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "163",
            "organizationId": "3de1a546-6943-4b52-a4ea-f17238ff00dd",
            "country": "Spain"
          },
          {
            "id": "8e87719e-835e-4e9b-b96a-b9b23fd7fb8c",
            "name": "Investigational Site Number :7240010",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "164",
            "organizationId": "0b9db1e7-5214-48b4-bf57-22fef5951248",
            "country": "Spain"
          },
          {
            "id": "4a71a850-1ee7-4b5f-9052-ce95e7ce1322",
            "name": "Investigational Site Number :7240012",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "165",
            "organizationId": "62f03c0a-9ec2-41f8-b869-9c48ef41ce86",
            "country": "Spain"
          },
          {
            "id": "04904837-8757-4c3f-a969-96adf1b1dd93",
            "name": "Investigational Site Number :7560003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "166",
            "organizationId": "21721cdb-e654-42b2-8d22-f81a232c9827",
            "country": "Switzerland"
          },
          {
            "id": "906904ec-8e64-4363-a6e7-41d83c33f4f1",
            "name": "Investigational Site Number :7560002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "167",
            "organizationId": "e0819f88-f362-4f7e-b68f-250f32d510a5",
            "country": "Switzerland"
          },
          {
            "id": "39e90b8b-6f30-4a7f-8af2-889f113035ad",
            "name": "Investigational Site Number :7560004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "168",
            "organizationId": "5aba3829-5e19-484a-a99b-5fafd4692021",
            "country": "Switzerland"
          },
          {
            "id": "07167f4c-86c2-4487-a1ce-df36318d4aaa",
            "name": "Investigational Site Number :7920002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "169",
            "organizationId": "22e7721d-bcea-47b5-8c69-82ef50aad302",
            "country": "Turkey (TÃ¼rkiye)"
          },
          {
            "id": "7b264d43-56aa-416e-bca4-18e2e24ae440",
            "name": "Investigational Site Number :7920005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "170",
            "organizationId": "9f86593d-bdde-41b3-9746-5b02b3f22501",
            "country": "Turkey (TÃ¼rkiye)"
          },
          {
            "id": "65f13a94-93ad-4fe6-af2d-822769e32a68",
            "name": "Investigational Site Number :7920006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "171",
            "organizationId": "4f538be1-bd44-41a6-8451-507e44d91aad",
            "country": "Turkey (TÃ¼rkiye)"
          },
          {
            "id": "ad518211-32af-4a27-ba60-03f3bdb91957",
            "name": "Investigational Site Number :7920004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "172",
            "organizationId": "ac8acbf8-dfb9-4a77-bcd8-ad7ba5bccafc",
            "country": "Turkey (TÃ¼rkiye)"
          },
          {
            "id": "6da2dc58-3b93-4d28-878d-43940d723f0c",
            "name": "Investigational Site Number :7920001",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "173",
            "organizationId": "760911cd-6a72-42fb-ac85-1bc80299bf85",
            "country": "Turkey (TÃ¼rkiye)"
          },
          {
            "id": "72e4351e-ddc3-4c74-a5b4-66c47eadbfa6",
            "name": "Investigational Site Number :7920003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "174",
            "organizationId": "46e6c1c6-7cb6-4cc0-b607-c586a1c02a77",
            "country": "Turkey (TÃ¼rkiye)"
          },
          {
            "id": "1a37100d-dde9-450e-bcd8-7cb632e60bad",
            "name": "Investigational Site Number :8040020",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "175",
            "organizationId": "d30db27b-d464-412c-a77e-57d91f7005f5",
            "country": "Ukraine"
          },
          {
            "id": "dc626cd6-3e9c-4921-b053-2ddb8af5f3b3",
            "name": "Investigational Site Number :8040002",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "176",
            "organizationId": "9085c3f1-c281-4887-b4e7-b3a603efe095",
            "country": "Ukraine"
          },
          {
            "id": "617bdd30-8262-4400-8fd7-7e3e54c28297",
            "name": "Investigational Site Number :8040019",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "177",
            "organizationId": "a0031450-e0e2-4c9c-a90a-44310c6bd61c",
            "country": "Ukraine"
          },
          {
            "id": "fc7647e9-fa05-42e6-8f67-e9ed3e924807",
            "name": "Investigational Site Number :8040005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "178",
            "organizationId": "704f3d82-3036-4254-b34b-a2fde53307b4",
            "country": "Ukraine"
          },
          {
            "id": "7c70ebe9-6865-44b2-a034-74bf94b08883",
            "name": "Investigational Site Number :8040022",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "179",
            "organizationId": "2850b3f4-b506-4b0a-a6c4-a3f6bfc8969f",
            "country": "Ukraine"
          },
          {
            "id": "80eeaa27-04ec-4b5b-8e6d-79006231bcc1",
            "name": "Investigational Site Number :8040018",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "180",
            "organizationId": "a9dc36fe-3d95-4fb0-b1fc-63b8cbef8119",
            "country": "Ukraine"
          },
          {
            "id": "be0eec74-3524-43f2-b16f-6836d13d800e",
            "name": "Investigational Site Number :8040007",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "181",
            "organizationId": "7e4911bd-b16e-4435-8407-c4851a3246d5",
            "country": "Ukraine"
          },
          {
            "id": "9bbe511b-c8df-471e-a0d1-8ffd84854d1a",
            "name": "Investigational Site Number :8040006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "182",
            "organizationId": "0a15f614-1bef-4679-b72a-a47d344a56c4",
            "country": "Ukraine"
          },
          {
            "id": "e31385b2-fdac-46f2-8a7c-9e4ded5aadb0",
            "name": "Investigational Site Number :8040003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "183",
            "organizationId": "c1c3bdba-21a1-44b9-a474-40b96217ab1e",
            "country": "Ukraine"
          },
          {
            "id": "404afa3a-e8f1-4f40-9647-f4a636a32be7",
            "name": "Investigational Site Number :8260003",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "184",
            "organizationId": "0ae39091-e8ba-4d4b-a00d-03407309197e",
            "country": "United Kingdom"
          },
          {
            "id": "1e131359-9cc6-41d6-bb13-5ef2edbb258c",
            "name": "Investigational Site Number :8260016",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "185",
            "organizationId": "4d025313-712b-4364-a9b4-834b18cda8f4",
            "country": "United Kingdom"
          },
          {
            "id": "cd572dfe-0db0-4ba1-b8e8-afb4c275cab2",
            "name": "Investigational Site Number :8260009",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "186",
            "organizationId": "fbb32e65-14bb-44aa-913b-9f4ecdf80933",
            "country": "United Kingdom"
          }
        ],
        "administrations": [
          {
            "id": "5c0f6179-363a-4051-bfbd-a9a1514c33a6",
            "name": "Administration of SAR442168",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "1b1ad188-7f4e-447e-8d8e-06e3151f36db",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "ceb105f7-e4f9-46eb-a4fc-80774186c82b",
            "name": "Administration of SAR442168 (Tolebrutinib)",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "ecbbec56-544e-4ccc-810b-3aa233c2d8ba",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "e204c622-9f94-42c9-998d-c573fa227ab9",
            "name": "Administration of Teriflunomide (Aubagio)",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "8f24ecce-9feb-4f14-978c-f0241cdc9302",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "48cd1f91-a654-4e24-a287-5be74cfc9bc5",
            "name": "Administration of Placebo",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "5981afe8-d5c9-4950-b0ec-3f701e433f61",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (AubagioÂ®) in participants with relapsing forms of multiple sclerosis (GEMINI 2)"
  },
  "administrations": [
    {
      "id": "10f17ef5-90e6-4ef3-bf60-4dadf85146f9",
      "name": "SAR442168 60 mg daily",
      "instanceType": "Administration",
      "dose": "60 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "540a12ed-f0d0-423d-84fc-0bda1db60aa7",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Approximately 18 to 36 months"
    },
    {
      "id": "0ea710aa-5640-4e92-8cbd-dfce06323a29",
      "name": "Teriflunomide 14 mg daily",
      "instanceType": "Administration",
      "dose": "14 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "2a1fba3b-371b-479a-835d-24fe5471bbeb",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Approximately 18 to 36 months"
    },
    {
      "id": "5685298f-6c4e-48bd-98fe-e69aca241bbb",
      "name": "Cholestyramine elimination procedure",
      "instanceType": "Administration",
      "dose": "8 g",
      "doseFrequency": "3 times daily",
      "route": {
        "id": "3c1e9acb-8bb0-43fa-8ae6-d6bddaaf5f2b",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "11 days"
    },
    {
      "id": "f7d86c91-b849-401c-8a88-f27c038c0ca4",
      "name": "MRI contrast administration",
      "instanceType": "Administration",
      "dose": "As per respective label",
      "doseFrequency": "Per scheduled MRI visits",
      "route": {
        "id": "52861c42-bcbd-4a99-8620-db2f0e39f5a1",
        "code": "Intravenous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intravenous",
        "instanceType": "Code"
      },
      "duration": "Single dose per scan"
    }
  ],
  "substances": [
    {
      "id": "077e8fa1-c1ad-455a-ac3d-c170d9af8a34",
      "name": "tolebrutinib",
      "instanceType": "Substance",
      "description": "Brutonâ€™s tyrosine kinase (BTK) inhibitor (SAR442168)"
    },
    {
      "id": "56a62e0e-3438-4ce9-a62c-96fe7724184c",
      "name": "teriflunomide",
      "instanceType": "Substance",
      "description": "Active substance in Aubagio"
    },
    {
      "id": "ebd87038-462b-47cc-8a64-efe66fa98478",
      "name": "cholestyramine",
      "instanceType": "Substance",
      "description": "Bile acid sequestrant used for drug elimination"
    }
  ],
  "studyDefinitionDocument": {
    "id": "5f75884f-129d-4cd6-89a0-900c7ce62459",
    "name": "A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (AubagioÂ®) in participants with relapsing forms of multiple sclerosis (GEMINI 2)",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "1",
    "versionDate": "20-Dec-2023",
    "contentIds": [
      "8bf139a4-a427-4ead-971b-facb658e8d2f",
      "cb376be6-aca9-40dd-aabc-48c0c5d111bb",
      "d15aa0d8-cb82-48be-910a-2e7f42d58b3e",
      "b0ac7f31-631c-4b36-90a8-38de32dd2335",
      "14374b30-a2b7-4d89-9af0-4bb4d1eab737",
      "2f837bd0-0273-45e4-8d7e-7cc2cbd53035",
      "bdcc93a8-eda3-4640-9fd1-25f8090e0759",
      "39fab4e4-d8be-430e-a9c4-0ea602519688",
      "15db8110-1358-4b03-97aa-afa0b97a8e7a"
    ]
  },
  "geographicScope": {
    "id": "82f61412-340b-4e60-af07-b4e3e5e8d87a",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "b81d0c22-6cc7-47fd-8157-22295428b663",
      "53c45572-97ad-41f7-85d3-ebefadf78222",
      "84f9c941-56df-4bbd-977d-6a56ccf31de3",
      "fec91fe2-e45a-4536-8657-30d08bbe8e3a",
      "84d17e5a-4a65-4fd1-8dae-625a71125eb3",
      "750c07c9-7019-4ee5-bb42-984b8aef4dbc",
      "2acb7347-7ae8-48ac-8bb2-41def78479f1",
      "42efe2d1-d36b-4a56-ad22-f6caf08dc262",
      "56f27b60-7a85-436d-b5b4-1a386010eb95",
      "57777e38-ecfe-4554-84b4-1840bbf197fd",
      "85feb9bc-bad0-49a1-9c40-894cdb9ab71b",
      "7211282c-02c0-4c50-a105-279ed2594f47",
      "48f026ab-f7e7-4d95-b99d-c0388aa3d53b",
      "24c8d50c-e25f-41a2-bcfd-7411815c3bb2",
      "a02196b0-fa2b-4c91-ade5-aa1d9289553e",
      "c4847397-f424-4c9c-a2af-c200719f73a4",
      "1b8e546d-23e3-4391-b971-ab206c0e7e77",
      "e38d7d99-0430-4d67-bfe2-1d96febddbec",
      "949d9950-0cf9-4064-9736-2f38a9a3140c",
      "35a937e1-4275-4ba1-9d06-82b0ee5e0c72",
      "0dc98b29-83de-456f-a145-50e2fc387a51",
      "0a0780db-731d-4887-bbb7-ddb7e4b2c8a5",
      "1d976f77-b831-43c3-8215-bb92df8a00cb"
    ],
    "regions": [
      "North America",
      "Europe",
      "South America",
      "Middle East"
    ]
  },
  "countries": [
    {
      "id": "b81d0c22-6cc7-47fd-8157-22295428b663",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    },
    {
      "id": "53c45572-97ad-41f7-85d3-ebefadf78222",
      "name": "France",
      "instanceType": "Country",
      "code": "FR"
    },
    {
      "id": "84f9c941-56df-4bbd-977d-6a56ccf31de3",
      "name": "Belgium",
      "instanceType": "Country",
      "code": "BE"
    },
    {
      "id": "fec91fe2-e45a-4536-8657-30d08bbe8e3a",
      "name": "Czech Republic",
      "instanceType": "Country",
      "code": "CZ"
    },
    {
      "id": "84d17e5a-4a65-4fd1-8dae-625a71125eb3",
      "name": "Greece",
      "instanceType": "Country",
      "code": "GR"
    },
    {
      "id": "750c07c9-7019-4ee5-bb42-984b8aef4dbc",
      "name": "Hungary",
      "instanceType": "Country",
      "code": "HU"
    },
    {
      "id": "2acb7347-7ae8-48ac-8bb2-41def78479f1",
      "name": "Latvia",
      "instanceType": "Country",
      "code": "LV"
    },
    {
      "id": "42efe2d1-d36b-4a56-ad22-f6caf08dc262",
      "name": "Netherlands",
      "instanceType": "Country",
      "code": "NL"
    },
    {
      "id": "56f27b60-7a85-436d-b5b4-1a386010eb95",
      "name": "Norway",
      "instanceType": "Country",
      "code": "NO"
    },
    {
      "id": "57777e38-ecfe-4554-84b4-1840bbf197fd",
      "name": "Portugal",
      "instanceType": "Country",
      "code": "PT"
    },
    {
      "id": "85feb9bc-bad0-49a1-9c40-894cdb9ab71b",
      "name": "Slovakia",
      "instanceType": "Country",
      "code": "SK"
    },
    {
      "id": "7211282c-02c0-4c50-a105-279ed2594f47",
      "name": "Spain",
      "instanceType": "Country",
      "code": "ES"
    },
    {
      "id": "48f026ab-f7e7-4d95-b99d-c0388aa3d53b",
      "name": "United Kingdom",
      "instanceType": "Country",
      "code": "GB"
    },
    {
      "id": "24c8d50c-e25f-41a2-bcfd-7411815c3bb2",
      "name": "Germany",
      "instanceType": "Country",
      "code": "DE"
    },
    {
      "id": "a02196b0-fa2b-4c91-ade5-aa1d9289553e",
      "name": "Denmark",
      "instanceType": "Country",
      "code": "DK"
    },
    {
      "id": "c4847397-f424-4c9c-a2af-c200719f73a4",
      "name": "Austria",
      "instanceType": "Country",
      "code": "AT"
    },
    {
      "id": "1b8e546d-23e3-4391-b971-ab206c0e7e77",
      "name": "Finland",
      "instanceType": "Country",
      "code": "FI"
    },
    {
      "id": "e38d7d99-0430-4d67-bfe2-1d96febddbec",
      "name": "Italy",
      "instanceType": "Country",
      "code": "IT"
    },
    {
      "id": "949d9950-0cf9-4064-9736-2f38a9a3140c",
      "name": "Poland",
      "instanceType": "Country",
      "code": "PL"
    },
    {
      "id": "35a937e1-4275-4ba1-9d06-82b0ee5e0c72",
      "name": "Romania",
      "instanceType": "Country",
      "code": "RO"
    },
    {
      "id": "0dc98b29-83de-456f-a145-50e2fc387a51",
      "name": "Sweden",
      "instanceType": "Country",
      "code": "SE"
    },
    {
      "id": "0a0780db-731d-4887-bbb7-ddb7e4b2c8a5",
      "name": "Brazil",
      "instanceType": "Country",
      "code": "BR"
    },
    {
      "id": "1d976f77-b831-43c3-8215-bb92df8a00cb",
      "name": "Israel",
      "instanceType": "Country",
      "code": "IL"
    }
  ],
  "ingredients": [
    {
      "id": "4374a9bd-5c6d-4daa-af03-fcf0c23d0908",
      "name": "Tolebrutinib",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "SAR442168"
    },
    {
      "id": "1c143379-4f6a-4bc3-b91d-8ca7a4abc974",
      "name": "Teriflunomide",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "Aubagio"
    },
    {
      "id": "9e28ce7e-98f1-4ad5-ad9c-2a55aab6a013",
      "name": "Gadolinium",
      "role": "Active",
      "instanceType": "Ingredient"
    },
    {
      "id": "9e03733e-f5fa-4636-9300-08c786e9a63f",
      "name": "Cholestyramine",
      "role": "Active",
      "instanceType": "Ingredient"
    }
  ],
  "strengths": [
    {
      "id": "c847e75c-7290-4442-a84a-0462f757b78c",
      "instanceType": "Strength",
      "value": 60,
      "unit": "mg",
      "numerator": {
        "value": 60,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "tablet"
      }
    },
    {
      "id": "0493dcf7-5976-4596-98da-8152852f6cb2",
      "instanceType": "Strength",
      "value": 14,
      "unit": "mg",
      "numerator": {
        "value": 14,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "tablet"
      }
    },
    {
      "id": "2846eddb-193a-4548-b825-4e4a89fb6f30",
      "instanceType": "Strength",
      "value": 8,
      "unit": "g",
      "numerator": {
        "value": 8,
        "unit": "g"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "e34d19ab-34e7-4f7f-91d2-6d3e7db5211e",
      "name": "Screening to Randomization",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "7878bee6-21db-4b56-b52b-e0f9ea96858a",
      "toElementId": "19853648-2277-47ec-938d-48544748f8b4",
      "text": "Participant must meet all inclusion and no exclusion criteria; IMP must be available at site."
    },
    {
      "id": "11acfc36-4d33-4427-88b2-1de20d68e590",
      "name": "Definitive Discontinuation for Pregnancy",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Female participant becomes pregnant or wishes to become pregnant."
    },
    {
      "id": "691295de-29c1-4887-9711-3fa8fe330980",
      "name": "Temporary Discontinuation for Cytopenia",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Follow safety algorithm for neutropenia and thrombocytopenia per Appendix 6."
    },
    {
      "id": "b3c771b2-1341-4bea-a0ce-d20d7b8d7b73",
      "name": "Rescue Therapy Allowance",
      "instanceType": "TransitionRule",
      "transitionType": "Rescue Therapy",
      "text": "Short term use (3 to 5 days) of glucocorticoids for MS relapse treatment is allowed."
    }
  ],
  "documentContentReferences": [
    {
      "id": "02dbae0b-c41a-4e6c-be06-52738d314b72",
      "name": "Accelerated Elimination Procedure",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.1.1",
      "sectionTitle": "Noninvestigational medicinal product",
      "description": "Reference for procedures following intervention period for male and female participants"
    },
    {
      "id": "c2711a1d-f631-45f2-a463-20bc671d6d58",
      "name": "Contraception Appendix",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.4",
      "sectionTitle": "Appendix 4: Contraceptive Guidance and Collection of Pregnancy Information",
      "description": "Reference for highly effective contraceptive methods"
    },
    {
      "id": "b579befe-2603-416f-b7e8-e2d12b1bba8e",
      "name": "Country-specific Contraception",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.11",
      "sectionTitle": "Appendix 9: Country-Specific Requirements",
      "description": "Reference for specific requirements in UK, Germany, and Denmark"
    },
    {
      "id": "1dd939da-d792-4b45-9b47-1965aeac6c28",
      "name": "Informed Consent Appendix",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.1.3",
      "sectionTitle": "Appendix 1: Regulatory, Ethical, and Study Oversight Considerations",
      "description": "Reference for legally authorized representative signature requirements"
    },
    {
      "id": "8c7e90a1-9ffd-4ba0-a563-81b0670971e7",
      "name": "TB Screening",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.2",
      "sectionTitle": "Appendix 2: Clinical Laboratory Tests",
      "description": "Description of screening tests for Tuberculosis"
    },
    {
      "id": "5a4d3aaf-6745-4334-9e1a-0e7047fba529",
      "name": "Liver Safety Algorithm",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.6",
      "sectionTitle": "Appendix 6: Liver and other safety: actions and follow-up assessments",
      "description": "Reference for IMP discontinuation criteria and safety algorithms"
    },
    {
      "id": "88f7626e-2946-42ee-82c5-c350ceb3e0f7",
      "name": "Drug Metabolism Appendix",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.8",
      "sectionTitle": "Appendix 8A: Examples of Drugs with a Potential to Change SAR442168 Metabolism",
      "description": "List of prohibited CYP3A inducers and CYP2C8 inhibitors"
    }
  ],
  "commentAnnotations": [
    {
      "id": "7709fbf9-5c51-4d3b-8621-e15ee0c93a0b",
      "text": "Sanofi corporation organized and existing under the laws of France is the ultimate parent of a worldwide group of affiliates",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Sponsor Name",
      "pageNumber": 1
    },
    {
      "id": "cb459bb7-0db2-4727-ad7c-7476ecf3dd69",
      "text": "All assessments shall be done as designated in this SoA unless not permitted according to local regulations.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "1.3 Schedule of Activities (SoA)",
      "pageNumber": 25
    },
    {
      "id": "70d6e676-659c-4e5e-9960-ccc58f5d42cb",
      "text": "The interval between screening and randomization visits can range from 11 days (minimum) to 28 days (maximum).",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schedule of Activities - Footnote a",
      "pageNumber": 25
    },
    {
      "id": "769c98a7-642e-483c-aaff-ce92ea4de067",
      "text": "The Investigator may consult with an infectious disease expert if required, eg, test results are unclear or there is a suspicion of false positive test results.",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "5.2 Exclusion Criteria - E 02",
      "pageNumber": 42
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "3c71cfc5-bfa7-44f0-b719-59aea713a337",
      "versionNumber": "1 (electronic 15.0)",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2023-12-20",
      "description": "Include liver function test monitoring guidance and update co-medication guidance per Health Authority request",
      "amendmentNumber": "11"
    },
    {
      "id": "d81c1a8b-1f98-41c8-9768-10ede39a1188",
      "versionNumber": "1 (electronic 14.0)",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2023-11-17",
      "description": "Amended Clinical Trial Protocol 10",
      "amendmentNumber": "10"
    },
    {
      "id": "dadef2e4-83c1-4745-8563-a72697b729c6",
      "versionNumber": "1 (electronic 1.0)",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-02-28",
      "description": "Original Protocol",
      "amendmentNumber": "Original"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "9907e2a3-cfbd-4f14-aa46-6683ae20621b",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "affectedSection": "Section 1.3 - Schedule of Activities (SoA)",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Addition of Week 3 visit header and associated footnote."
    },
    {
      "id": "cb0066bf-65f3-4891-b04d-16fdd01b8ff7",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "affectedSection": "Section 10.6 - Appendix 6: Liver and other safety",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Incorporation of liver function test monitoring guidance previously held in the study manual."
    },
    {
      "id": "934e1d4f-5204-4a25-9deb-8a9201abd65c",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "affectedSection": "Section 10.8 - Appendix 8A: Drug Metabolism",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Updates to co-medication guidance and metabolic interaction references."
    },
    {
      "id": "04c90f5e-065f-4190-a631-287da3ea9d36",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "affectedSection": "Section 10.11.4 - Country-specific provisions",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "New section for US, Brazil, and Israel regarding FDA partial clinical hold conditions and prohibited inhibitors."
    },
    {
      "id": "9ba6e16a-9599-419b-9eeb-c4b1355b6713",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "affectedSection": "Throughout Document",
      "impactLevel": "Administrative",
      "instanceType": "StudyAmendmentImpact",
      "description": "Reformatting, editorial changes, and updates to table of contents and abbreviations."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "85c8de5e-a49f-4287-84bc-49b350eb6714",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "reasonText": "Include liver function test monitoring guidance previously in the study manual",
      "category": "Safety",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "e42032ca-31d6-4ff4-91d4-9394375a2455",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "reasonText": "Update co-medication guidance as per Health Authority request",
      "category": "Regulatory",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "784a682d-1b1b-488b-b93e-a83b2724302f",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "reasonText": "Correction of error regarding modafinil classification as a weak rather than moderate CYP3A inducer",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "d0e5bd71-1d11-4922-a092-2c50ac2d454d",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "reasonText": "Updated guidance for CYP inhibitors/inducers based on information from DDI study",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "806a46a2-c75d-4244-a7c3-91fef821af95",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.3",
      "afterText": "Week 3 added in the visit header and in footnote â€˜lâ€™",
      "summary": "Added Week 3 visit to the Schedule of Activities."
    },
    {
      "id": "ca355df0-6775-4fca-aa6b-42742b795bd9",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "10.8",
      "beforeText": "Reference to www.druginteractioninfo.org",
      "afterText": "Recommendation for the sites to refer to the drug label for metabolic interactions",
      "summary": "Removed external website reference for drug interactions."
    },
    {
      "id": "ca880f2a-4ffb-499d-b54a-8be9ef444492",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "changeType": "Deletion",
      "instanceType": "StudyChange",
      "sectionNumber": "10.8",
      "beforeText": "modafinil in the list of moderate CYP3A inducers",
      "afterText": "modafinil removed from the list",
      "summary": "Removed modafinil from prohibited list as it is a weak inducer."
    },
    {
      "id": "83f5344a-1676-4c15-80bb-57ddabb22628",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "10.8",
      "beforeText": "rifabutin in the list of potent CYP3A inducers",
      "afterText": "rifabutin moved to the list of moderate CYP3A inducers",
      "summary": "Reclassified rifabutin based on DDI study data."
    },
    {
      "id": "6ccfda56-ffc1-49a0-b84c-e8be9a193be7",
      "amendmentId": "0d071cfa-810f-4705-a44c-5480ff6b1033",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "10.11.4",
      "afterText": "Prohibited use of CYP3A and CYP2C8 inhibitors and restriction of grapefruit/grapefruit juice",
      "summary": "Added specific restrictions for sites following FDA partial clinical hold."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "issues_found"
  }
}